Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

PHARMACOLOGY AND TOXICOLOGY

PHARMACOLOGY AND TOXICOLOGY References 1. (a) Wilson, R. H.; Deeds, F., and Rather, L. J.: Toxicity Studies on Subtilin , Proc. Soc. Exper. Biol. & Med. 78:517, 1951. 2. (b) Sacks, L. E.: Subtilin Considered as a Germicidal Surface Active Agent , Antibiotics & Chemother. 2:79, 1952. 3. (c) Kaiser, E.: Über die Wirkung von Subtilin und Subtilin Tyrothricin Kombination in Vivo et in Vitro , Wien. med. Wchnschr. 101: 254, 1951. 4. (d) Quinn, L.: Globicin, a New Antibotic from Bacillus Subtilis , Antibotics & Chemother. 2:215, 1952. 5. (e) Micks, D. W.; Whitney, D. M., and Anigstein, L.: Effect of Sanguinin, an Antibacterial Agent from Blood, on Streptococcal Infection in Mice , Proc. Soc. Exper. Biol. & Med. 78:573, 1951. 6. (f) Davisson, J. W.; Tanner, F. W., Jr.; Finlay, A. C., and Solomons, I. A.: Rimocidin , Antibotics & Chemother , 1:289, 1951. 7. (g) Wachter, R. F.; Bohonos, N., and Quakenbusch, F. W.: Xanthellin: An Antibiotic with Anti-Brucella Activity , Antibotics & Chemother 1:399, 1951. 8. (h) Kenner, B. A., and Murray, F. J.: Gliotoxin Studies , Antibotics & Chemother 1:509, 1951. 9. (i) Berger, J.; Rachlin, A. I.; Scott, W. E.; Sternbach, L. H., and Goldberg, M. W.: Antibiotics from Streptomyces , J. Am. Chem. Soc. 73:5295, 1951. 10. (j) Dimick, K. P.: Hemolytic Action of Gramicidin and Tyrocidin , Proc. Soc. Exper. Biol. & Med. 78:782, 1951. 11. (k) Hall, E. A.; Kavanagh, F., and Asheshov, I. N.: Action of 45 Antibacterial Substances on Bacterial Viruses , Antibiotics & Chemother. 1:369, 1951. 12. (l) Paul, H. E.; Harrington, C. M.; Bender, R. C., and Briggs, W. P.: Resistance and Cross Resistance of Bacteria to Nitrofurans , Proc. Soc. Exper. Biol. & Med. 79:199, 1952. 13. (m) Asnis, R. E.; Cohen, F. B., and Gots, J. S.: Studies on Bacterial Resistance to Furacin , Antibiotics & Chemother. 2:123, 1952. 14. (n) Bender, R. C., and Paul, H. E.: Metabolism of the Nitrofurans , J. Biol. Chem. 191:217, 1951. 15. (o) Asnis, R. E., and Gots, J. E.: Studies on the Action of Nitrofurans on Bacterial Enzyme Systems , Arch Biochem. 30:35, 1951. 16. (p) Pritikin, R. I., and Duchon, M. L.: Eye Conditions Similar to Those Produced by Modern Warfare , Mil. Surgeon 109:706, 1951. 17. (q) Mierecki, G. P.: Bacteriological Examination of Eye Ointments , Klin. Monatsbl. Augenh. 110:606, 1951. 18. (r) Raper, K. P.: The Progress of Antibiotics , Scient. Am. 186:49, 1952. 19. (s) Hull, F. E.: Management of Eye Casualties in the Far East Command During the Korean Conflict: A Preliminary Report , Tr. Am. Acad. Ophth. 50:885, 1951. 20. (t) Wheat, R. P.; Zuckerman, A., and Rautz, L. H.: Infection Due to Chromobacteria , A. M. A. Arch. Int. Med. 88:461, 1951. 21. (u) Killough, J. H. M.; Magill, G. B., and Smith, R. C.: Treatment of Amebiasis with Fumagillin , Science 115:71, 1952.Crossref 22. (v) McCowen, M. C.; Callender, M. E., and Lawlis, J. F., Jr.: Fumagillin (H-3), a New Antibiotic with Amebicidal Properties , Science 113:202, 1951.Crossref 23. (w) Raubitscheck, F.; Acker, R. F., and Waksman, S. A.: Production of an Antifungal Agent of the Fungicidin Type by Streptomyces Aureus , Antibiotics & Chemother. 2:179, 1952. 24. (x) Hazen, E. L., and Brown, R.: Fungicidin, an Antibiotic Produced by a Soil Actinomycete , Proc. Soc. Exper. Biol. & Med. 76:93, 1951. 25. (y) Takano, Y.: The Therapeutic Value of Guanofuracin in Various Diseases of the Outer Eye , Acta Soc. ophth. Jap. 55:399, 1951. 26. (z) Dubois-Poulsen, A.; Dubois-Verlière, and Tibi, A.: The Salts of Propionic Acid in External Affections of the Eye , Ann. ocul. 184:894, 1951. 27. (a′) Melodia, C.: Sodium Propionate in the Treatment of External Ocular Infections , Ann. ottal. e clin. ocul. 77:359, 1951. 28. (b′) Heatley, N. G.; Kelly, B. K., and Smith, N.: Assay of Micrococcin, an Almost Insoluble Antibiotic , J. Gen. Microbiol. 6:30, 1952. 29. (c′) Wilson, A. T., and Rosenblum, H.: The Antistreptococcal Property of Milk , J. Exper. Med. 95:25, 1952. 30. (a) Novak, M., and Taylor, W.: Prophylactic Treatment of Tetanus with Procaine Penicillin , Proc. Inst. Med. Chicago 18:61, 1950. 31. (b) Pelner, L., and Waldman, S.: Sodium Dehydrocholate , Postgrad. Med. 2:49, 1952. 32. (c) Dailsir, G., and Weinstein, L.: Streptococcal Bacteriostatic Antibody in Patients Treated with Penicillin , Proc. Soc. Exper. Biol. & Med. 78:160, 1951. 33. (d) Weinberg, E. D.: Influence of Various Sources of Nitrogen on the Activity of Antibiotics , Antibiotics & Chemother. 2:130, 1952. 34. (e) Elias, W.; Price, A., and Merrianon, H. J.: A New Repository Form of Penicillin , Antibiotics & Chemother. 1:491, 1951. 35. (f) Longacre, A. B.: Compenamine , Antibiotics & Chemother. 1:223, 1951. 36. (g) Siegal, S.: Allergy to Penicillin-O in Management of Penicillin Sensitivity , Am. J. Med. 11:196, 1951. 37. (h) Díaz-Rivera, R. S.; Ramirez, E.; Pons, E. R., and Torregrosa, M. V.: Management of Tetanus , J. A. M. A. 147:1635, 1951. 38. (i) Burnell, J. M., and Kirby, W. M. M.: Effectiveness of a New Compound, Benemid, in Elevating Serum Penicillin Concentrations , J. Clin. Invest. 30:697, 1951. 39. (j) Harkavy, J.: Cardiovascular Allergy Due to Penicillin, Sulfadiazine and Bacterial Sensitization , J. Allergy 23:104, 1952. 40. (k) Spring, M.: Purpura and Nephritis After Administration of Procaine Penicillin , J. A. M. A. 147:1139, 1951. 41. (l) Adair, C. V.; Woodin, W. G., and Bunn, P. A.: Clinical and Pharmacological Studies with Allyl Mercaptomethyl Penicillin (Penicillin-O) , Am. J. Med. 11:188, 1951.Crossref 42. (m) Epstein, M. M., and Allen, J. R.: Treatment of Neurosyphilis with Penicillin Combined with Artificial Fever Therapy , A. M. A. Arch. Dermat. & Syph. 63:419, 1951. 43. (n) Robinson, H. M., and Robinson, H. M., Jr.: Antibiotics in Early Syphilis , A. M. A. Arch. Dermat. & Syph. 63:687, 1951. 44. (o) Hahn, R. D.: Treatment of Neurosyphilis with Penicillin and with Penicillin Plus Malaria , Am. J. Syph. 35:433, 1951. 45. (p) Lepper, M. H.; Rodriguez, J.; Blatt, N., and Spies, H. W.: Use of Dibenzylethylenediamine Penicillin , Antibiotics & Chemother. 2:175, 1952. 46. (q) Flippen, H.; Matteucci, W. V.; Schimmel, N. H.; Bartholomew, E. L., and Boger, W.: The Hydroiodide of Diethylaminoethyl Ester of Penicillin-G, Neo-Penil , Antibiotics & Chemother. 2:208, 1952. 47. (r) Kadison, E. R.; Ishihara, S. J., and Waters, T.: A New Form of Penicillin with Antiallergic Properties , Am. Pract. & Digest Treat. 2:411, 1951. 48. (s) Jensen, K. A.; Dragsted, P. J.; Nielsen, E. J., and Fredrickson, E: Leocillin , Acta path. et microbiol. scandinav. 28:407, 1951. 49. (t) Jensen, K. A.; Dragsted, P. J.; Møller, P., and Kaier, I.: Investigations on Penicillin Preparations and Dosage , Ugesk. læger 112:1075, 1950. 50. (u) Tada, H.: Comparison of Various Bases for Penicillin Ointment , Acta Soc. ophth. jap. 55:405, 1951. 51. (v) Kennedy, R. J., and Vogel, A. W.: Intraocular Inflammation with the Gas-Forming Bacillus Clostridium Welchii , A. M. A. Arch. Ophth. 45:528, 1951. 52. (a) Sorsby, A.; Ungar, J., and Bailey, M. L.: Streptomycin in Ophthalmology , Brit. M. J. 1:19, 1952. 53. (b) Bignell, J. L.: Infection of the Cornea with B-Pyocyaneus , Brit. J. Ophth. 35:419, 1951. 54. (c) Kmonicek, J.: Interesting Complication in the Streptomycin Treatment of Iridocyclitis , Ceskoslov. Ofth. 7:343, 1951. 55. (d) Payne, H. G.; Spencer, J. N., and Schultz, F. H., Jr.: Oral Toxicity of Bacitracin , Antibiotics & Chemother. 1:387, 1951. 56. (e) Eggers, H.: Clinical Experience with Bacitracin , Am. J. Ophth. 34:1706, 1951. 57. (f) Leopold, I. H.: Pharmacology and Toxicology , A. M. A. Arch. Ophth. 46:159, 1951. 58. (h) Birge, H. L.: The Diagnosis of Ocular Mycotic Infection , A. M. A. Arch. Ophth. 46:225, 1951. 59. (i) Emerson, R.: Molds and Men , Scient. Am. 186:28, 1952. 60. (i) Longacre, A. B., and Waters, R. M.: Parenteral Bacitracin in Surgical Infections , Am. J. Surg. 81:599, 1951 61. (k) Observations on Absorption of Bacitracin , Surg. Gynec. & Obst. 92:913, 1951. 62. (l) Friedberg, C. K., and Bader, M. E.: Acute Staphylococcic Endocarditis Cured with Aid of Bacitracin , J. A. M. A. 147:46, 1951. 63. (m) Kadison, E. R., and Borovsky, M. P.: The Treatment of Infantile Diarrhea with a New Combination of Antibiotics , J. Pediat. 38:576, 1951. 64. (a) Killough, V. H.: Aureomycin in Tropical Disease , Proc. Roy. Soc. Med. 45:109, 1952. 65. (b) Karp, A., and Snyder, J. C.: In Vitro Effect of Aureomycin, Terramycin and Chloramphenicol on Typhus Rickettsiae , Proc. Soc. Exper. Biol. & Med. 79:216, 1952. 66. (c) Snelling, C. E., and Johnson, R.: Aureomycin in Cross Infection , Canad. M. A. J. 66:6, 1952. 67. (d) Furth, F. W.; Coulter, M. P., and Howland, J. W.: Effect of Aureomycin and Terramycin on the X-Radiated Rat , Am. J. Path. 28:185, 1952 68. Effect of Aureomycin on the Radiation Syndrome in Dogs , Furth Am. J. Path. 28:25, 1952. 69. (e) Rosenthal, S. M.; Lillie, R. D., and Vender, E.: Influence of Chemotherapy on the Delayed Deaths Following Extensive Burns in Mice , Federation Proc. 11:387, 1952. 70. (f) Schoenbach, E. B.; Spencer, H. C., and Monnier, J.: Treatment of H. Influenzae Meningitis with Aureomycin and Chloramphenicol , Am. J. Med. 12:263, 1952. 71. (g) McVay, L. V., Jr., and Carroll, D. S.: Aureomycin in the Treatment of Systemic North American Blastomycosis , Am. J. Med. 12:289, 1952. 72. (h) Reiches, A. J.: Antibiotic Sensitivity and Moniliasis , A. M. A. Arch. Int. Med. 64:604, 1951. 73. (i) Ayre, J. E.: Regression of Anaplastic Lesions of the Cervix Using Aureomycin , Antibietics & Chemother. 1:339, 1951. 74. (j) Brainerd, H. D.; Bruin, H. P.; Meikeljohn, G., and O'Gara, L.: Studies on the Clinical Pharmacology of Aureomycin , Antibietics & Chemother. 1:447, 1951. 75. (k) Forbes, S. D.: Retinal Detachments, Spontaneous Reattachments Following Aureomycin Therapy , Am. J. Ophth. 34:1597, 1951. 76. (l) Pritkin, R. I., and Duchon, M. L.: Herpes Zoster Ophthalmicus , Am. J. Ophth. 34:893, 1951. 77. (m) McVay, L. B., Jr., and Sprunt, D. H.: Study of Moniliasis and Aureomycin Therapy , Proc. Soc. Exper. Biol. & Med. 78:759, 1951. 78. (n) Biscay, V. M., and Carbonell, A. F.: Brucellosis Laboratory Autoinfection , Rev. méd. cubana 62:151, 1951. 79. (o) McVay, L. V., Jr.; Guthrie, F., and Sprunt, D. H.: Aureomycin in Treatment of Actinomycosis , New England J. Med. 245:91, 1951. 80. (p) Rais, D. B.: Aureomycin in the Koch-Weeks Conjunctivitis , Bull. Soc. ophth. France 1:34, 1951. 81. (q) Murty, K. K.: Aureomycin and Streptomycin in Ophthalmic Practice , Indian M. Guide 4:195, 1951. 82. (r) Mercier, A.: Aureomycin in Ocular Therapy , Bull. Soc. ophth. France 1:101, 1951. 83. (s) Trope, R. A.: Topical Aureomycin in Ophthalmology , Sind M. J. 24:117, 1951. 84. (t) Manheim, S. D.: Anorectal Complications of Aureomycin, Terramycin and Chloromycetin Therapy , New York J. Med. 51:2759, 1951. 85. (a) Lloyd, E. L.: Aplastic Anemia Due to Chloramphenicol , Antibiotics & Chemother. 2:1, 1952. 86. (b) Clarke, P. S.: Chloramphenicol in Treatment of Cutaneous Anthrax , Brit. M. J. 86:1952. 87. (c) Burnell, J. M., and Kirby, W. M. M.: Serum Concentrations of Chloramphenicol Following Intravenous and Intramuscular Administration , J. Lab. & Clin. Med. 38:234, 1951. 88. (d) Usadek, H. E.; Curtis, W. P., and Mill, E. J.: Skin Eruption Due to Chloramphenicol , A. M. A. Arch. Dermat. & Syph. 64:217, 1951. 89. (e) Romansky, M. J.; Olansky, S.; Taggert, S. R.; Landmen, G. S., and Robin, E. D.: Chloromycetin in the Treatment of Various Types of Syphilis , Am. J. Syph. 35:234, 1951. 90. (f) White, J. S.: The Newer Antibiotics with Special Reference to Chloromycetin , South African M. J. 25:527, 1951. 91. (g) Doggart, J. H.: Chemotherapy in Ophthalmology , Practitioner 1:66, 1951. 92. (h) Berens, C., and Gulyash, J.: Recent Advances in the Use of Antibiotics and Steroids in Ophthalmology , Quart. Rev. Ophth. 7:1, 1951. 93. (i) Brown, S. R.: Hodgkin's Disease Controlled by Chloromycetin , Hawaii M. J. 10:356, 1951. 94. (j) Kelley, R. S.; Hunt, A. D., Jr., and Tashman, S. G.: Studies on the Absorption and Distribution of Chloramphenicol , Pediatrics 8:362, 1951. 95. (k) van Gelderen, F. T.: Experiences with Chloromycetin , Maandschr. kindergeneesk. 19:172, 1951. 96. (l) Littman, N. L.; Paul, J. S., and Fusillo, M. H.: Treatment of Pulmonary Actinomycosis with Chloramphenicol , J. A. M. A. 148:608, 1952. 97. (m) Tomaszewski, W.: Findings on Lingual Scrapings Taken During Treatment with Chloramphenicol and Aureomycin , J. Clin. Path. 4:393, 1951. 98. (n) Roberts, W.: Chloramphenicol in Ocular Infections , Am. J. Ophth. 34:1081, 1951. 99. (o) Willcox, R. R.: Chloromycetin in the Treatment of Chancroid , Brit. M. J. 1:509, 1951. 100. (a) Gustafson, G. E., and Kaletsky, S.: Effect of Oral Terramycin Prior to Whole Body Irradiation , Proc. Soc. Exper. Biol. & Med. 78:489, 1951. 101. (b) Reiss, E.; Pulaski, E. J.; Artz, C. P., and Schaeffer, J. R.: Terramycin in Treatment of Peritonitis , A. M. A. Arch. Surg. 64:5, 1952. 102. (c) Miura, Y.; Nakamura, Y.; Matsudaira, H., and Komeiji, T.: The Mode of Action of Terramycin , Antibiotics & Chemother. 2:152, 1952. 103. (d) Greene, H.: Terramycin in the Treatment of Trichomonas , Antibiotics & Chemother. 2:119, 1952. 104. (e) Castaneda, M. R., and Ibarra, G. G.: Terramycin in the Treatment of Human Brucellosis , Antibiotics & Chemother. 2:86, 1952. 105. (f) Ruiz-Sanchez, F.; Casillas, J.; Paredes E, M.; Velasquez, J., and Riebeling, R.: Terramycin in the Treatment of Malaria , Antibiotics & Chemother. 2:51, 1952. 106. (g) Caffery, E. L.; Alford, B. H., and Musselman, M. M.: Levels of Terramycin in the Serum After Administration of Terramycin Base , Antibiotics & Chemother. 2:72, 1952. 107. (h) Hall, H. E.; Hightower, J. A.; Diaz Rivera, R.; Byrne, R. J.; Smadel, J. E., and Woodward, T. E.: Evaluation of Antibiotic Therapy in Human Leptospirosis , Ann. Int. Med. 35:981, 1951. 108. (i) Wolman, B., and Hozel, A.: Terramycin in Infections of Infants and Children , Brit. M. J. 1:419, 1952. 109. (j) Mitsui, Y.; Tanaka, C.; Iwashige, Y., and Yamashita, K.: Terramycin in Ophthalmology , Antibiotics & Chemother. 1:253, 1951. 110. (k) Luttermoser, G. W.; Haskins, W. T.; Coleman, N., and Jumper, J. R.: Experimental Endamoeba Histolytica Infections in Rabbits with Reference to Chemotherapy , Am. J. Trop. Med. 1:162, 1952. 111. (l) Lepri, G.: The Action of Terramycin in Some Ocular Infections , Rass. ital. ottal. 20:15, 1951. 112. (m) Town, A. E.: Ophthalmic Use of Terramycin , Am. J. Ophth. 34:725, 1951. 113. (n) Azzolini, A., and Foldi, S.: Researches on the Tolerance and on the Action of Terramycin in the Eye , Gior. ital. oftal. 4:114, 1951. 114. (o) Linnen, H. J.: Experimental Research in Animal Eyes with Crystalline Terramycin Hydrochloride , Klin. Monatsbl. Augenh. 118:561, 1951. 115. (p) Liebowitz, D., and Schwartz, H.: Leptospiral Infection Treated with Terramycin , J. A. M. A. 147:122, 1951. 116. (q) Frisk, A. R., and Tunevall, G.: In Vitro Activity, Absorption and Excretion of Terramycin , Scandinav. J. Clin. & Lab. Invest. 3:175, 1951. 117. (r) Poure, A. M.; Snyder, M. J., and Minor, J. U., Jr.: Use of Terramycin in Rocky Mountain Spotted Fever , Bull. Johns Hopkins Hosp. 89:30, 1951. 118. (s) Willcox, R. R.: Anorectal Syndrome and Other Mild Side-Effects of Terramycin , Lancet 2:154, 1951. 119. (t) Miyamura, S., and Kanazawa, Y.: Cup Assay of Terramycin , Antibiotics J. 4:470, 1951. 120. (u) Lepri, G., and Capalbi, S.: Influence of Terramycin on the Course of Experimental Ocular Tuberculosis , Brit. J. Ophth. 36:75, 1952. 121. (v) Lepri, G., and Sicca, G. T.: Observations on the Penetration of Terramycin into the Aqueous Humor Following Local Administration , Arch. ottal. 55:383, 1951. 122. (w) Cannon, E. J.; Nichols, A. C., and Leopold, I. H.: Studies on the Intraocular Penetration and Toxicity of Terramycin , A. M. A. Arch. Ophth. 47:344, 1952.Crossref 123. (x) Douvas, N. G.; Featherstone, R. M., and Braly, A. E.: Role of Terramycin in Ophthalmology , A. M. A. Arch. Ophth. 46:57, 1951.Crossref 124. (y) Sandusky, W. R.; Keeble, C. F.; Wharton, W. P., and Taylor, R. N.: Prophylactic Use of Terramycin in Experimental Clostridii welchii Infection , Surgery 31:365, 1952. 125. (z) Cannon, E. J., and Leopold, I. H.: Effectiveness of Terramycin and Other Antibiotics Against Experimental Bacterial Keratitis , A. M. A. Arch. Ophth. 47:426, 1952.Crossref 126. (a) Florestano, H. J., and Bahler, M. E.: Antifungal Properties of the Polymyxins , Proc. Soc. Exper. Biol. & Med. 79:141, 1952. 127. (b) Light, A.; Tornaben, J. A., and De Beer, E. J.: A Comparison of the Renal Effects of Polymyxin A, Aerosporin, and a Mercurial Diuretic , Antibiotics & Chemother. 2:63, 1952. 128. (c) Jackson, D. M.; Lowbury, E. J. L., and Topley, E.: Pseudomonas Pyocyanea in Burns , Lancet 2:137, 1951. 129. (d) Brownlee, G.; Bushby, S. R. M., and Short, E. I.: The Chemotherapy and Pharmacology of the Polymyxins , Brit. J. Pharmacol. 7:170, 1952. 130. (e) Lieberman, D., and Jawetz, E.: Treatment of Chronic Shigella Infection in Children with Oral Polymyxins , Pediatrics 8:249, 1951. 131. (f) Jawetz, E.: Infections with Pseudomonas Aeruginosa Treated with Polymyxin B , A. M. A. Arch. Int. Med. 89:90, 1952. 132. (g) Keating, S. B.: A Note on the Use of Antibiotics in the Treatment of Infections with Gram-Negative Bacilli , M. J. Australia 2:709, 1951. 133. (a) Hambre, D. M.; Pansy, F. E.; Lapedes, D. N.; Perlman, D.; Bayou, A. P., and Donovick, R.: Some Characteristics of the Neomycins , Antibiotics & Chemother. 2:135, 1952. 134. (b) Dutcher, J. D.; Hosansky, N.; Donin, M. N., and Wintersteiner, O.: Neomycin B and C and Some of Their Degradation Products , J. Am. Chem. Soc. 73:1384, 1952. 135. (c) McVay, L., Jr.; Laird, R. L., and Stern, T. N.: Neomycin in Treatment of Human Amebiasis , Am. J. M. Sc. 223:20, 1952. 136. (d) Livingood, C. S.; Nilasena, S.; King. W. C.; Stevenson, R. A., and Mullins, J. F.: Pyogenic Infection Treated with Neomycin , J. A. M. A. 148:334, 1952. 137. (e) Kile, R. L.; Rockwell, E. M., and Schwarz, J.: Use of Neomycin in Dermatology , J. A. M. A. 148:339, 1952. 138. (f) Vogel, A. W.; Leopold, I. H., and Nichols, A.: Neomycin: Ocular Penetration and Toxicity , Am. J. Ophth. 34:1357, 1951. 139. (g) Forbes, A. M.: A Clinical Evaluation of Neomycin in Different Bases , South. M. J. 45:235, 1952. 140. (h) Ditkowsky, S.; Goldman, A., and Goldin, M.: Pseudomonas Meningitis Treated with Neomycin , Pediatrics 9:101, 1952. 141. (a) Collier, H. D. J., and Waterhouse, P. O.: The Activities of Some 2-4-Diaminopteridines and Sulphathiazole Against Streptococcus Foecalis and Staphylococcus Aureus , Brit. J. Pharmacol. 7:161, 1952. 142. (b) Quinn, L. H., and Burnside, R. M.: Gantrisin , Eye, Ear, Nose & Throat Month. 30:81, 1951. 143. (c) Hagerman, D. D., and Franzblau, S. A.: Gantrisin® (Sulfisoxazole)-Induced Granulocytopenia , J. A. M. A. 147:1657, 1951. 144. (d) Hawking, F., and Laurence, J. S.: The Sulfonamides , New York, Grune & Stratton Inc., 1951. 145. (e) Findlay, G. M.: Recent Advances in Chemotherapy , Ed. 3, Philadelphia, The Blakiston Company, 1950. 146. (f) Hatschek, G.: Further Contributions to the Subjunctival Use of Prontosil , Klin. Monatsbl. Augenh. 118:629, 1951. 147. (g) Reiser, K. A.: Studies on Sulfonamide Therapy , Klin. Monatsbl. Augenh. 118: 508, 1951. 148. (h) Belousova, R. V.: Complications of the Eye During the Administration of Disulfone , Vestnik. oftal. 30:42, 1951. 149. (i) Kahan, A., and Torok, E.: Functional Intoxication of the Retina by Sulfonamides , Szemészet ophth. Hungary 88:85, 1951. 150. (j) Klinvanskaya, A. A.: The Toxic Influence of the Sulfonamide Drugs on the Eye , Vestnik. oftal 30:32, 1951. 151. (k) Leskowitz, S.; Fox, C. L., Jr., and Raymond, S.: Isolation and Identification of Para-Aminobenzoic Acid Produced by Staphylococci Resistant to Sulfonamides , J. Exper. Med. 95:247, 1952. 152. (a) Bacterial Versatility, editorial , Ann. Int. Med. 36:185, 1952. 153. (b) Miller, C. P.: New Problems in the Treatment of Infectious Disease , Ann. Int. Med. 35:763, 1951. 154. (c) Waisbren, B. A.; Carr, C., and Struxness, D.: Role of Inhibitors and Mutations in Antibiotic Resistance of Escherichia Coli , Antibiotics & Chemother. 1:54, 1951. 155. (d) Bacterial Resistance in Chemotherapy, editorial , Brit. M. J. 425:1952. 156. (e) Mitchison, D. A.: Segregation of Streptomycin-Resistant Variants of Mycobacterium Tuberculosis into Groups with Characteristic Levels of Resistance , J. Gen. Microbiol. 5:596, 1951. 157. (f) Eagle, H.: Further Observations on the Zone Phenomenon in the Bactericidal Action of Penicillin , J. Bact. 62:663, 1951. 158. (g) Kaipainen, W. J.: Relationship of Bacteria to Streptomycin , Ann. Med. exper. et biol. fenniae 29, (Supp. 1) , 1951. 159. (h) Gocke, E. M., and Finland, H.: Cross Resistance to Antibiotics , J. Lab. & Clin. Med. 38:719, 1951. 160. (i) Chandler, C. A.; Davidson, V. Z.; Long, P. H., and Monnier, J. J.: Studies on Resistance of Staphylococci to Penicillin , Bull. Johns Hopkins Hosp. 89:81, 1951. 161. (j) Monnier, J. J., and Schoenbach, E. B.: Resultant Sensitivity of Microorganisms to Various Antibiotics , Antibiotics & Chemother. 1:472, 1951. 162. (k) Superinfections During Antibiotic Treatment, editorial , Brit. M. J. 1:537, 1952. 163. (l) Bierman, H. R., and Jawetz, E.: Effect of Prolonged Administration of Antibiotics on the Human Fecal Flora , J. Lab. & Clin. Med. 37:394, 1951. 164. (m) Abbott, J. D.; Fernando, H. V. J.; Gurling, K., and Meade, B. W.: Pulmonary Aspergillosis Following Post-Influenza Bronchopneumonia Treated with Antibiotics , Brit. M. J. 1:523, 1952. 165. (n) Tomaszewski, T.: Side-Effects of Chloramphenicol and Aureomycin with Special Reference to Oral Lesions , Brit. M. J. 1:388, 1951. 166. (o) Garrod, L. P.: Reactions of Bacteria to Chemotherapeutic Agents , Brit. M. J. 1:205, 1951.Crossref 167. (p) Pappenfort, R. B., and Schnall, E. S.: Moniliasis in Patients Treated with Aureomycin , A. M. A. Arch. Int. Med. 88:729, 1951.Crossref 168. (q) Ainslie, D.: Treatment of Blepharitis , Brit. M. J. 2:582, 1951.Crossref 169. (r) Keefer, C. S.: Alterations in Normal Bacterial Flora of Man and Secondary Infections During Antibiotic Therapy , Am. J. Med. 11:665, 1951.Crossref 170. (s) Editorial: Sensitivity of Bacterial Antibiotics , New England J. Med. 245:868, 1951.Crossref 171. (t) Heatherman, N. E., and Clapper, W. E.: Relation Between Resistance to Chemotherapeutic Agents and other Biochemical Properties of Some Viridans Streptococci and Enterococci , J. Lab. & Clin. Med. 38:881, 1951. 172. (u) Lemke, C. E., and Gates, L. E.: Distribution and Antibiotic Sensitivity in 55 Strains of Klebsiella Pneumoniae , J. Lab. & Clin. Med. 38:899, 1951. 173. (v) Dowling, H. F.: Antibiotics , Illinois M. J. 100:992, 1951. 174. (w) Metabolic Aspects of Streptomycin Resistance, editorial , J. A. M. A. 147:1361, 1951. 175. (x) English, A. R., and McCoy, E.: Gross Comparison of Streptomycin Sensitive and Streptomycin Resistant Micrococcus Pyogenes , J. Bact. 62:19, 1951. 176. (y) Clancy, C. F.: The Sensitivity of Freshly Isolated Bacteria to Neomycin , J. Bact. 61:715, 1951. 177. (z) Cross Resistance to Antibiotics, editorial , J. A. M. A. 148:470, 1952. 178. (a′) Gezon, H. M., and Fasan, D. M.: Cross Resistance of Streptococci to Five Streptomyces Antibiotics , Science 114:422, 1951. 179. (b′) Fusillo, M. H., and Romansky, M. J.: The Simultaneous Increase in Resistance of Bacteria to Aureomycin and Terramycin , Antibiotics & Chemother. 1:107, 1951. 180. (c′) Reiss, E.; Pulaski, E. J.; Amspischer, W. H., and Contreras, A. A.: Penicillin Sensitivity of Staphylococci , New England J. Med. 246:611, 1952. 181. (d′) Summero, G. A. C.: Penicillin-Resistant Staphylococci , Lancet 1:135, 1952. 182. (e′) Sherris, J. C., and Florey, M. E.: Relation of Penicillin Sensitivity in Staphylococci to Clinical Manifestation of Infection , Lancet 1:309, 1951. 183. (f′) Lepnik, M. J.; Kligman, A. M., and Strauss, R.: Antibiotics and Fungous Infections , J. Invest. Dermat. 18:247, 1952. 184. (a) Miles, C. P.; Coleman, V. R.; Gunnison, J. B., and Jawetz, E.: Antibiotic Synergism , Proc. Soc. Exper. Biol. & Med. 78:738, 1951. 185. (b) Shlaes, W. H.; Volini, I. F.; Felsenfeld, O., and Burbridge, E.: The Antibacterial Action of Combinations of Penicillin and Sulfonamides , Antibiotics & Chemother. 2:21, 1952. 186. (c) Pratt, R., and Dufrenoy, J.: Mechanism of Antibiotic Action and Trends in Antibiotic Chemotherapy , Texas Rep. Biol. & Med. 9:76, 1951. 187. (d) Gunnison, J. P.: Speck, R. S., and Bruff, J. A.: Studies on Antibiotic Synergism and Antagonism , Antibiotics & Chemother. 1:259, 1951. 188. (e) Bliss, E. A.; Warth, P. T., and Long, P. H.: Studies on Combinations of Antibiotics , Bull. Johns Hopkins Hosp. 91:49, 1952. 189. (f) Jawetz, E.; Gunnison, J. P.; Speck, R. S., and Coleman, B. R.: Studies on Antibiotic Synergism and Antagonism , A. M. A. Arch. Int. Med. 87:349, 1951. 190. (g) Armstrong, C. W. J., and Larner, A. E.: The Effect of Combinations of Antibiotics , J. Lab. & Clin. Med. 37:584, 1951. 191. (h) Robbins, W. C., and Tompsett, R.: Results of Combined Therapy with Penicillin and Streptomycin , Am. J. Med. 10:278, 1951. 192. (i) Spink, W. W.; Hall, W. H., and Magoffin, R.: Follow-up Study of Therapy in 48 Culturally Proved Cases of Brucellosis: Streptomycin, Sulfadiazine, Aureomycin and Chloramphenicol , A. M. A. Arch. Int. Med. 88:419, 1951. 193. (j) Wallach, R., and Pomerantz, N.: Combined Antibiotic Therapy , A. M. A. Arch. Int. Med. 88:840, 1951. 194. (k) Jawetz, E., and Gunnison, J. B.: Studies on Antibiotic Synergism and Antagonism: A Scheme of Combined Antibiotic Action , Antibiotics & Chemother. 2:243, 1952. 195. (l) Wellman, W. E.: Combinations of Antibiotics in Treatment of Infectious Disease , Minnesota Med. 34:537, 1951. 196. (m) Panzardi, D., and Pasca, G.: The Action of Bacitracin and Streptomycin Associated with Penicillin on the Bacterial Flora of the Conjunctiva , Boll. ocul. 31:79, 1951. 197. (n) Antibiotic Combinations, Editorial ; New England J. Med. 245:989, 1951. 198. (o) Finland, M.; Jackson, G. G.; Kass, E. H.; Haight, T. H., and Womack, C. R.: Some Recent Observations of Staphylococcal Infections in Relation to Antibiotic Therapy , Tr. A. Am. Physicians 64:343, 1951. 199. (p) Hugo, D.: Infections in and About the Eye and Their Treatment by the Antibiotics , Proc. Transvaal Mine and Med. Officers' A. 31:17, 1951. 200. (q) Jawetz, E.: Gunnison, J. B., and Speck, R. S.: Antibiotic Synergism and Antagonism , New England J. Med. 245:966, 1951. 201. (r) Antibiotic Antagonism, Editorial , J. A. M. A. 147:513, 1951. 202. (s) Speck, R. S.; Jawetz, E., and Gunnison, J. B.: Studies on Antibiotic Synergism and Antagonism , A. M. A. Arch. Int. Med. 88:168, 1951. 203. (t) Meleney, F. L.; Johnson, B. A., and Teng, P.: The Importance of Laboratory Data in the Treatment of Surgical Infections by Antibiotics, with Particular Reference to the Synergistic Action of Penicillin and Bacitracin , J. Mt. Sinai Hosp. 18:257, 1952. 204. (u) Lepri and Capalbi: Influence of Terramycin on Course of Ocular Tuberculosis , Brit. J. Ophth. 36:75, 1952. 205. Ghanahy, S. S.: Ophthalmia Neonatorum , Antiseptic 48:626, 1951. 206. Clark, S. G., and Culler, A. M.: Aureomycin as Prophylaxis Against Ophthalmia Neonatorum , Am. J. Ophth. 34:840, 1951. 207. Leff, N.: Prevention of Ophthalmia Neonatorum by Flushing with Sterile Water , West. J. Surg. 59:176, 1951. 208. Toth, Z.: Is the Crede Method in Ophthalmia Neonatorum Untimely and Superfluous? Klin. Monatsbl. Augenh. 118:613, 1951. 209. Prophylaxis of Ophthalmia Neonatorum, editorial , J. A. M. A. 148:122, 1952.Crossref 210. O'Brien, D.: Terramycin in the Prophylaxis of Ophthalmia Neonatorum , Lancet 1:347, 1952.Crossref 211. Culler, A. M., and Clark, S. G.: Aureomycin as Prophylaxis Against Ophthalmia Neonatorum , Am. J. Ophth. 9:82, 1951. 212. Lehrfeld, L.: Prophylaxis of Ophthalmia Neonatorum , Eye, Ear, Nose & Throat Month. 30:367, 1951. 213. (a) Geller, H. O., and Thygeson, P.: Aureomycin, Chloromycetin, Terramycin in Experimental Herpes Simplex Virus Infections , Am. J. Ophth. 34:165, 1951. 214. (b) Polemann, G.: Inoculation Vaccinia: Treatment with Aureomycin , Med. Welt 20:2747, 1951. 215. (c) Holmes, W. J.: An Epidemic of Conjunctivitis in Hawaii , Hawaii M. J. 11:94, 1951. 216. (d) Benedek, P.: Herpes Zoster Ophthalmicus Treated with Aureomycin , Mil. Surgeon 108:481, 1951. 217. (e) Ciotola, G.: Urea in the Treatment of Herpes Keratitis , Boll. ocul. 34:17, 1951. 218. (f) Latte, B., and Pino, G.: Experimental Infection of the Human Conjunctiva by the Virus of Newcastle Disease in Volunteers , Boll. ocul. 30:553, 1951. 219. (g) Voisin, J.; Dismut, G.; Reboul, R., and Garcie-Bouran: Aureomycin in Herpes Zoster , Bull. Soc. ophth., France 1:29, 1951. 220. (h) Schaeffer, G., and Svendsen, I. B.: Herpes Zoster Healed with Aureomycin and Chloramphenicol , Ugesk. læger 113:1537, 1951. 221. (i) Hallett, J. W.; Leopold, I. H.; Vogel, A. W.; Cannon, E. J., and Steinmetz, C. C.: Treatment of Experimental Herpes Simplex Keratitis in the Rabbit , A. M. A. Arch. Ophth. 46:33, 1951. 222. (j) Bubbage, N. F.: Therapy of Herpes Zoster with Chloromycetin , M. J. Australia 1:399, 1951. 223. (k) Kass, E. H.; Aycock, R. R., and Finland, M.: Chemical Evaluation of Aureomycin and Chloramphenicol in Herpes Zoster , New England J. Med. 246:167, 1952. 224. (l) Carter, A. B.: Investigation into Effects of Aureomycin and Chloramphenicol in Herpes Zoster , Brit. M. J. 1:987, 1951. 225. (m) Eaton, M. D.; Levenson, C. G., and Perry, M.: Inhibition of the Growth of Viruses in the Chick Embryo by Aromatic Diamidines , J. Immunol. 68:1, 1952. 226. (a) Waccache, R.: Clinical Trial of Aureomycin in Trachoma , Am. J. Ophth. 34:1591, 1951. 227. (b) Pasca, G., and Altier, I. A.: Contribution to Tracheoma Therapy with Chloramphenicol , Día méd. 23:1866, 1951. 228. (c) Vautien, P.: Trial of Aureomycin in Trachoma , Rev. internat trachome 28:202, 1951. 229. (d) Zeppa, R.: High Doses of Penicillin in Trachoma , Riv. ital. tracoma 3:23, 1951. 230. (e) Tani, M.: The Mass Treatment of Trachoma by the Internal Use of Sulfathiazole and Its Late Effect , Acta Soc. ophth. Jap. 55:38, 1951. 231. (f) Mazalan, T.: Recurrences of Trachoma Treated with Sulfonamides , Českoslov. ofth. 7:149, 1951. 232. (g) Benmussa, A.: A Trial of Collective Antitrachoma Treatment , Rev. internat. trachome 28:344, 1951. 233. (h) Berkovitch, M. E.: A Course of Treatment for Trachoma , Vestnik. oftal 30:21, 1951. 234. (i) Thygeson, P.: The Trachoma Psittacosis, Lymphogranuloma Venereum Group of Viruses, the Chlamydozoaceae , Am. J. Ophth. 34:7, 1951. 235. (j) Siniscal, A. A.: The Sulfonamides and Antibiotics in Trachoma , J. A. M. A. 148:637, 1952.Crossref 236. (k) Andrade, L. D.: Trachoma Diagnosis and Treatment , Brit. J. Ophth. 35:601, 1951.Crossref 237. (l) Sztrilich, L.: Modern Treatment of Trachoma , Szemészet ophth. Hungary 88:148, 1951. 238. (m) Marin Amat, M.: Present State of the Treatment of Trachoma with Sulfonamides and Antibiotics , Arch. Soc. oftal. hispano-am. 11:641, 1951. 239. (n) Otian, R. G.: Treatment of Trachoma in Children with Hypodermic Injections of 0.5% Sulfidone , Vestnik. oftal. 30:15, 1951. 240. (o) Pavkovic-Burgarski, D.: Treatment of Trachoma with Sulfonamides and Penicillin , Srpski Arhiv. celok. lek. 49:145, 1951. 241. (p) Sakon, H.; Kohn, M., and Raphael, R.: Results Obtained with Aureomycin and Chloramphenicol in the Treatment of Trachoma , Rev. internat. trachoma 28:309, 1951. 242. (q) Ching, R.: Aureomycin in the Treatment of Trachoma , A. M. A. Arch. Ophth. 45:657, 1951.Crossref 243. (r) Beauvieux, J.; Julien, R. J., and Chabot, J.: Pure Florid Trachoma Treated by Aureomycin , Rev. internat trachome 28:269, 1951. 244. (s) Sarkies, J. W. R.: Aureomycin in Trachoma , Brit. J. Ophth. 35:549, 1951.Crossref 245. (t) Ng-van-hieu: Trial of Treatment of Granular Trachoma in Its Different Stages with Aureomycin Drops and Ointment , Ann. ocul. 184:938, 1951. 246. (u) Lavat: Aureo- mycin in the Treatment of Trachoma , Semaine Méd. 27:899, 1951. 247. (v) del Rio Cabanes, J. L.: Aureomycin in Trachoma , Arch. Soc. oftal. hispano-am. 11:635, 1951. 248. (w) Marin Enciso, E.: A Contribution to the Treatment of Trachoma with Aureomycin , Arch. Soc. oftal. hispano-am. 11:628, 1951. 249. (x) Geraci, P.: A Preliminary Note in the Use of Terramycin in Trachoma and Other Ocular Diseases , Riv. ital. tracoma 2:55, 1951. 250. (y) Choumakov, M. P.; Fradkin, M. Y.; Schlykova, B. D.; Avakyan, A. A., and Zaytzeva, N. S.: A New Method of Treatment of Trachoma with Chloromycin® and Syntomycin , Vestnik. oftal. 30:3, 1951. 251. (z) Bierent, P.: Treatment of Trachoma with Aromatic Diamidines , Rev. internat, trachome 28:324, 1951. 252. (a′) Sezer, F. N.: Tarsitis as a Cause of Sulfonamide Resistance in Trachoma , Am. J. Ophth. 34:1508, 1951. 253. (b′) Mitsui, Y.: Tanaka, C.; Toya, H.; Iwashige, Y., and Yamashita, J.: Terramycin in the Treatment of Trachoma , A. M. A. Arch. Ophth. 46:235, 1951.Crossref 254. (c′) Cosgrove, K. W.: The Control of Trachoma , South. M. J. 45:152, 1952.Crossref 255. (a) Straub, W.: Experiences with Ocular Toxoplasmosis , Klin. Monatsbl. Augenh. 118:43, 1951. 256. (b) Wilder, H. C.: Toxoplasma Chorioretinitis in Adults , A. M. A. Arch. Ophth. 47:425, 1952.Crossref 257. (c) Gingrich, W. D., and Darrow, E. M.: Effect of Endochin on Experimental Toxoplasmosis , Am. J. Trop. Med. 31:12, 1951. 258. (d) Kass, E., and Steen, E.: Aureomycin in Treatment of Acute Experimental Toxoplasmosis in Rabbits , Acta path. et microbiol. Scandinav. 28:165, 1951.Crossref 259. (a) Ross, E. J.: Transfer of Non-Electrolytes Across the Blood-Aqueous Barrier , J.: Physiol. 112:229, 1951. 260. (b) Langham, M.: Affecting the Penetration of Antibiotics into the Aqueous Humor , Brit. J. Ophth. 35:614, 1951.Crossref 261. (c) Leopold, I. H.; Nichols, A., and Vogel, A. W.: Penetration of Chloramphenicol into the Eye , A. M. A. Arch. Ophth. 44:22, 1950.Crossref 262. (d) Leopold, I. H.: Clinical Trial with Chloramphenicol in Ocular Infections , A. M. A. Arch. Ophth. 45:44, 1951.Crossref 263. (a) Gurta, S. P.: Modern Therapy in Ophthalmic Diseases , Antiseptic 49:95, 1952. 264. (b) Duca, C. J.; Rothlauf, M. V., and Saidi, J. V.: Studies on Experimental Tuberculosis , Antibiotics and Chemother. 2:16, 1952. 265. (c) Grunberg, E., and Leiwant, B.: Antitubercular Activity in Vivo of Nicotinaldehyde Thiosemicarbazone and Its Isomers , Proc. Soc. Exper. Biol. & Med. 77:47, 1951. 266. (d) Cruickshank, A. H., and Mitchell, G. W., Jr.: Myocardial, Hepatic and Renal Damage Resulting from Para-Aminobenzoic Acid Therapy , Bull. Johns Hopkins Hosp. 88:211, 1951. 267. (e) Hoggarth, E., and Martin, A. R.: Thiosemicarbazones in the Chemotherapy of Tuberculosis , Brit. J. Pharmacol. 6:454, 1951. 268. (f) Hasegawa, S.: Cepharanthine , Jap. J. Exper. Med. 20:69, 1949. 269. (g) Ebina, T.; Kanho, I., and Yamasaki, T.: Cepharanthine , Tohoku J. Exper. Med. 52:67, 1949. 270. (h) Steel, S. J.: Acquired Sensitivity to Para-Amino-Salicylic Acid , Brit. M. J. 1:415, 1952.Crossref 271. (i) Oatway, W. H., and Reding, F.: An Expanded Use of Streptomycin and PAS , Arizona Med. 8:26, 1951. 272. (j) Lorker, J.: Streptokinase in Tuberculous Meningitis , Lancet 1:1334, 1951. 273. (k) New Antituberculosis Drugs, editorial , J. A. M. A. 148:1034, 1952.Crossref 274. (l) Grunberg, E., and Schnitzer, R. J.: Studies on the Activity of Hydrazine Derivatives of Isonicotinic Acid in the Experimental Tuberculosis of Mice , Quart. Bull. Sea View Hosp. 13:3, 1952. 275. (m) Bernstein, J.; Lott, W. A.; Steinberg, P. A., and Yale, H. L.: Chemotherapy of Experimental Tuberculosis: Isonicotinic Acid Hydrazide and Related Compounds , Am. Rev. Tuberc. 65:357, 1952. 276. (n) Stenken, W., Jr., and Wolinsky, E.: Antituberculous Properties of Hydrazines of Isonicotinic Acid , Am. Rev. Tuberc. 65:365, 1952. 277. (o) Zieper, I., and Lewis, R. A.: Tuberculosis in a Macacus Rhesus Treated with Isonicotinyl Hydrazide , Quart. Bull. Sea View Hosp. 13:12, 1952. 278. (p) Robitzek, E. H.; Selikoff, I. J., and Ornstein, G. G.: Chemotherapy of Human Tuberculosis with Hydrazine Derivatives of Isonicotinic Acid , Quart. Bull. Sea View Hosp. 13:27, 1952. 279. (q) Bosworth, D. M.; Wright, H. A., and Fielding, J. W.: Marsillid in the Treatment of Tuberculosis Orthopedic Lesions , Quart. Bull. Sea View Hosp. 13:52, 1952. 280. (r) Elmendorf, B. F., Jr.; Cawthon, M. V.; Muschenheim, C., and McDermott, W.: Absorption, Distribution, Excretion and Short-Term Toxicity of Isonicotinic Acid Hydrazide in Man , Am. Rev. Tuberc. 65:429, 1952. 281. (s) Selikoff, I. J.; Robitzek, E. H., and Ornstein, G. G.: Toxicity of Hydrazine Derivatives of Isonicotinic Acid in the Chemotherapy of Human Tuberculosis , Quart. Bull. Sea View Hosp. 13:17, 1952. 282. (t) Rubin, B.; Hassert, G. L., Jr.; Thomas, B. G. H., and Burke, J. C.: Pharmacology of Isonicotinic Acid Hydrazide , Am. Rev. Tuberc. 65:392, 1952. 283. (u) Sykowski, P.: Streptomycin in Eales's Disease , Am. J. Ophth. 34:889, 1951. 284. (v) Hughes, F. J.; Mardis, R. E.; Dye, W., and Temple, C. W.: Combined Intermittent Regimens in Treatment of Nonmiliary Pulmonary Tuberculosis , Dis. Chest 21:1, 1952.Crossref 285. (w) Glorig, A.: Effect of Dihydrostreptomycin Hydrochloride in Auditory Mechanism , Ann. Otol. Rhin. & Laryng. 63:27, 1951. 286. (x) Adair, C. V.; Drobeck, B., and Bunn, P. A.: Use of Antituberculous Agents in Tuberculosis , Am. Rev. Tuberc. 64:207, 1951. 287. (y) Lepri, G.: The Effect of Hyaluronidase on the Diffusion of Experimental Tuberculous Infection of the Eye , Gior. ital. oftal. 4:373, 1951. 288. (z) Wegner, W., and Lintz, R.: Experiences with Chemotherapy in Ocular Tuberculosis , Klin. Monatsbl. Augenh. 119:350, 1951. 289. (a′) Gandolfi Morpurgo, F.: Thiosemicarbazone in the Treatment of Ocular Tuberculosis , Arch. ottal. 55:293, 1951. 290. (b′) Belgorou, H. E.; Alexander, H.; Meidt, C. E., and McGaley, J.: Tibione in Treatment of Tuberculosis , Dis. Chest 20:1, 1951.Crossref 291. (c′) Volini, I. F.; Kadison, E. R., and Felsenfeld, O.: New Antibiotics in Treatment of Tuberculosis , Dis. Chest 20:19, 1951.Crossref 292. (d′) O'Connor, J. B.; Christie, F. J., and Howlett, K. J., Jr.: Hemotoxicity of Dihydrostreptomycin , Am. Rev. Tuberc. 63:312, 1951. 293. (e′) Finley, A. C.: Viomycin , Am. Rev. Tuberc. 63:1, 1951. 294. (f′) Bartz, O. R.: Viomycin , Am. Rev. Tuberc. 63:4, 1951. 295. (g′) Ehrlich, L.: Viomycin , Am. Rev. Tuberc. 63:7, 1951. 296. (h′) Harvey, G. L.: Viomycin , Am. Rev. Tuberc. 63:17, 1951. 297. (i′) Warring, F. C., Jr., and Howlett, K. J., Jr.: Allergic Reactions to Para-Aminosalicylic Acid , Am. Rev. Tuberc. 65:235, 1952. 298. (j′) Marsh, K.: Drugs Employed in Chemotherapy of Tuberculosis , Antibiotics & Chemother. 1:318, 1951. 299. (k′) Fabrizio, A. M.: Effect of Purified Fractions of Tuberculin on Leucocytes from Normal and Tuberculous Animals in Tissue Cultures , Am. Rev. Tuberc. 65:250, 1952. 300. (l′) Gaby, W. L.; Black, J., and Bondi, A., Jr.: A Study of Tuberculins by the Hemaglutination Procedure , Am. Rev. Tuberc. 65:272, 1952. 301. (m′) Meddlebrook, G., and Dubos, R. J.: Specific Serum Agglutinations of Erythrocytes Sensitized with Extracts of Tubercle Bacilli , J. Exper. Med. 88:521, 1948. 302. (n′) Kass, I.: Studies on the in vitro Effects of Radioactive I-131 Labeled 3,5 Diiodo Pas on the Tubercle Bacillus , Am. Rev. Tuberc. 65:316, 1952. 303. (o′) Perry, T. L.: Failure of Neomycin as an Adjunct to Streptomycin in Tuberculous Meningitis , Am. Rev. Tuberc. 65:325, 1952. 304. (p′) Sykowski, P.: Streptomycin in Miliary Choroidal Tuberculosis , Am. J. Ophth. 35:414, 1952. 305. (q′) Gross, G., and Haase, A.: Experimental Investigations of the Effect of Thiosemicarbazone and Paraaminosalicylic Acid on the Course of Intraocular Tuberculosis in Guinea Pigs , Klin. Monatsbl. Augenh. 118:573, 1951. 306. (r′) Bunn, P. A., and Drobeck, B.: Use of Rabbit Eye as Tissue to Study Tuberculosis , Am. Rev. Tuberc. 64:197, 1951. 307. (s′) Mendenhall, E., and Shaw, R. R.: Recent Trends in Treatment of Pulmonary Tuberculosis , J. A. M. A. 148:595, 1952.Crossref 308. (t′) James, J. A.; Sides, L. J.; Dye, W. E., and Dyke, V. F.: Intermittent Streptomycin Regimens , Am. Rev. Tuberc. 63:275, 1951. 309. (u′) Horne, N. W., and MacAskill, J.: Effect of Para-Aminosalicylic Acid (PAS) Alone and in Association with Streptomycin in Experimental Ocular Tuberculosis , Brit. J. Ophth. 35:459, 1951.Crossref 310. (v′) Irradiated Tuberculosis Vaccine, editorial , J. A. M. A. 146:931, 1951. 311. (w′) Myers, J. A.: Immunity in Tuberculosis , J. A. M. A. 146:1492, 1951.Crossref 312. (x′) Dahlstrom, G., and Difs, H.: The Efficacy of BCG Vaccination: A Study on Vaccinated and Tuberculin-Negative, Unvaccinated Conscripts , Acta tuberc. scandinav. 25:1, 1951. 313. (y′) Damato, F. J.: BCG Vaccine in Phlyctenular Conjunctivitis , Brit. J. Ophth. 35:416, 1951.Crossref 314. (z′) Don, C., and Gregory, J.: Toxicity of Dihydrostreptomycin Sulfate for the Auditory Nerve , Lancet 1:72, 1952.Crossref 315. (a″) Pitts, T. W., and Tempel, C. W.: Antimicrobial Treatment of Pulmonary Tuberculosis , Journal-Lancet 72:180, 1952. 316. (b″) Hirsch, J. G., and Dubos, R. J.: The Effect of Spermine on Tubercle Bacilli , J. Exper. Med. 95:191, 1952.Crossref 317. (c″) Progress in the Treatment of Tuberculosis, editorial , New England J. Med. 246:468, 1952.Crossref 318. (d″) Shane, S. J.; Laurie, J. H.; Riley, C., and Boutilier, M.: Effect of Combined Therapy on the Emergence of Streptomycin Resistant Strains of Tubercle Bacilli , New England J. Med. 246:132, 1952.Crossref 319. (e″) Bavin, E. M.; Brach, A. S.; Falconer, R., and Friedman, R.: Nisin in Experimental Tuberculosis , Lancet 1:127, 1952.Crossref 320. (f″) Viellard, R.: Treatment of Tuberculoma of the Iris with Streptomycin , Bull. Soc. ophth. France 2:214, 1951. 321. (g″) Palich-Szanto, O.: Toxicity of Paraaminosalicylic Acid , Orvosi-hetil. 92:1329, 1951. 322. (h″) Sykowski, P.: Streptomycin Causing Optic Neuritis , Am. J. Ophth. 34:1446, 1951. 323. (i″) Linhart, W. O.: Induced Ocular Tuberculosis , A. M. A. Arch. Ophth. 46:271, 1951.Crossref 324. (j″) Woods, A. C.; Wood, R. M., and Naquin, H. A.: Studies in Experimental Ocular Tuberculosis , A. M. A. Arch. Ophth. 45:546, 1951.Crossref 325. (k″) Woods, A. C., and Wood, R. M.: Studies in Experimental Ocular Tuberculosis , A. M. A. Arch. Ophth. 47:477, 1952.Crossref 326. (l″) Mitzukawa, T., and Nakayama, H.: Studies on the Appearance of Tuberculous Eye Allergy , Acta Soc. ophth. Jap. 55:367, 1951. 327. (m″) Irvine, K. W.: The Present Position of B.C.G. Vaccination , Postgrad. M. J. 28:211, 1952.Crossref 328. (a) Lind, H. E., and Swanton, E.: Routine Bacteriologic Sensitivity , Antibiotics & Chemother. 2:25, 1952. 329. (b) Eisenberg, G. M.: Bacterial Susceptibility to Antibiotics: Concept of Bacterial Inhibition , J. Philadelphia Gen. Hosp. 2:127, 1951. 330. (c) Laboratory Control of Antibiotic Therapy, editorial , J. A. M. A. 147:1360, 1951. 331. (d) Patrick, W. C.; Craig, G. H., and Bachman, F. C.: Diameter of Inhibition Zones Correlated with Tube Sensitivities Using Six Antibiotics , Antibiotics & Chemother. 1:133, 1951. 332. (e) Theodore, F. H.: Contamination of Ocular Solutions , J. A. M. A. 147:1381, 1951. 333. (f) Gray, J. P.: Status of Antibiotics , Rhode Island M. J. 34:474, 1951. 334. (g) Marshall, A. K.: The Dosage Schedule of Chemotherapeutic Agents , Pharmacol. Rev. 4:85, 1952. 335. (h) Long, P. H.: Clinical Use of Antibiotics , A. M. A. Arch. Ophth. 46:360, 1951. 336. (i) Leopold, I. H.: Principles of Antibiotic Therapy in Ophthalmology , A. M. A. Arch. Ophth. 46:360, 1951. 337. (j) Braley, A. E.: Antibiotics in External Eye Disease , Am. J. Ophth. 34:1046, 1951. 338. (k) Sorsby, A.; Bailey, N. L.; Joseph, R., and Ainsley, D.: Discussion of the Newer Antibiotics in Ophthalmology , Proc. Roy. Soc. Med. 44:737, 1951. 339. (l) Swan, K. C.: Some Contemporary Concepts of Scleral Disease , A. M. A. Arch. Ophth. 45:630, 1951. 340. (m) Wooldridge, W. E.: Antifungal Antibiotics of Clinical Significance , South. M. J. 45:351, 1952. 341. (n) Brownlee, G.: The Most Recent Antibiotic Agents , Postgrad. M. J. 28:139, 1952. 342. (o) Douvas, N. G.: Recent Developments in Ocular Therapeutics , J. Iowa M. Soc. 42:54, 1952. 343. (p) Spaulding, E. H., and Anderson, T. G.: Selection of Antimicrobial Agents by Laboratory Means , J. A. M. A. 147:1336, 1951. 344. (q) Nelson, W. E.: Clinical Basis for Selection of Patients for Antimicrobial Therapy , J. A. M. A. 147:1340, 1951. 345. (r) Laboratory Control of Antibiotic Therapy, editorial , Nelson J. A. M. A. 147:1360, 1951. 346. (s) Jackson, G. G., and Finland, M.: Comparison of Methods for Determining Sensitivity of Bacteria in Vitro , A. M. A. Arch. Int. Med. 88:446, 1951.Crossref 347. (t) Matthew, W. B.: Occupational Injuries to the Eye and Their Treatment , J. Internat. Coll. Surgeons 17:187, 1952. 348. (u) Leopold, I. H.: Therapy of Infection Associated with Intraocular Surgery or Trauma, Read at the Annual Meeting of the Ophthalmology Section of American College of Surgeons, Atlantic City, N. J. Feb. 11-12, 1952. 349. (v) Meleney, F. L.; Johnson, B. A., and Teng, P.: The Importance of Laboratory Data in the Treatment of Surgical Infections by Antibiotics , J. Mt. Sinai Hosp. 18:257, 1952. 350. Micks, Whitney, and Anigstein.1e Davisson and others.1f Wachter and others.1g Kenner and Murray.1h McCowen, Callender, and Lawlis.1v Raubitscheck, Acker, and Waksman.1w 351. Elias, Price, and Merrianon.2e Longacre.2f Siegal.2g Adair, Woodin, and Bunn.2l Epstein and Allen.2m Kadison, Ishihara, and Waters.2r 352. Longacre.2f Jensen and others.2t 353. Grunberg and Leiwant.17c Hoggarth and Martin.17e Wegner and Lintz.17z Gandolfi Morpurgo.17a′ Belgorou and others.17b′ Volini, Kadison, and Felsenfeld.17c′ Marsh.17j′ Gross and Haase.17q′ Bunn and Drobec.17r′ 354. Gurta.17a Cruickshank and Mitchell.17d Steel.17h Hughes and others.17v Adair, Drobeck, and Bunn.17x Lepri.17y Wegner and Lintz.17z Volini, Kadison, and Felsenfeld.17c′ Warring and Howlett.17i′ Marsh.17j′ Gross and Haase.17q′ Bunn and Drobeck.17r′ Mendenhall and Shaw.17s′ Horne and MacAskill.17u′ Pitts and Tempel.17a″ Editorial.17c″ Shane and others.17d″ 355. Lepri and Capalbi.6u Gurta.17a Duca, Rothlauf, and Saidi.17b Oatway and Reding.17i Sykowski.17u Hughes and others.17v Glorig.17w Adair, Drobeck, and Bunn.17x Wegner and Lintz.17z Volini, Kadison, and Felsenfeld.17c′ O'Connor, Christie, and Howlett.17d′ Bartz.17e′ Finley.17e′ Ehrlich.17g′ Harvey.17h′ Marsh.17j′ 356. Hughes and others.17v Mendenhall and Shaw.17s′ James and others.17t′ 357. Marsh.17j′ Woods, Wood, and Naquin.17j″ Woods and Wood.17k″ 358. Geller and Thygeson.13a Ciotola.13e Hallett and others.13i 359. Benedek.13d Voisin and others.13g Schaeffer and Svendsen.13h Bubbage.13j Kass, Aycock, and Finland.13k Carter. 13l 360. Wilson, Deeds, and Rather.1a Sacks.1b Kaiser.1c Quinn.1d Micks, Whitney, and Anigstein.1e Davisson and others.1f Wachter, Bohonos and Quakenbusch.1g Kenner and Murray.17h Berger and others.1i Dimick.1j Takano.1y Dubois-Poulsen, Dubois-Verlière, and Tibi.1z Siegal2g Harkavy.2j Spring.2k Adair, Woodin, and Bunn.2l Kmonicek.3c Payne, Spencer, and Schultz.3d Eggers.3e Reiches.4h Ayre.4i McVay and Sprunt.4m Mercier.4r Usadek, Curtis, and Mill.5d Berens and Gulyash.5h van Gelderen.5k Roberts.5n Willcox.6s Cannon, Nichols, and Leopold.6w Douvas, Featherstone, and Braly.6x Brownlee, Bushby, and Short.7d Hambre and others.8a Vogel, Leopold, and Nichols.8f Hagerman and Franzblau.9c Cruickshank and Mitchell.17d Steel.17h Editorial.17k Selikoff, Robitzek, and Ornstein.17s O'Connor, Christie, and Howlett.17d′ Warring and Howlett.17i′ 361. Dubois-Poulsen, Dubois-Verlière, and Tibi.1z Melodia.1a′ 362. Lepri and Sicca.6v Cannon, Nichols, and Leopold.6w Douvas.6x Frisk and Tunevall.6q 363. Selye, H.: Annual Report on Stress , Montreal, Canada, Acta, Inc., Medical Publishers, 1951. 364. (a) Pentini, G.: The Eye and the General Adaptation Syndrome , Ann. ottal. e clin ocul. 77:287, 1951. 365. Romani, J. D.: Malignant Postoperative Fevers , Semaine hôp. Paris 27:1951. 366. Blair, J. R.: Dimitroff, J. M., and Hingeley, J. A.: Acquired Resistance to Cold Exposure in the Rabbit and the Rat , Federation Proc. 10:15, 1951. 367. Daniels, F., Jr.; Fainer, D. C.; Bommarito, C. L., and Bass, D. E.: The Climatization to Cold in Man , Federation Proc. 10:32, 1951. 368. Miline, R., and Kosak, O.: Effect of Noise and Vibration on the Neuroendocrine System , Med. Preg. , 1951, No. (9) . 369. Bean, J. W.: Adrenal Alteration Induced by Oxygen at High Pressure , Federation Proc. 10:11, 1951. 370. Henri, F., and Mast, H.: Behavior of the White Blood Picture, Especially of the Eosinophiles in Rats After Administration of Dibenamine and of Hydergin,® Ztschr. klin. Med. 148:143, 1951. 371. Sawyer, C. H., and Parkerson, G. R., Jr.: ACTH Release in Response to Stress Is Partially Prevented by an Adrenergic Blocking Agent, SKF 501 , Federation Proc. 10:119, 1951. 372. Patrono, D.: Streptomycin and the Adrenal Cortex, Quad. Sc. 1o Smeraldo, Rome, 1950. 373. Tomitti, E., and Matzner, K. H.: Neurotropic Toxic Effect of Penicillin , Klin. Wchnschr. 28:560, 1950.Crossref 374. Barnard, R. D.: Corticotherapeutic Equivalents of Terramycin , New York J. Med. 50:1852, 1950. 375. Salicylates and Cortisone in Rheumatic Diseases , Lancet 1:780, 1951. 376. (a) Cohen, S. J.: A Comparison of Hydrolytic Procedures for Conjugated Urinary Corticoids , Federation Proc. 10:173, 1951. 377. (b) Jacobson, R. P., and Pincus, G.: The Chemical Nature and Sythesis of Cortisone in the Chemistry of Adrenal Steroids , Am. J. Med. 10:531, 1951.Crossref 378. (c) Venning, E. H.: Enzymatic Hydrolysis of the Urinary Corticoids, Program of the 33d Meeting of The Association for the Study of Internal Secretions, Atlantic City, N. J. 1951, p. 43. 379. Wick, A. M.; Hillyard, L., and MacKay, E. M.: Method for Measuring the Effect of Adrenocorticotropic Hormone on Lipoid Soluble Reducing Substances of Rabbit Plasma , Endocrinology 148:137, 1951.Crossref 380. (a) Chen, C., and Tewell, H. E., Jr.: Corticosteroid Determination with Blue Tetrazolium , Federation Proc. 10:377, 1951. 381. (b) Mader, W. J., and Buck, R. R.: Colorimetric Determination of Cortisone: Use of Blue Tetrazolium , Analyt. Chem. 24:666, 1952.Crossref 382. Burton, R. B.; Zaffaroni, A., and Kentman, E. H.: Paper Chromatography of Steroids , J. Biol. Chem. 188:763, 1951. 383. Hoffman, H., and Standinger, H.: Paper Chromatographical Separation and Determination of the Adrenal Cortex, Hormones , Naturwissenschaften 9:213, 1951.Crossref 384. Kretchewsky, D., and Kirk, M. R.: Detection of Steroids in Paper Chromatography , Arch. Biochem. 36:346, 1952.Crossref 385. Best, W. R., and Samter, M.: Variations That Occur in Eosinophil Counts of Blood and Bone Marrow , Blood 6:61, 1951. 386. Proti, F. T.; Clayton, A. B. E., and McSwiney, R. R.: Comparison of Human Bioassay of ACTH with Adrenal Ascorbic Acid Depletion and Inhibition of Tissue Responses , Endocrinology 7:22, 1951. 387. Reinhardt, W. O.; Hungerford, G. F., and Li, C. H.: Eosinopenic Response of Mice to ACTH, Protein and Peptide , Federation Proc. 10:109, 1951. 388. Reinhardt, W. O., and Li, C. H.: Apparent Discrepancies in the Evaluation of Adrenocorticotropic Hormone (ACTH) Activity by two Bioassay Methods , Proc. Soc. Exper. Biol. & Med. 77:229, 1951. 389. Gordon, E. S.; Kelsey, C., and Meyer, E. S.: Adrenal Stimulation by Intravenous ACTH , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 30. 390. Kanee, A.: Corticotropin (ACTH) administered Intravenously , A. M. A. Arch. Dermat. & Syph. 65:95, 1952. 391. Jelliffe, A. M.; Steward, P. A., and Beaumont, G. E.: ACTH by Intravenous Infusion , Lancet 1:1260, 1951. 392. Mandel, W.; Singer, M. J.; Gudmundson, H. R.; Meister, L., and Modern, F. W. S.: Intravenous Use of ACTH , J. A. M. A. 146:546, 1951. 393. Renold, A. E.; Forsham, P. H.; Maisterrena, J., and Thorn, G. W.: Intravenously Administered ACTH , New England J. Med. 244:796, 1951. 394. Forsham, P. H.; Renold, A. E., and Frawley, T. F.: Nature of ACTH Resistance, Program of the Association for the Study of Internal Secretions, 33d Meeting, Atlantic City, N. J., 1951, p. 20. 395. Rohm, E. N., Jr., and Hollander, J. L.: Allergy to ACTH in the Use of Beef ACTH , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 391. 396. (a) McLester, J. G.: Physiologic Effects, Contraindications, Dosage and Control of ACTH and Cortisone Therapy , J. M. A. Alabama 20:319, 1951. 397. (b) Proctor, E. L., and Rawson, E. J.: Adrenocortical Failure Following Treatment with Cortisone and ACTH , Am. J. Clin. Path. 21:158, 1951. 398. (c) Parmer, L. G.; Katonah, F., and Angrist, A. A.: Comparative Effects of ACTH, Cortisone, Corticosterone, Desoxycorticosterone, Pregnenolone, on Growth and Development of Infant Rats , Proc. Soc. Exper. Biol. & Med. 77:215, 1951. 399. (d) Frawley, T. F.: Recognition and Prevention of Complications of ACTH and Cortisone Therapy , A. M. A. Arch. Indust. Hyg. 3:587, 1951. 400. (e) Sulzberger, M.: Effects of ACTH and Cortisone on Certain Skin Diseases , J. Invest. Dermat. 6:323, 1951. 401. (f) Lourel, F. C.; Franklin, W.; Beale, H. D., and Scheller, I. W.: Occurrence of Convulsive Seizures During Treatment of Asthma with Cortisone Acetate , New England J. Med. 244:49, 1951. 402. (g) Dorfman, A.: Status Epilepticus Coincident with the Use of Pituitary Adrenocorticotropic Hormone , J. A. M. A. 146:25, 1951. 403. (h) Morrison, J. F.; Eimor, A. H.; Bazeley, P. L., and Thayer, J. H.: Antigenic Properties of Growth Hormone and ACTH , Nature, London , 169:28, 1952. 404. (i) Boland, E. W., and Headley, M. E.: Results of Long Continued Cortisone Administration in Rheumatoid Arthritis , California Med. 74:416, 1951. 405. (j) Engleman, E. P.; Kunkel, P.; Welsh, J. E., Jr., and Molyneaux, M. G.: Experiences with Cortisone Given Orally , California Med. 75:1, 1951. 406. (k) Krupp, M. A.; Saier, M., and Keddie, F.: Experience with Cortisone and ACTH in Private Clinic , California Med. 75:6, 1951. 407. (l) Rowe, A., Jr.; Lamb, G. R.; Taylor, F. B., and Kinsel, L. W.: Experience with ACTH and Cortisone in Private Practice , California Med. 75:11, 1951. 408. (m) Cosgriff, S. W.: Thrombo-Embolic Complications Associated with ACTH and Cortisone Therapy , J. A. M. A. 147:924, 1951.Crossref 409. Engelman, E. P.; Krupp, M. A., and Kunkel, P.: The Oral Use of Cortisone Suspension in Syrup , J. A. M. A. 145:402, 1951.Crossref 410. Boland, E. W., and Headley, N. E.: The Oral Use of Cortisone Acetate , J. A. M. A. 145:8, 1951.Crossref 411. (a) Smith, R. W., Jr., and Steffensen, E. H.: ACTH and Cortisone in the Treatment of Arthritic Disease , New England J. Med. 245:972, 1951.Crossref 412. (b) McDonald, P. R.; Leopold, I. H.; Vogel, A., and Mulberger, R.: Evaluation of Compound F in Ocular Disease, Read at the Fourth Wills Hospital Clinical Conference, Philadelphia, March 22, 1952. 413. Hollander, J. L.; Brown, E. M.; Jessar, R. A., and Brown, C. Y.: Hydrocortisone and Cortisone Injected into Arthritic Joints , J. A. M. A. 147:629, 1951. 414. Fraser, F. C.: Experimental Production of Congenital Anomalies , Canad. M. A. J. 64:270, 1951. 415. Experimental Production of Congenital Anomalies with Cortisone, editorial , J. A. M. A. 148:206, 1952. 416. Fraser, F. C., and Fainstat, T. D.: Production of Congenital Defects in the Offspring of Pregnant Mice Treated with Cortisone: Progress Report , Pediatrics 8: 527, 1951. 417. Silverman, W. A.; Day, R. L., and Blodi, F. C.: Inhibition of Growth and Othei Effects of ACTH in Premature Infants , Pediatrics 8:177, 1951. 418. Wilson, R., and Rowe, R.: Some Special Problems in the Use of ACTH and Cortisone Therapy in Children , J. Pediat. 40:164, 1952.Crossref 419. Locke, W.; Talbot, N. B.; Jones, H. S., and Worcester, J.: Studies of the Combined Use of Measurements of Sweat Electrolyte Composition and Rate of Sweating as an Index of Adrenal Cortical Activity , J. Clin. Invest. 30:325, 1951.Crossref 420. Conn, J. W.; Louis, L. H., and Fajans, S. S.: Probability That Compound F Is the Hormone Produced by the Normal Human Adrenal Cortex , Science 113:713, 1951.Crossref 421. Forsham, P. H.; Renold, A. E., and Lesh, J. B.: Metabolic Effects of Small Molecular ACTH: A Preliminary Report , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 7. 422. Payne, R. W.; Rosenberg, I. N.; Raben, M. S.; Cleroux, A. P., and Astwood, E. B.: Effectiveness of Corticotropin Suspension, Program of the 43d Meeting of the American Society for Clinical Investigation, 1951, p. 44. 423. Shulman, L. E.; Harvey, A. M. G.; Howard, J. A., and Schoenrich, E. H.: Clinical Studies with ACTH in Bronchial Asthma , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 401. 424. (a) Wolfson, W. Q.; Thompson, R. E.; Robinson, W. D.; Duff, I. F.; Cohn, C.; Lewis, L., and Hunt, H. D.: Development, Evaluation and Clinical Use of Long-Acting ACTH Preparations , in Mote, P. R.: Proceedings, Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 1. 425. (b) Wolfson, W. Q.; Thompson, R. E.; Robinson, W. D.; Duff, I. F.; Cohn, C., and Lewis, L.: An Excellent Tolerated, Heat-Stable, Long-Acting ACTH Preparation Suitable for Prolonged and Ambulatory Treatment, Program of the 33d Meeting of the Association for the Study of Internal Secretions, Atlantic City, 1951, p. 80. 426. Mason, H. L.; Hoehn, W. N., and Kendall, E. C.: Chemical Studies of the Suprarenal Cortex , J. Biol. Chem. 124:459, 1938. 427. Perera, G. A.; Ragan, C., and Werner, S. C.: Clinical and Metabolic Study of 17-Hydroxycorticosterone (Kendall Compound F): Comparison with Cortisone , Proc. Soc. Exper. Biol. & Med. 77:326, 1951. 428. Thorn, G. W.: Adrenals in Health and Disease , Tr. & Stud. Coll. Physicians, Philadelphia 19:95, 1952. 429. Mason, H. L.: Isolation of Adrenal Cortical Hormones from Urine , J. Biol. Chem. 182:131, 1950. 430. Mason, H. L.; Nelson, D. H.; Reich, H., and Samuels, L. D.: Isolation of Steroid Hormone from the Adrenal Vein Blood of Dogs , Science 111:578, 1950. 431. Boland, E. W., and Headley, M. E.: Compound F Used Orally in Patients with Rheumatoid Arthritis , J. A. M. A. 148:981, 1952. 432. Jacobsen, R. P., and Pincus, G.: The Chemistry of Adrenal Steroids , Am. J. Med. 10:531, 1951. 433. Perera, G. A.; Ragan, C., and Werner, S. C.: Clinical and Metabolic Study of 17-Hydroxycorticosterone (Kendall's Compound F): Comparison with Cortisone , Proc. Soc. Exper. Biol. & Med. 77:326, 1951. 434. Thorn, G. W.; Renold, A. P.; Wilson, D. L.; Frawley, F. F.; Jenkins, D.; Garcia-Reyes, J., and Forsham, P. H.: Clinical Studies on the Activity of Orally Administered Cortisone , New England J. Med. 245:549, 1951.Crossref 435. Conn, J. W.; Louis, L. H.; Fajans, S. S.; Johnson, B. J.; Barott, G. W.; Hogg, L. W.; Blood, J. P., and Weiss, M.: Metabolic Effects in Man of Orally and Parenterally Administered Compound F and Compound F Acetate , Proc. Centr. Soc. Clin. Res. 24:23, 1951. 436. (a) Shechmeister, I. L., and Pond, P. P.: Response of Mice to Inoculation with Certain Avirulent Bacteria After Exposure to Sublethal Total Body X-Ray , Federation Proc. 10:418, 1951. 437. (b) Rebuck, J. W.; Smith, R. W., Jr., and Margulis, R. P.: ACTH and Leukocytic Performance in Windows in Man , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 460. 438. (c) Opsahl, J. C.; Long, C. N. H., and Fry, E. G.: Chorionic Gonadotropin, ACTH and Adrenal Hyaluronidase Relationship , Yale J. Biol. & Med. 23:399, 1951. 439. (d) Menkin, V.: Effect of Commercial Cortisone Acetate Suspension on Capillary Permeability , Am. J. Physiol. 164:294, 1951. 440. (e) Martin, S. P.; Bennett, I. L., and Chaudhuri, S.: The Effect of a Series of Bacteria and Their Products on the Human Leukocyte, Program of the 43d Meeting of the American Society Clinical Investigation, 1951, p. 38. 441. (f) Anderson, G. E.; Wiesel, L. L.; Hillman, R. W., and Stump, W. N.: Sulfhydryl Inhibition as a Mechanism in the Effects of ACTH and Cortisone , Proc. Soc. Exper. Biol. & Med. 76:825, 1951. 442. (g) Smith, D. T., and Reinmuth, O. M.: Effect of ACTH on Pneumonia Induced with Tuberculin in Lungs of Sensitized Rabbits , Federation Proc. 10:4, 1951. 443. (h) Garmuth, F. G., Jr.; Nedcel, G. A.; Ottinger, B., and Oyama, J.: Anatomic and Histologic Changes in Rabbits with Experimental Hypersensitivity Treated with Compound E and ACTH , Proc. Soc. Exper. Biol. & Med. 76:177, 1951. 444. (i) O'Neill, G. Q.; Ford, R. T.; Dughi, D. N., and Faddis, E.: A Critique of Laboratory Methods for the Evaluation of Agents for Use in Collagen Diseases , Federation Proc. 10:328, 1951. 445. (j) Sutliff, W. D., and Norman, S. L.: Adrenocorticotropic Hormone in Cutaneous and Systemic North American Blastomycosis , in Mote, J. R.: Proceedings Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 391. 446. (k) Ungar, G., and Damgaard, E.: Studies on Fibrinolysin-Antifibrinolysis System in Serum: Action of Anterior Pituitary, Adrenal Cortex and Spleen , J. Exper. Med. 93:89, 1951. 447. (l) Ungar, G.; Damgaard, E., and Weinstein, H. P.: Anaphylactic Arthritis in Guinea Pigs and Its Hormonal Control , Federation Proc. 10:422, 1951. 448. (m) Selye, H.: Role of Somatotropic Hormone in the Production of Malignant Nephrosclerosis, Periarteritis Nodosa, and Hypertensive Disease , Brit. M. J. 1:263, 1951 449. (n) The Effects of the Local Injection of Electrophoretically Pure Somatotropic Hormone , Rev. canad. biol. 9:476, 1951 450. (o) The Physiology and Pharmacology of the 11-Desoxysteroids, Program of the Steroid Hormone Conference, México, D. F., Philadelphia, The Blakiston Company, 1951. 451. (p) Reid, E.: Assay of Diabetogenic Pituitary Preparations , J. Endocrinol. 7:120, 1951. 452. (q) Selye, H.: Influence of STH, ACTH and Cortisone upon Resistance to Infection , Canad. M. A. J. 64:49, 1951. 453. (r) Adams, F. H.; Berglund, E.; Balkan, S. G., and Chisholm, P.: Pituitary Adrenocorticotropic Hormone in Severely Burned Children , J. A. M. A. 146:31, 1951. 454. (s) Adams, F. H.; Berglund, E., and Tamerin, J. A.: ACTH in Burns , J. A. M. A. 145:925, 1951. 455. (t) Whitelaw, M. J.: Physiological Reaction to Pituitary Adrenocorticotropic Hormone (ACTH) in Severe Burns , J. A. M. A. 145:85, 1951. 456. (u) Frawley, T. F.; Roche, N.; Jenkins, D., and Thorn, G. W.: The Role of the Pituitary Adrenocortical System in the Response to Anoxia, Program of the 43d Meeting of the American Society for Clinical Investigation, 1951, p. 17. 457. Selye, footnotes 65 m, n, o, q. 458. Lanman, J. T.; Guy, L. P., and Dancis, L.: Adrenocorticotropic Hormone in the Therapy of Retrolental Fibroplasia , Pediatrics 9:27, 1952. 459. Finland, M.; Kass, E. H., and Ingber, S. H.: Further Observations on the Effects of ACTH , in Mote, J. R.: Proceedings of Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 478. 460. Kass, E. H., and Finland, M.: Role of Adrenal Steroids in Infection and Immunity , New England J. Med. 244:464, 1951. 461. Woods, A. C., and Wood, R. M.: Studies in Experimental Ocular Tuberculosis , A. M. A. Arch. Ophth. 47:477, 1952.Crossref 462. Svedberg, B.; Dahlstrom, B., and Luft, R.: Effect of Adrenocorticotropic Hormone (ACTH) on Experimental Tuberculosis in Mice: Preliminary Report , Acta endocrinol. 60:50, 1951. 463. Smith, G. H., and Opsahl, J. C.: The Adrenal Hyaluronidase Relationship in Infection , Yale J. Biol. & Med. 23:361, 1951. 464. (a) Edelmann, A., and Katsh, S.: Survival of Rats Adrenalectomized After X-Ray Irradiation , Federation Proc. 10:38, 1951. 465. (b) Katsh, S., and Edelmann, A.: Adrenal Cortical Requirements of Adrenalectomized X-Ray Irradiated Rats , Federation Proc. 10:73, 1951. 466. Abernathy, R.: Effect of Cortisone on Experimental Brucellosis, Program of the 43d Meeting of the American Society Clinical Investigation, 1951, p. 5. 467. Mogabgab, W. J., and Lewis, T.: Effects of Cortisone on Bacterial Infection , J. Lab. & Clin. Med. 39:271, 1952. 468. Lemaistre, C. A.; Tompsett, R.; Muschenheim, C., and others: Effect of Adrenocorticotropic Hormone and Cortisone in Patients with Tuberculosis , J. Clin. Invest. 30:445, 1951. 469. Kleinschmidt, R. F., and Johnston, J. M.: Miliary Tuberculosis in Cortisone-Treated Patient: Case Report with Autopsy , Ann. Int. Med. 35:694, 1951. 470. ACTH and Cortisone in Infection, Editorial , New England J. Med. 245:75, 1951. 471. Deleterious Effects of ACTH and Cortisone in Tuberculosis, Editorial , New England J. Med. 245:662, 1951. 472. Lemaistre, C., and Tompsett, R.: Emergence of Pseudotuberculosis in Rats Given Cortisone , J. Exper. Med. 95:393, 1952. 473. Swartzman, G., and Fisher, A.: Alteration of Experimental Poliomyelitis Infection in the Syrian Hamster with the Aid of Cortisone , J. Exper. Med. 95:347, 1952. 474. Boyer, F., and Chedid, L.: Antitoxic Action of Cortisone , Compt. rend. Acad. Sc. 233:1232, 1951. 475. Kirk, J. E.: Steroid Hormones and Aging , J. Gerontol. 6:253, 1951. 476. Cunmun, P.: Action of Cortisone and of Desoxycorticosterone on Dinitrophenol Fever , Rev. canad. biol. 9:426, 1951. 477. Douglas, W. W., and Paton, W. D. M.: The Hypothermic and Antipyretic Effect of Preparations of ACTH , Lancet 1:342, 1952. 478. Hahn, E. O.; Houser, H. B.; Rammelkamp, G. H., Jr.; Denny, M. W., and Wanamaker, L. W.: Effect of Cortisone on Acute Streptococcal Infections and Post-Streptococcal Complications , J. Clin. Invest. 30:274, 1951. 479. Kohler, V., and Munich, W.: Effect of Synthetic Adrenal Cortex Hormone Desoxycorticosterone on the Blood Sugar During a Short Fast , Endokrinologie 28:60, 1951. 480. Pentini, G., and Formaro, L.: The Eye in the General Adaptation Syndrome , Folia endocrinol. 3:893, 1951. 481. (a) Rich, A. R.; Bennett, I. L.; Cochran, T. H.; Griffith, P. C., and McGoon, D. C.: Effect of ACTH and Cortisone upon Experimental Anaphylactic Glomerulonephritis , Bull. Johns Hopkins Hosp. 88:189, 1951. 482. (b) Sheltar, M. R.; Schmidt, H. L.; Lincoln, R. B.; DeVore, J. K.; Bullock, J. A., and Hellbaum, A. A.: Response of Serum Polysaccharide Fractions and Protein Fractions Following Cortisone Treatment , J. Lab. & Clin. Med. 39:372, 1952. 483. (c) Balmain, J. H.; Folley, S. J., and Glascock, R. F.: Inhibition of Fatty Acid Synthesis in Rat Mammary Gland Slices by Cortisone in Vitro and Its Antagonism by Insulin , Nature, London , 169:447, 1952. 484. (d) Layton, L. L.: Effects of Cortisone upon Chondroitin Sulphate Synthesis by Animal Tissues , Proc. Soc. Exper. Biol. & Med. 76:596, 1951. 485. (e) Adams, F. H.; Kelley, B. G.; Dwan, P. F., and Glick, D.: Response to Serum Hyaluronidase Inhibitor and Mucoproteins to Adrenocorticotropic Hormone in Rheumatic States , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 572 486. (f) Response of the Serum Hyaluronidase Inhibitor and Mucoproteins to Adrenocorticotropic Hormone in Rheumatic States: Mucolytic Enzyme Systems, 15 , Pediatrics 7:472, 1951. 487. Meyer, K., and Rappaport, T. M.: The Mucopolysaccharides of the Brown Substance of Connective Tissue , Science 113:596, 1951. 488. Steen, A. S.: Effect of Cortisone on Tissue Cultures , Brit. J. Ophth. 35:741, 1951. 489. Maumenee, E.: Influence of Donor Recipient Sensitization of Corneal Grafts , Am. J. Ophth. 34:142, 1951. 490. Newell, F. W., and Dixon, J. M. Effect of Subconjunctival Cortisone upon the Immediate Union of Experimental Corneal Grafts , Am. J. Ophth. 34:977, 1951. 491. Baxter, H.; Schiller, C.; Whiteside, J. H., and Straith, R. E.: Effect of ACTH on Survival of Homografts in Man , Plastic & Reconstruct. Surg. 7:492, 1951. 492. (a) Baxter, H.; Schiller, C.; Whiteside, J. H., and Straith, R. E.: Influence of Cortisone on Skin and Wound Healing in Experimental Animals , Plast. & Reconstruct. Surg. 7:24, 1951 493. (b) Influence of ACTH on Wound Healing in Man , Baxter Plast. & Reconstruct. Surg. 7:85, 1951. 494. (c) Upton, A. C., and Coon, W. W.: Effects of Cortisone and Adrenocorticotropic Hormone on Wound Healing in Normal and Scorbutic Guinea Pigs , Proc. Soc. Exper. Biol. & Med. 77:153, 1951. 495. Findlay, C. W., Jr., and Howes, E. L.: Combined Effect of Cortisone and Partial Protein Depletion on Wound Healing , New England J. Med. 246:597, 1952. 496. Fornaro, L.: Influence of Desoxycorticosterone and of Corticotropic Hormone on the Process of Healing of Corneal Wounds , Rass. ital. ottal. 20:90, 1951. 497. Fornaro, L.: The Eye in the General Adaptation Syndrome , Rass. ital. ottal. 21:28, 1951. 498. Conway, H., and Stark, R. B.: ACTH in Plastic Surgery , Plast. & Reconstruct. Surg. 8:354, 1951. 499. Spain, D. M.; Molomut, N., and Haber, A.: Studies of the Cortisone Effects on the Inflammatory Response , J. Lab. & Clin. Med. 39:383, 1952. 500. Conway, H., and Stark, R. B.: Corticotropin (ACTH) in Treatment of Keloids , A. M. A. Arch. Surg. 64:47, 1952. 501. Billingham, R. E.; Krohn, P. L., and Medawar, P. M.: Effect of Locally Applied Cortisone Acetate on Survival of Skin Homografts in Rabbit , Brit. M. J. 2:1049, 1951. 502. Skin Homografts in Clinical Practise, editorial Billingham Brit. M. J. 2:1073, 1951. 503. (a) Tompkins, E. H.: The Response of Monocytes to Adrenal Cortical Extract , J. Lab. & Clin. Med. 39:365, 1952. 504. (b) Schulman, I.; Lanman, J. T.; Laxdal, O. E., and Holt, L. E., Jr.: Effects of ACTH and Cortisone on Leukemia in Childhood , Pediatrics 8:34, 1951. 505. (c) Dobriner, K.: Adrenal Function in Steroid Excretion in Disease , in Symposium on Steroids in Experimental and Clinical Practice , Philadelphia, The Blakiston Company, 1951, p. 130. 506. (d) Burton, R. B.; Zaffaroni, A.; Izzo, A. J., and Kutmann, E. H.: Studies on the Nature of the Adrenal Cortical Excretion in Patients with Malignancy, Program of the 43d Meeting American Society Clinical Investigation, 1951, p. 11. 507. (e) Funk, C.; Tomashefsky, P.; Soukup, R., and Ehrlich, A.: Effect of the Hormonal Factors on Growth of a Transplanted Rat Tumor , Federation Proceedings 10:185, 1951. 508. (f) Alpert, L. K.; Zimmerman, J., and Cherr, E. H.: Effects of ACTH, Cortisone and Nitrogen Mustard on Malignant Diseases , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 235. 509. (g) Farber, S.; Downing, V.; Schwachman, H.; Toch, R.; Appleton, R.; Held, F.; King, J. P., and Feriozi, D.: Action of ACTH and Cortisone on Children with Disseminate Cancer , in Mote, J. R.: Proceedings Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 226 510. (h) The Action of ACTH and Cortisone in Acute Leukemia , in Mote, J. R.: Proceedings Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 251. 511. ( i) Cummings, M. M.; Drummond, M. C.; Michael, M., Jr., and Bloom, W. L.: Influence of Cortisone on Artificially Induced Peritoneal Exudates , Bull. Johns Hopkins Hosp. 90:185, 1952. 512. (j) Pillers, E. N. K.; Burchenal, J. H.; Eliel, L. P., and Pearson, O. H.: Resistance to Corticotropin Cortisone, and Folic Acid Antagonists in Leukemia , J. A. M. A. 148:907, 1952. 513. (a) Adlersberg, D.; Schaefer, E., and Drachman, S. R.: Development of Hypercholesteremia During Cortisone and ACTH Therapy , J. A. M. A. 144:969, 1950 514. (b) Studies on Hormonal Control of Serum Lipid Partition in Man , J. Clin. Endocrinol. 11:67, 1951. 515. (c) Bloom, B., and Pierce, F. T., Jr.: Relationship of ACTH and Cortisone to Serum Lipoproteins in Atherosclerosis in Humans , Metabolism 1:155, 1952. 516. (d) Pierce, F. T., Jr., and Bloom, B.: Relationship of ACTH and Cortisone to Serum Lipoproteins of the Rabbit , Metabolism 1:163, 1952. 517. (e) Stanler, J.; Pick, R., and Katz, L. N.: Effects of Desoxycorticosterone Acetate on Cholesterolemia, Blood Pressure and Atherogenesis in Chicks , Circulation 4:262, 1951. 518. DeVries, J.: The Effect of ACTH on Circulating Antibody Levels , J. Immunol. 65:119, 1950. 519. (b) Bjørneboe, M.; Fischel, E. E., and Stoerk, H.: Effect of Cortisone and ACTH on the Concentration of Circulating Antibodies , J. Exper. Med. 93:37, 1951. 520. (c) Mirick, G. S.: Effects of ACTH and Cortisone on Antibodies in Humans , Bull. Johns Hopkins Hosp. 88:332, 1951. 521. (d) Hahn, E. O.; Houser, H. B.; Rammelkamp, C. H., Jr.; Denny, F. W., and Wanamaker, L. W.: Effect of Cortisone on Acute Streptococcal Infections and Post-Streptococcal Complications , J. Clin. Invest. 30:274, 1951. 522. (a) Kass, R. H., and Finland, N.: Role of Adrenal Steroids in Infection and Immunity , New England J. Med. 244:464, 1951. 523. (b) Sprague, R. G.: Cortisone and ACTH: A Review of Certain Physiologic Effects and Their Clinical Implications , Am. J. M. Sc. 10:567, 1951. 524. (c) Witlow, N. J.: Treatment of Severe Burns with ACTH , in Mote, J. R.: Proceedings of Second Clincial ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 322. 525. (d) Ebert, R. H., and Wissler, R. W.: In Vivo Observations of the Effects of Cortisone on the Vascular Reaction to Large Doses of Horse Serum, Using the Rabbit Ear Chamber Technique , J. Lab. & Clin. Med. 38:499, 1951. 526. (e) Elliott, K. A. C., and Yrarrazaval, S.: An Effect of Adrenalectomy and Cortisone on Tissue Permeability in Vitro , Nature, London 169: 460, 1952. 527. (g) States, editorial, ACTH, Cortisone and Hypersensitive Disease Ann. Int. Med. 36:911, 1952. 528. (h) Wedgewood, R. J.; Ajwn, C. B. Z., and Janeway, C. A.: The Mechanism of Action of ACTH in Experimental Nephritis Due to a Foreign Protein , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 108. 529. (i) Grob, D.; Schoenrich, E. H.; Winkenwerder, W. C., and Harvey, A. M.: Influence of ACTH on the Reactivity of the Bronchial Tree, Skin and Secretory Glands to Specific Antigens, Histamine and Mecholyl in Bronchial Asthma , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 499. 530. (j) Grace, H. W.; Frank, L., and Wyse, R. J.: Effect of Cortisone upon Hypersensitivity Due to Lymphogranuloma Venereum , A. M. A. Arch. Dermat. & Syph. 65:348, 1952. 531. (k) Ehrich, W. E.: The Nature of Collagen Diseases , Am. Heart J. 43:121, 1952.Crossref 532. (l) Rantz, L. A.; Creger, W. C., and Choy, S. H.: Immunological Hyperreactivity in the Pathogens of Rheumatic Fever and Other Diseases , Am. J. Med. 12:115, 1952.Crossref 533. (m) Holman, J., and Goth, A.: Histamine Release in the Human Skin and the Effect of Cortisone , Federation Proc. 11:358, 1952. 534. (n) Winter, C. A., and Flataker, L.: Cortisone and Related Hormones: Effect on Response to Analgesic Drugs , J. Pharmacol. & Exper. Therap. 103:93, 1951. 535. (o) Goth, A.; Holman, J., and Copenhaver, J. H.: Mechanism of Action of Cortisone in Experimental Hypersensitivity , Federation Proc. 11:349, 1952. 536. (p) Thomas, L., and Good, R. A.: The Effect of Cortisone on the Schwartzman Reaction , J. Exper. Med. 95:409, 1952. 537. (q) Goldman, L.; Preston, R., and Rockwell, E.: The Local Effect of 17-Hydroxycorticosterone 21-Acete in the Diagnostic Patch Test Reaction , J. Invest. Dermat. 18:89, 1952. 538. (r) Ebert, R. H., and Wissler, R. W.: The in Vivo Observations of Vascular Reactions to Large Doses of Horse Serum Using Rabbit Ear Chamber Technique , J. Lab. & Clin. Med. 38:511, 1951. 539. (a) Woods, A. C.: The Present Status of ACTH and Cortisone in Clinical Ophthalmology , Am. J. Ophth. 34:945, 1951. 540. (b) Dickey, R. L.: Cortisone and ACTH in the Treatment of Diseases of the Eye , Delaware M. J. 23:11, 1951. 541. (c) Henderson, J. W., and Hollenhorst, R. W.: Clinical Observations on the Use of Cortisone in Ophthalmic Diseases , Tr. Am. Acad. Ophth. 55:543, 1951. 542. (d) Moutinho, H., and Vasto, O. P.: Ocular Therapy with Local Applications of Cortisone , A. M. A. Arch. Ophth. 11:241, 1951. 543. (e) Berens, C., and Girard, L. J.: ACTH and Cortisone , J. Florida M. A. 37:695, 1951. 544. (f) McLean, J. M.: Present Status of ACTH and Cortisone in Treatment of Eye Diseases , Sight-Saving Rev. 21:67, 1951. 545. (g) Hill, H. F.; Dennis, R. H., and Shannon, E. G.: ACTH and Cortisone in Ophthalmology , J. Maine M. A. 42:47, 1951. 546. (h) Krupp, M. A.; Saier, M.; Keddie, F.; Tanner, R., and Snell, A. M.: Experience with Cortisone and ACTH in a Private Clinic , California Med. 75:6, 1951. 547. (i) Rowe, A., Jr.; Lamb, G. R.; Taylor, F. B., and Kinsell, L. W.: Experience with ACTH and Cortisone in Private Practice , California Med. 75:11, 1951. 548. (j) Paich-Szanto, O.: The Intermittent Form of Sympathetic Ophthalmitis and Its Therapy , Klin. Monatsbl. Augenh. 118:499, 1951. 549. (k) Laws, H. W., and Howard, R. P.: Sympathetic Ophthalmia Treated Successfully with ACTH , Canad. M. A. J. 64:530, 1951. 550. (l) Vesterdal, E.: ACTH in the Treatment of Sympathetic Ophthalmia , Acta ophth. 29:239, 1951. 551. (m) Haik, G. M.; Waugh, R. L., Jr., and Lyda, W.: Sympathetic Ophthalmia , A. M. A. Arch. Ophth. 47:437, 1952.Crossref 552. (n) Lavery, F. S.; Werner, L. E.; O'Donoghue, S.; Guinan, P. M., and MacDougald, J.: Use of Cortisone in Diseases of the Eye , Brit. M. J. 1:1285, 1951.Crossref 553. (o) Barrious, R. R., and Barrière, R. B.: Cortisone in Ophthalmology , Arch. Soc. oftal. hispano-am. 11:276, 1951. 554. (p) McLean, J. M.; Gordon, D. M., and Koteen, H.: Clinical Experience with ACTH and Cortisone in Ocular Disease , Tr. Am. Acad. Ophth. 55:565, 1951. 555. (q) MacCaslin, M. F.: Cortisone and ACTH in Ophthalmology , Rev. brasil. oftal. 9:207. 556. (r) Fog, T.: Corticotropin (ACTH) Treatment of Disseminated Sclerosis , Nord. med. 46:1742, 1951. 557. (s) Lerner, M.: Dendritic Ulcer Treated with Cortisone , Brit. J. Ophth. 35:435, 1951.Crossref 558. (t) Koch, F. P.: ACTH and Cortisone in Ophthalmologic Practice , New York J. Med. 51:2411, 1951. 559. (u) Hogan, M. J.: Engelman, E. P.; Thygeson, P., and Krupp, M.: Effect of ACTH and Cortisone on Ocular Disease , Am. J. Ophth. 34:73, 1951. 560. (v) Duke-Elder, S.: The Clinical Value of Cortisone, ACTH in Ocular Disease , Brit. J. Ophth. 35:637, 1951.Crossref 561. (w) Duke-Elder, S.; Duthie, O. M.; Foster, J.; Law, F. W.; Lister, A.; Reid, A. M.; Scott, G. I.; Zorab, E. C., and Goldsmith, A. J. B.: A Series of Cases Treated Locally by Cortisone , Brit. J. Ophth. 35:672, 1951.Crossref 562. (x) Duke-Elder, S., and Ashton, N.: Action of Cortisone on Tissue Reactions of Inflammation and Repair with Special Reference to the Eye , Brit. J. Ophth. 35:695, 1951.Crossref 563. (y) Garcianocito, P. F.: Ocular Diseases and Cortisone , Semana méd. 99:531, 1951. 564. (z) Guinan, P. M.: Recurrent Choroiditis Treated with Cortisone , Brit. J. Ophth. 35:431, 1951.Crossref 565. (a') Pinkerton, O. D.: Cortisone in Interstitial Keratitis , Am. J. Ophth. 34:1746, 1951. 566. (a) Lavat: Cortisone in the Treatment of Phlyctenular Keratoconjunctivitis , Semana méd. 27:1000, 1951. 567. (b) Horne, G. O.: Topical Treatment of Cortisone in Syphilitic Ocular Disease , Brit. M. J. 2:1289, 1951.Crossref 568. (c) Lavery, F. S.; Werner, L. E., and O'Donoghue, D.: Use of Cortisone in Diseases of Eye , Brit. M. J. 2:1285, 1951.Crossref 569. (d) Thygeson, P.: Etiology and Treatment of Phlyctenular Keratoconjunctivitis , Am. J. Ophth. 34:1217, 1951. 570. (e) Siltzbach, L. E.: Effect of Cortisone in Sarcoidosis , Am. J. Med. 12:139, 1952.Crossref 571. (f) Gindel, B. R.; Young, J. M., and Greiner, D. J.: Sarcoidosis , Am. J. Med. 12:205, 1952.Crossref 572. (g) Siltzbach, L. E.; Posner, A., and Medine, M. M.: Cortisone Therapy in Sarcoidosis , J. A. M. A. 147:927, 1951.Crossref 573. (h) Small, M. J.: Favorable Response of Sarcoidosis to Cortisone Treatment , J. A. M. A. 147:932, 1951.Crossref 574. (i) Lovelock, F. J., and Stone, D. J.: Cortisone Therapy of Boeck's Sarcoid , J. A. M. A. 147:930, 1951.Crossref 575. (j) Small, M. J.: Pulmonary Sarcoidosis , J. A. M. A. 147:932, 1951.Crossref 576. (k) Kierland, R. R.; O'Leary, P. A.; Brunsting, L. A., and Didcoct, J. W.: Cortisone and Corticotropin (ACTH) in Dermatology , J. A. M. A. 148:23, 1952.Crossref 577. (l) Maddin, S., and Danto, J. L.: Results of Topical Application of Cortisone in Congenital Syphilitic Interstitial Keratitis , A. M. A. Arch. Dermat. & Syph. 64:437, 1951. 578. (m) Freedlander, A. S.: Observations on Use of ACTH and Cortisone in Treatment of Asthma, Hay Fever and Other Allergic Conditions , Ann. Allergy 9:588, 1951. 579. (n) Sharnoff, J. G.; Carideo, H. L., and Stein, I. D.: Cortisone-Treated Scleroderma: Report of a Case with Autopsy Findings , J. A. M. A. 145:1230, 1951. 580. (o) Ormsby, H. L.; Shirley, B. Y.; Aikenhead, J. F., and Murray, R. G.: ACTH and Cortisone in Eye Disease , Canad. M. A. J. 66:62, 1952. 581. ( p) Beerman, H.; Ford, W. T.; Nicholas, L., and Katzenstein, L.: Syphilis , A. M. A. Arch. Int. Med. 89:309 582. 464, 1952. 583. (q) Cortisone in Interstitial Keratitis, Editorial , Am. J. Syph. 35:88, 1951. 584. (r) Vesterdal, E.: ACTH in the Treatment of Sympathetic Ophthalmia , Acta ophth. 29:239, 1951 585. (s) Acute Fibrinous Iridocyklitis , Vesterdal Acta ophth. 29:509, 1951. 586. (t) Lawrence, H. G., Jr.: Value of ACTH and Cortisone in Ocular Inflammations , South. M. J. 45:65, 1952. 587. (u) Crawford, H. E.: Cortisone in Secondary Glaucoma , Am. J. Ophth. 34:1320, 1951. 588. (v) Mundy, M. L.; Howard, R. M.; Stillman, P. H., and Bevans, M.: Cortisone Therapy in a Case of Rheumatoid Nodules of the Eye in Chronic Rheumatoid Arthritis , A. M. A. Arch. Ophth. 45:531, 1951. 589. (w) Kellerman, L.: Pregnenolone Therapy in Uveitis , A. M. A. Arch. Ophth. 46:419, 1951. 590. (x) Thiel, R.: Cortisone Therapy in Eye Disease , Klin. Monatsbl. Augenh. 119:161, 1951. 591. (y) Schwarz, F.: Cortisone Therapy in Ophthalmic Disease , Kresge Eye Inst. Bull. 2:59, 1951. 592. (z) Arruga, H.: Cortisone in Ophthalmology , Arch. Soc. oftal. hispano-am. 11:585, 1951. 593. (a') Perera, C. A., and McLean, J.: Use of ACTH and Cortisone , A. M. A. Arch. Ophth. 46:105, 1951.Crossref 594. (a) Rama, G.: Cortisone and Corticostimulants in Ophthalmology , Arch. ottal. 55: 461, 1951. 595. (b) Offret, G., and Forest,: Cortisone in Local Application , Bull. Soc. opht. France 1:20, 1951. 596. (c) Olson, B. G.: Evaluation of ACTH and Cortisone in Eye Disease , Bull. Univ. Minnesota Hosp. 22:398, 1951. 597. (d) Polan, C. M.: ACTH and Cortisone Therapy of Ocular Conditions , West Virginia M. J. 47:285, 1951. 598. (e) Paufique, L.; Chavanne, H., and Rougier, J.: First Trials of Cortisone in Ocular Therapeutics , Bull. Soc. opht. France 2:184, 1951. 599. (f) Bohringer, H. R., and Wettler, H.: Experiences with Local Cortisone Therapy , Von Graefes Arch. Ophth. 152:89, 1951.Crossref 600. (g) Southgate, P. T.: ACTH in Acute Recurrent Choroiditis , Eye, Ear, Nose & Throat Month. 30:47, 1951. 601. (h) Rubino, A., and Tiberi, G. F.: Cortisone and Corticotropin Therapy in Ophthalmology , Gior. ital. oftal. 4:329, 1951. 602. (i) Rouher, F.: Cortisone Instillation in Some Ocular Infections , Bull. Soc. opht. France 2:130, 1951. 603. (j) Meiffret, A.: A Case of Sympathetic Ophthalmitis Treated and Cured with ACTH , Bull. Soc. opht. France 2:189, 1951. 604. (k) Moutinho, H.: Inflammatory Ocular Lesions of Ethmoidal or Cryptogenic Origin: Surgical Therapeutics and Cortisone , Bol. Soc. port. oto-neuro-oftal. 1:19, 1951. 605. (l) Smith, V. L.: Bilateral Transverse Optic Neuritis: Report of Two Cases with Cortisone Therapy , A. M. A. Arch. Ophth. 46:363, 1951. 606. (m) Wammock, V. S.; Biderman, A. A., and Jordan, R. S.: Erythema Multiforme Exudativum (Stevens-Johnson Syndrome) , J. A. M. A. 147:637, 1951. 607. (n) Kristensen, H. P. O.: Case of Temporal Arteritis Treated with ACTH , Ugesk. læger 113:1353, 1951. 608. (o) Appelmans, M.; Michiels, J., and van Assche, E.: Rheumatic Polyarthritis and Keratoconjunctivitis Sicca and Cortisone , Ophthalmologica 122:337, 1951. 609. (p) Lavat: Cortisone in the Treatment of Phlyctenular Keratoconjunctivitis Semana méd. 27:1000, 1951. 610. (q) Irvine, S. R., and Irvine, M. D.: Effect of Cortisone on the Primary and Secondary Aqueous and on Corneal Vascularization in Rabbits , Bull. Johns Hopkins Hosp. 89:288, 1951. 611. (r) Ripps, J. H.: Cortisone for Canine Eye Infections , J. Am. Vet. M. A. 118:304, 1951. 612. (s) Hallett, J. W.; Leopold, I. H.; Vogel, A. W.; Cannon, E. J., and Steinmetz, C. C.: Treatment of Experimental Herpes Simplex Keratitis in the Rabbit , A. M. A. Arch. Ophth. 46:33, 1951.Crossref 613. (t) Hallett, J. W.; Leopold, I. H., and Steinmetz, C. C.: Effect of Systemic Cortisone and Corticotropin on Experimental Herpes Simplex Keratitis , A. M. A. Arch. Ophth. 46: 268, 1951.Crossref 614. (u) Thygeson, P.; Geller, H. O., and Schwartz, A.: Cortisone in Experimental Herpes Simplex Keratitis , Am. J. Ophth. 34:885, 1951. 615. (v) Ormsby, H. L.; Dempster, G., and Van Rooyen, C. E.: Effect of Cortisone on Experimental Induced Herpetic Keratitis in the Rabbit , Am. J. Ophth. 34:1687, 1951. 616. (w) Potter, W. B.: Cortisone Therapy in Anterior Segment Inflammation , Am. J. Ophth. 34:1650, 1951. 617. (x) Agatston, H.: Use of Cortisone in Ocular Conditions , Am. J. Ophth. 34:1655, 1951. 618. (y) Steffensen, E. H., and Kukora, J.: ACTH, Intermedin and Cortisone in the Treatment of Retinitis Pigmentosa , Am. J. Ophth. 34:1655, 1951. 619. (z) Johnsson, S., and Högberg, B.: Observations on the Connexion Between Intermedin and Adrenocorticotropic Hormone , Nature, London , 169:286, 1952.Crossref 620. (a) Gordon, D. M.; McLean, J. M.; Koteen, H.; Bousquet, F. P.; McCusker, W. D.; Baras, I.; Wetsig, P., and Norton, E. W. D.: Use of ACTH and Cortisone in Ophthalmology , Am. J. Ophth. 34:1670, 1951. 621. (b) Millikan, C. H., and Eaton, L. M.: Clinical Evaluation of ACTH and Cortisone in Myasthenia Gravis , Neurology 1:145, 1951.Crossref 622. (c) Torda, C., and Wolff, H. G.: Effects of Administration of Adrenal Corticotropic Hormone (ACTH) on Patients with Myasthenia Gravis , A. M. A. Arch. Neurol. & Psychiat. 66:163, 1951. 623. (d) Baggenstoss, A. H.; Shick, R. M., and Polley, H. F.: Cortisone in Periarteritis Nodosa , Am. J. Path. 25:537, 1951. 624. (e) Simpson, W. G.; Rosenblum, B. F.; Wood, C. E., and Stammer, E. L.: Local Cortisone Acetate Therapy in Congenital Syphilitic Interstitial Keratitis , J. Ven. Dis. Inform. 32:116, 1951. 625. (f) Torda, C., and Wolff, H. G.: Effects of Administration of ACTH on Patients with Myasthenia Gravis , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 126. 626. (g) Smelser, G. K., and Ozanics, V.: Relation of Steroid Hormones to Development of Experimental Exophthalmos , Am. J. Ophth. 34:87, 1951. 627. (h) Fritz, A.: Action of Cortisone on the Ocular Capillaries , Bull. Soc. Beige opht. 97:160, 1951. 628. (i) Bourquin, J. B.: Effect of Cortisone on Experimental Inflammation of the Rabbit Anterior Chamber Caused by Sterile Talc Powder , Experientia 7:221, 1951. 629. (j) Goldman, L., and Richfield, D. F.: Effect of Corticotropin and Cortisone on Development and Progress of Pigmented Nevi , J. A. M. A. 147:941, 1951. 630. (k) Bottino, C.: The Blood-Aqueous Barrier and Luminous Stimuli , Ann. ottal. e clin. ocul. 77: 281, 1951. 631. (l) Ashton, N., and Cook, C.: Effect of Cortisone on Healing of Corneal Wounds Brit. J. Ophth. 35:708, 1951. 632. (m) Ashton, N.; Cook, C., and Langhan, M.: Effect of Cortisone on Vascularization and Opacification of Cornea Induced by Alloxan , Brit. J. Ophth. 35:718, 1951. 633. (n) Lister, A., and Greaves, D. P.: Effect of Cortisone on the Vascularization Which Follows Corneal Burns , Brit. J. Ophth. 35:725, 1951.Crossref 634. (o) Cook, C., and MacDonald, R. K.: Effect of Cortisone on the Permeability of the Blood-Aqueous Barrier to Fluorescein , Brit. J. Ophth. 35:730, 1951.Crossref 635. (p) Steen, A. S.: Effect of Cortisone on Tissue Cultures , Brit. J. Ophth. 35:741, 1951.Crossref 636. (q) von Sallmann, N. L.; Jones, I. S.; Wiggins, R. L., and Lokulosa, E. D.: Influence of Cortisone on Wound Healing, Macrophagocytosis, and Capillary Permeability , Wien. klin. Wchnschr. 63:684, 1951. 637. (r) Leopold, I. H.; Purnell, J. E.; Cannon, E. J.; Steinmetz, C. G., and McDonald, P. R.: Local Cortisone in Ophthalmology , Am. J. Ophth. 34:361, 1951. 638. (s) Fritz, A.: Study of the Effects of Cortisone on the Capillary Stream of the Eye , Bull. Soc. opht. France 2:153, 1951. 639. (t) Cordier, D.; Cordier, G., and Bavoux, M.: Changes in the Potassium Content of Aqueous Humor Caused by Experimental Traumatic Shock , Experientia 6:345, 1951.Crossref 640. (u) Lepri, G., and Montanari, L.: Action of Corticotropic Hormone, ACTH, of Desoxycorticosterone Acetate, and of Adrenal Cortex Extract on Contents of Hyaluronidase in the Aqueous Humor , Arch. ottal. 55:329, 1951. 641. (v) Simonelli, M., and Calamandrei, G.: Behavior of the Blood-Aqueous Barrier After the Administration of ACTH , Gior. ital. oftal. 4:340, 1951. 642. (w) Tarantino, C.: Presence of ACTH in the Placenta , Folia endocrinol. 4:197, 1951, 643. (y) Opsahl, J. C., and Long, C. N. H.: Identification of ACTH in Human Placental Tissue , Folia endocrinol. 24:199, 1952. 644. (z) Pelloja, M.: Role of Pituitary and Adrenal Glands in Inhibition of Hyaluronidase by Salicylates in Vivo , Lancet 1:733, 1952. 645. (a') Little, H. O.: Cortisone in a Perforating Eye Wound , Brit. J. Ophth. 35:790, 1951.Crossref 646. (a) Wood, R. M.: Effect of Cortisone and ACTH on Ocular Inflammation Secondary to the Injection of Irritant Substances , Bull. Johns Hopkins Hosp. 90:134, 1952. 647. (b) Clayton, B. E.; Hardesty, R. M., and Pinneger, J. L.: Studies on Antibody Formation to ACTH in Man , J. Endocrinol. 8:5, 1952. 648. Simpson and others.101e Woods.98a Pinkerton.98a' Horne.99b Kierland and others.99k Maddin and Danto.99l Beerman and others.99p Crawford.99u 649. Woods.98a Berens and Girand.98e McLean.98f Hill, Dennis, and Shannon.98g Paich-Szanto.98j Laws and Howard.98k Vesterdal.98l Duke-Elder and others.98w Perera and McLean.99a' Schwarz.99y Arruga.99z Meiffret.100j Agatston.100x 650. Millikan and Eaton.101b Torda and Wolff.101c 651. Bottino.101k Bourquin.101i Selye.32 von Sallmann and others.101q Leopold and others.101r Fritz.101s Wood.102a 652. Wood.102a Fritz.101h Ashten, Cook and Langhan.101m Lister and Greaves.101n von Sallmann and others.101q Leopold and others.101r Fritz.101s 653. Cook and MacDonald.101o von Sallmann and others.101q Leopold and others.101r Fritz.101s Simonelli and Calamandrei.101v Wood.102a 654. Wood.102a Ashtonand Cook.101l Steen.101p von Sallmann and others. 101q Leopold and others.101r 655. Leopold, I. H.: Autonomic Drugs: Their Influence on Choroidal Vessel Calber , Tr. Am. Ophth. Soc. 49:625, 1951. 656. Bergel, F.: Parasympathomimetics and Anticholinesterases , J. Pharm. & Pharmacol. 3:385, 1951. 657. Mazzella, H., and Minz, B.: Acetylcholine in the Aqueous Humor of the Rabbit Eye , Compt. rend. Soc. biol. 145:632, 1951. 658. McLennan, H., and Elliott, K. A. C.: Adenosine Diphosphate Concentration and the Synthesis of Acetylcholine by Brain Preparation , Arch. Biochem. 36:89, 1952. 659. Ing, H. R.; Kordick, P., and Tudor Williams, D. P. H.: Studies on the Structure Action Relationships of the Choline Group , Brit. J. Pharmacol. 7:103, 1952. 660. von Euler, U. S.: The Nature of Adrenergic Nerve Mediators , Pharmacol. Rev. 3:247, 1951 661. Arterenol-Adrenomedullary Hormone and Chemical Transmitter of Adrenergic Nerves , Ergebn. Physiol. 46:261, 1950.Crossref 662. Wakim, K. G., and Essex, H. E.: Comparison of the Circulatory Effects of Epinephrine and Norepinephrine , Circulatation 5:370, 1952.Crossref 663. West, G. B.: Nor-Adrenalin: A Depressor Action in the Normal Animal , J. Pharm. & Pharmacol. 3:340, 1951 664. Can Adrenaline Potentiate the Action of Noradrenaline? West J. Pharm. & Pharmacol. 3:571, 1951 665. Analysis of Pharmacopoeial Samples of Adrenaline, a Limit Test for Noradrenaline in Adrenaline , West J. Pharm. & Pharmacol. 4:95, 1952. 666. West, G. B.: Some Actions of Methylene Blue and of Mepyramine in the Body , J. Pharm. & Pharmacol. 3:656, 1951. 667. (b) Holmstedt, B.: Synthesis and Pharmacology of Dimethylamidoethoxy-Phosphoryl Cyanide (Tabun) , Acta physiol. scandinav. ( (Supp. 90) ) 25:11, 1951. 668. Schrader, G.: Development of New Insecticides on the Basis of Organic Fluorene and Phosphorus Compounds, Weinheim, Monographie zu Agnew Chemie, no. 62, 1951. 669. Hamblen, D. O., and Marchand, J. F.: Phosphate Ester Poisoning: A New Problem for the Internist , Ann. Int. Med. 36:50, 1952. 670. Douglas, W. W., and Matthews, P. B. C.: Acute Tetraethylpyrophosphate Poisoning in Cats and Its Modification by Atropine or Hyoscine , J. Physiol. 116:202, 1952. 671. Callaway, J.; Davies, D. R., and Rutland, J. P.: Blood Cholinesterase Levels and Range of Personal Variation in a Healthy Adult Population , Brit. M. J. 2:812, 1951. 672. Barnes, J. M., and Davies, D. R.: Blood Cholinesterase Levels in Workers Exposed to Organo-Phosphorus Insecticides , Brit. M. J. 2:816, 1951. 673. Dickens, P. F., Jr.; Rizzolo, J., and Bayliss, M. W.: Treatment of Nerve Gas Casualties , U. S. Armed Forces M. J. 2:1609, 1951. 674. Mouter, L. A.: Specificity of Cobra Venom Cholinesterase , Biochem. J. 50:122, 1951. 675. Reder, J. A.; Ellenwood, L. E., and Coon, J. M.: Tolerance to Octamethyl Pyrophosphoramide , Federation Proc. 11:386, 1952. 676. Koelle, G.: Types and Distributions of Cholinesterases in the Rabbit , Federation Proc. 11:363, 1952. 677. Whittaker, V. P.: Specificity Mode of Action and Distribution of CHE , Physiol. Rev. 31:312, 1951. 678. Kalow, W.: A Comparison of the Serum Cholinesterases of Man and Horse , Federation Proc. 11:360, 1952. 679. Brooks, V. B., and Myers, D. K.: Cholinesterase Content of Normal and Denervated Skeletal Muscle in the Guinea-Pig , J. Physiol. 116:158, 1952. 680. Kamijo, K., and Koelle, G. B.: Relationship Between Cholinesterase Inhibition and Ganglionic Transmission in the Cat , Federation Proc. 11:360, 1952. 681. Duke, H. N.; Pickford, M., and Watt, J. A.: The Immediate and Delayed Effect of DFP Injected into the Supraoptic Nuclei of Dogs , J. Physiol. 111:81, 1950. 682. Greig, M. E., and Mayberry, T. C.: Relationship Between Cholinesterase Activity and Brain Permeability , J. Pharmacol. & Exper. Therap. 102:1, 1951. 683. Hutchinson, A. O., and Widdowson, E. M.: Cholinesterase Activities in the Serum of Healthy British Children , Nature, London , 169:284, 1952. 684. Vorhaus, L. J.: Serum Cholinesterase in Health and Disease , Am. J. Med. 12:112, 1952. 685. DeRoetth, A., Jr.: Further Studies on Cholinesterase Activity in Ocular Tissues , Am. J. Ophth. 34:120, 1951. 686. Keele, C. A.: The Actions of Methonium Compounds with Special Reference to Paralysis of Autonomic Ganglia , Arch. Middlesex Hosp. 2:23, 1952. 687. Leopold, I. H.: Autonomic Drugs in Ophthalmology, read before the Chicago Ophthalmologic Society, Feb. 22, 1952. 688. Leopold, I. H.: Autonomic Drugs, read before the Pan-American Congress of Ophthalmology, Mexico, D. F., January, 1952. 689. Swan, K., and Gehrsitz, L.: Competitive Action of Myotics on the Iris Sphincter , A. M. A. Arch. Ophth. 46:477, 1951. 690. (a) Burns, B. D., and Paton, W. D. M.: Depolarization of the Motor End-Plate by Decamethonium and Acetylcholine , J. Physiol. 115:41, 1951. 691. (b) Taylor, D. B.: Some Basic Aspects of the Pharmacology of Synthetic Curariform Drugs , Pharmacol. Rev. 3:412, 1951. 692. (c) Paton, W. D. M., and Zaimis, E. J.: Actions and Clinical Assessment of Drugs Which Produce Neuromuscular Block , Lancet 1:568, 1950. 693. (d) Salama, A., and Wright, S.: Action in the Central Nervous System of Compounds RP3565 and RP3697 and of Tetramethyl Ammonium and Tetraethyl Ammonium , Brit. J. Pharmacol. 7:1: 1952 694. (e) Influence of Various Drugs on the Action of Curare on the Central System of the Cat , Salama Brit. J. Pharmacol. 7:14, 1952. 695. (f) Hey, P.: On Relationships Between Structure and Nicotine-Like Stimulant Activity in Choline Esters and Ethers , Brit. J. Pharmacol. 7:117, 1952. 696. (g) Kunkel, A. M.; Oikemus, A. H., and Wills, J. H.: Bis-Quarternary Aliphatic Compounds , Federation Proc. 11:365, 1952. 697. (h) Harvey, S. C.; Bankal, J. L.; Blaser, G.; Heaton, F. W., and Stewart, L. H.: Interrelation of Autonomic Ganglionic Effects of Hexamethylene-Bis-Hemethylammonium and Tetraethylammonium , Federation Proc. 11:355, 1952. 698. (i) Li, T. H.; Jacobs, B. R.; Aviado, D. M., Jr., and Schmidt, C. F.: Early Respiratory Depression by Curare and Curare-Potassium Antagonism , J. Pharmacol. & Exper. Therap. 104:149, 1952. 699. (j) Methonium Compounds in Hypertension, Letters to the Editor , Lancet 1:642, 1951. 700. (k) Hexamethonium Bitartrate, Letters to the Editor , Lancet 1:797, 1951. 701. (l) Douthwaite, A. H., and Thorne, M. G.: Effects of Hexamethonium Bromide on the Stomach , Brit. M. J. 1:111, 1951. 702. (m) Enderby, G. E. H., and Pelmore, J. F.: Controlled Hypotension and Postural Ischaemia to Reduce Bleeding in Surgery , Lancet 1:663, 1951. 703. (n) Bromism on Law-Salt Diets, Letters to the Editor , Enderby Lancet 1:347, 1951. 704. (o) Paton, W. D. M., and Perry, W. L. M.: Pharmacology of Toxiferines , Brit. J. Pharmacol. 6:299, 1951. 705. Greenafest, H.; Nachmansohn, D.; Kao, C. Y., and Chambers, R.: Mode of Blocking of Axonal Activity by Curare and Inhibitors of Acetyl Cholinesterase , Nature, London 169:190, 1952. 706. Margolin, S.; Doyle, M.; Giblin, J.; Makovsky, A.; Sprerlein, M. T.; Stephens, I.; Berchtold, H.; Belloff, G., and Tislow, R.: Pharmacological Properties of a New Parasympathetic Blocking Agent, N,N-Dimethyl 4-Piperidylidene 1,1 Diphenylmethane Methyl Sulfate (Prantal) , Proc. Soc. Exper. Biol. & Med. 78:576, 1951 707. Kiess, R. D., and Fralick, F. B.: A Preliminary Report on a New Cycloplegic and Mydriatic Drug , Am. J. Ophth. 34:1593, 1952. 708. Priestley, B. S., and Medine, M. M.: New Mydriatic and Cycloplegic Drug , Am. J. Ophth. 34:572, 1951. 709. Feldman, J. B.: Lachesine (E3) , Am. J. Ophth. 34:442, 1951. 710. Drucker, A. P., and Kazort, R. J.: Clinical Trial of a New Atropine-Like Drug , Am. J. Ophth. 34:847, 1951. 711. Gettes, B., and Leopold, I. H.: Cholinergic Blocking Agents in Ophthalmology, read before the Fourth Wills Hospital Clinical Conference, March 22, 1952. 712. Herzog, H.: Additional Comment Regarding Toxic Manifestations After the Application of Scopolamine Ointment to the Eye , Klin. monatsbl. Augenh. 118:636, 1951. 713. Brown, H. S.; Reekie, R. D., and Sinclair, W. J.: Acute Herpes Zoster Treated with Banthine , Northwest Med. 50:432, 1951. 714. Tuede, K. M., and Cahea, R. L.: Action of Atropine on Sympathetic Ganglia , Federation Proc. 11:398, 1952. 715. Reiter, C.: A New Synergistic Mydriatic Combination , Am. J. Ophth. 35:412, 1952. 716. Rycroft, B. W., and Romanes, G. J.: Preliminary Report on the Use of Methonium Compounds and General Anesthesia in Ophthalmic Surgery , Brit. J. Ophth. 36:29, 1952. 717. Berger, P. S.; Nathanson, M., and Bender, M. B.: Electrical Recordings of Normal and Abnormal Eye Movements Modified by Drugs , A. M. A. Arch. Neurol. & Psychiat. 67:357, 1952. 718. Bender, M. B.; Nathanson, M., and Green, M.: Effect of Intravenous Tolserol in Normal and Abnormal Ocular Movements , Am. J. Ophth. 34:579, 1951. 719. Burn, J. H., and Robinson, J.: Noradrenalin and Adrenaline in Vessels of the Rabbit Ear in Relation to Action of Amine Oxidase , Brit. J. Pharmacol. 6:101, 1951. 720. Robinson, J.: Amine Oxidase in the Iris and Nictitating Membrane of the Cat and the Rabbit , Brit. J. Pharmacol. 7:99, 1952. 721. Thompson, R. H. S., and Tickner, A.: Amine Oxidase in the Large and Small Arteries and Veins of the Rabbit , J. Physiol. 115:34, 1951. 722. Thompson, R. H. S., and Tickner, A.: The Occurrence and Distribution of Monoamine-Oxidase in Blood Vessels , J. Physiol. 115:34, 1951. 723. Spink, A., and Burn, J. H.: Thyroid Activity and Amine Oxidase in the Liver , Brit. J. Pharmacol. 7:93, 1952. 724. Fink, A. I.: The Inhibition of Thiamine Chloride on the Retinal Responses Caused by Nicotine , Am. J. Ophth. 34:139, 1951. 725. Iitsuka, T.: The Study of Micrometry of the Retinal Vessels , Acta Soc. Ophth. Jap. 55:170, 1951. 726. Henkes, H. E.: The Use of Electroretinography in Measuring the Effect of Vasodilatation , Angiology 2:125, 1951.Crossref 727. Bonamour, G.: The Choice and Method of Use of Vasodilators in Retinal Vascular Occlusions , Ann. ocul. 184:729, 1951. 728. Yamagishi, H.: The Effect of Physical Influences on the Retinal Arterial Blood Pressure , Acta Soc. ophth. jap. 55:197, 1951. 729. Iwanaga, T.: Effects of the Nitrite Group on the Caliber of the Retinal Vessels , Acta Soc. ophth. jap. 55:178, 1951. 730. Ferrata, L.: Action of Vasoconstrictors and Angioscotometry , Ann. ottal. e clin. ocul. 77:115, 1951. 731. Zahn, K.: Influence of Nicotinic Acid on Angioscotomata , Ceskoslav. ofth. 7:407, 1951. 732. (a) Stern, J. J.: Priscoline, a New Vasodilator , Am. J. Ophth. 35:187, 1952. 733. (b) Cholst, M. R.; Schilback, H. F.; Handelsman, M. B., and Levitt, L. M.: Retinal Response to Priscoline , Am. J. Ophth. 35:191, 1952 734. (c) Response of the Retinal Vessels to Priscoline in Diabetes Mellitus , Cholst Am. J. Ophth. 35:375, 1952. 735. (d) Frank, N.; Strazza, J. A., Jr., and Helsber, J. T.: Effects of Priscol in Treatment of Peripheral Vascular Diseases , Ann. Int. Med. 35:19, 1951.Crossref 736. (e) Selecka, I.: Priscol in Therapy of Degenerative Myopia , Českoslov. ofth. 7:209, 1951. 737. (f) Zarrabi, M.: Observations on Priscol in Ophthalmology , Ophthalmologica 122:76, 1951.Crossref 738. (g) Gallois, J.: Acute Glaucoma Following Priscol Administration , Bull. Soc. ophth. France 2:131, 1951. 739. Frede, R.: Use of Priscol in Chronic Eye Disease with Particular Reference to Intravitreous Injection , Med. Klin. 46:519, 1951. 740. Rosenman, R. H.; Freed, S. C., and Friedman, M.: The Peripheral Vascular Reactivity of Potassium Deficient Rats , Circulation 5:412, 1952.Crossref 741. Friedman, M.; Freed, S. C., and Rosenman, R. H.: Effect of Potassium Administration on (1) Peripheral Vascular Reactivity and (2) Blood Pressure of the Potassium Deficient Rat , Circulation 5:415, 1952.Crossref 742. Coston, T. O.: Ocular Symptoms of Stellate Ganglion Block , Am. J. Ophth. 34:1289, 1951. 743. (a) Scott, D. H.: Stellate Ganglion Block for Cerebrovascular Accident Involving Homonymous Hemianopsia , A. M. A. Arch. Ophth. 45:471, 1951.Crossref 744. (b) Leriche, R.: Treatment of Embolism and Thrombosis of the Cerebral Vessels , Brit. M. J. 1:231, 1952.Crossref 745. (c) Vascular Spasm, editorial , Leriche Brit. M. J. 1:93, 1952.Crossref 746. Page, I. H., and McCubbin, J. W.: Influence of Thyroidal Function on Vascular Reactivity in Dogs , Circulation 5:390, 1952.Crossref 747. Page, I. H.: Humoral and Vasomotor Controls of Blood Vessels , Bull. New York Acad. Med. 28:131, 1952. 748. Sayne, H. W.; Scheinberg, P.; Rich, M., and Belle, M. S.: Effect of Intravenous Papaverine Hydrochloride on the Cerebral Circulation , J. Clin. Invest. 31:111, 1952.Crossref 749. (a) Shenkin, H. A.: Effect of Various Drugs Upon Cerebral Circulation and Metabolism of Man , J. Appl. Physiol. 3:465, 1951. 750. (b) Morita, S.: Experimental Studies of the Relation Between the Pituitary Body and Intraocular Pressure , Acta Soc. Ophth. Jap. 55:134, 1951. 751. (c) Goodwin, R. C.: Changes in the Intraocular Pressure in Normal and Glaucomatous Eyes Following Furmethide , Am. J. Ophth. 34:1139, 1951. 752. Lourie, E. M.: Pharmacological Effects of Some Derivatives of Furan and Choline , Brit. J. Pharmacol. 7:130, 1952. 753. Grewal, R. S.: Methyl Furmethide , Brit. J. Pharmacol. 6:696, 1951. 754. Iselle, R.: Synthetic Miotic TS219 , Českoslov. ofth. 7:174, 1951. 755. Radnot, M.: Effect of Hormones in Cases of Glaucoma , Szemészet ophth. Hungary 88:114, 1951. 756. Treumer, K.: Treatment of Glaucoma with Lutein Hormone , Klin. Monatsbl. Augenh. 118:644, 1951. 757. Davson, H., and Matchett, P. A.: The Control of the Intraocular Pressure in the Rabbit , J. Physiol. 113:387, 1951. 758. Eidelman, V. M.: The Comparative Action of Carbachol, Pilocarpine, E. serin and Proserine on the Intraocular Tension , Vestnik. oftal. 30:34, 1951. 759. van Alphen, G. W. H. M., and Stokvis, B.: Psychosomatic Aspects of Intraocular Pressure , Nederl. tijdschr. geneesk. 95:2246, 1951. 760. Keasling, H. H.; Featherstone, R. M.; Schueler, F. W., and Gross, E. G.: Further Observations on Anesthetization of Rabbit's Cornea by Non-Surface Anesthetics , Proc Soc. Exper. Biol. & Med. 77:31, 1951. 761. Grieg, M. B.; Holland, W. C., and Lindvig, P. E.: Anesthetization of the Rabbit's Cornea by Nonsurface Anesthetics , Brit. J. Pharmacol. 5:461, 1950. 762. Apter, J. G.: Significance of the Unilateral Argyll Robinson Pupil, read before the Chicago Ophthalmological Society, Jan. 21, 1952. 763. Karp, M., and Sokol, J.: Intravenous Use of Alcohol in a Surgical Patient , J. A. M. A. 146:21, 1951. 764. (a) Seegers, W. H.: Influence of Certain Drugs on Blood Coagulation and Related Phenomena , Pharmacol. Rev. 3:278, 1951. 765. (b) Wright, I. S.: Pathogenesis and Treatment of Thrombosis , Circulation 5:161, 1952.Crossref 766. (c) Rehbein, A.; Jaretski, A., and Habif, D. V.: Response of Dicoumarol-Induced Hypoprothrombinemia to Vitamin K , Ann. Surg. 135:454, 1952.Crossref 767. (d) Gruber, C. M.; Lee, K. S., and Rieders, F.: Absorption, Distribution and Activity of Tromexan , Federation Proc. 11:352, 1952. 768. (e) Stirling, M., and Hunter, R. B.: Pharmacology of Bis 3-3'-(4 Oxycoumarinyl) Ethyl Acetate (Tromexan) , Lancet 2:611, 1951.Crossref 769. (f) Mangieri, C. N.; Engelberg, R., and Randall, L. O.: The Heparin-Like Activity of a New Anticoagulant, Treburon , J. Pharmacol. & Exper. Therap. 102:156, 1951. 770. (g) Lituras, J.; Vorzuner, J. J.; Sussman, L. N.; Applezweig, M., and Etiss, A. D.: Sublingual Administration of Heparin , Proc. Soc. Exper. Biol. & Med. 77:325, 1951. 771. (h) Manchester, B.; Sageman, C. B.; Rabkin, B., and Hill, E. B.: Experience with the New Anticoagulant Paritol C , Ann. West. Med. & Surg. 6:209, 1952. 772. (i) Hour, G. W.; Armbrust, C. A., Jr.; Levy, M. D., and Wagner, E. L.: Preliminary Report of the Antirheumatic Action of Heparin and Paritol C , Am. J. M. Sc. 223:258, 1952. 773. (j) Glick, D., and Sylvén, B.: Evidence for the Heparin Nature of the Nonspecific Hyaluronidase Inhibitor in Tissue Extracts and Blood Serum , Science 113:388, 1951. 774. (k) Crane, C.: Use of Heparin-Gelatin-Dextrose in Venous Thrombosis and Pulmonary Embolism , New England J. Med. 245:926, 1951. 775. (l) Cartasegna, F.: Treatment of Thrombosis of the Retinal Veins with Dicoumarol , Rass. ital. ottal. 20:153, 1951. 776. (m) Gasparri, F.: Anticoagulant Treatment in Venous Thrombosis of the Retina , Boll. ocul. 30:309, 1951. 777. (n) Wellman, E. W., and Allen, E. B.: Variable Effects of Identical Amounts of Dicoumarol on Prothrombin Values of Different Persons , Proc. Staff Meet., Mayo Clin. 26:257, 1951. 778. (o) Tullock, J. A., and Gilchrist, A. R.: Tromexan in the Treatment of Coronary Thrombosis , Am. Heart J. 42:864, 1951. 779. (p) Antibiotics and Blood Coagulation, editorial , New England J. Med. 246:240, 1952. 780. (q) Long, C. N.: Antibiotics and Blood Coagulation , J. A. M. A. 142:49, 1950. 781. (r) Macht, D. I.: Influence of Some Drugs and of Emotions on Blood Coagulation , J. A. M. A. 148:265, 1952. 782. (s) Duff, I. F.; Falls, H. F., and Linman, J. W.: Anticoagulant Therapy in Occlusive Vascular Disease of the Retina , A. M. A. Arch. Ophth. 46:601, 1951. 783. (t) Zwiauer, A., and Deutsch, E.: Influence of the Prothrombin Level on the Coagulation of Albumin in the Aqueous of the Anterior Chamber , von Graefes Arch. Ophth. 151:744, 1951. 784. (u) Elrod, P. D.; McCleery, R. S., and Ball, C. O. T.: An Experimental Study of the Effect of Heparin on Survival Time Following Lethal Burns , Surg. Gynec. & Obst. 92:35, 1951. 785. (v) Zwiauer, A.; Bornschein, H., and Deutsch, E.: Effect of Anticoagulants on the Clotting in the Plasmoid Fluid and Its Significance for the Intraocular Pressure , Am. J. Ophth. 34:1403, 1951. 786. (w) Hanson, H.; Mann, F., and Barker, N. W.: Clinical Experience with Anticoagulant No. 63 , Circulation 4:844, 1951.Crossref 787. (x) Coon, R. W.; Flynn, J. E., and Vassar, P. S.: In Vivo and in Vitro Effects of a Lipid Inhibitor of Blood Clotting , Federation Proc. 10:352, 1951. 788. (y) Barker, N. W.; Hanson, H. H., and Mann, F. D.: Bishydroxycoumarin, Ethyl Biscoumacetate and 4-Hydroxycoumarin Anticoagulant No. 63 , J. A. M. A. 148:274, 1952.Crossref 789. (z) Overman, R. S.; Sorenson, C. W., and Wright, I. S.: Effectiveness of Synthetic Water-Soluble Vitamin K Preparations in Bishydroxycoumarin-Induced Hypoprothrombinemia , J. A. M. A. 145:393, 1951.Crossref 790. (a') Watkin, D. M.; Van Italie, T. B.; Logan, W. B.; Geyer, R. P.; Davidson, C. J., and Stone, F. J.: Treatment of Dicoumarol-Induced Hypoprothrombinemia in Man with Emulsified Vitamin K, Administered Intravenously , J. Lab. & Clin. Med. 37:269, 1951. 791. Wright.174b Rehbein, Jaretski, and Habif.174c Gruber, Lee, and Rieders.174d Stirling and Hunter.174e Mangieri, Engelberg, and Randall.174f Lituras and others.174g Manchester and others.174h Crane.174k Cartasegna.174l Gasparri.174m Tullock and Gilchrist.174o Duff, Falls, and Linman.174s 792. Wright.174b Coon, Flynn, and Vassar.174x 793. Watkin and others.174a' Rehbein and others 174c Overman, Sorenson and Wright.174z 794. Zwiauer and Deutsch.174t Zwiauer, Bornschein, and Deutsch.174v 795. (a) Spoerl, E.: The Lethal Effects of Radiation , Scient. Am. 185:22 ( (Dec.) ) 1951. 796. (b) Wolf, B. S.: Mechanism of Biological Effects of Radiation , J. Mt. Sinai Hosp. 18:330, 1952. 797. (c) Hempelman, L. H.; Lisco, H., and Hoffman, J. G.: The Acute Radiation Syndrome , Ann. Int. Med. 36:279, 1952. 798. (d) Christenberry, K. W., and Furth, J.: Induction of Cataracts in Mice by Slow Neutrons and X-Rays , Proc. Soc. Exper. Biol. & Med. 77:559, 1951. 799. (e) Cogan, D. G., and Donaldson, D. D.: Experimental Radiation Cataracts , A. M. A. Arch. Ophth. 45:508, 1951. 800. (f) Cogan, D. G.; Donaldson, D. D., and Reese, A. B.: Clinical and Pathological Characteristics of Radiation Cataract , A. M. A. Arch. Ophth. 47:53, 1952. 801. (g) Kimura, S. J., and Ikui, H.: Atomic Bomb Radiation Cataract , Am. J. Ophth. 34:811, 1951. 802. (h) Rabinowitz, A.: Medical Aspects of the Atomic Bomb , South African M. J. 25:488, 1951. 803. (i) von Sallmann, L.; Munoz, C. M., and Barr, E.: Experimental Studies on Early Lens Changes After Roentgen Irradiation , A. M. A. Arch. Ophth. 47:305, 1952. 804. (j) von Sallmann, L.; Dische, Z.; Ehrlich, G., and Munoz, C. M.: Study on Penetration of Cysteine and Cystine into the Aqueous Humor of Rabbits and Its Relation to Early X-Irradiation Effects on the Eye , Am. J. Ophth. 34:95, 1951. 805. (k) von Sallmann, L., and Munoz, C. M.: Further Efforts to Influence X-Ray Cataract by Chemical Agents , A. M. A. Arch. Ophth. 47:21, 1952. 806. (l) Slepyan, A. H., and Cornbleet, T.: Cysteine as a Local Protective to Human Skin Against X-Rays , A. M. A. Arch. Dermat. & Syph. 64:425, 1951. 807. (m) Trovati, E.: Visual Disturbances and Temporary Ophthalmoscopic Changes in Children After Cranial Roentgen Therapy for Ringworm , Ann. ottal. e clin. ocul. 77:127, 1951. 808. (n) Brattgard, S. O.: The Study of the Effects of X-Ray on the Ganglionic Cells of the Retina , Nord. med. 46:1422, 1951. 809. (o) Barber, A. N.; Brauer, R. W., and Muelling, R. J., Jr.: Studies on the Effects of Beta Irradiation Applied Circumferentially to the Ciliary Body of Rabbits , Am. J. Ophth. 34:175, (May (Pt. 2) ) 1951. 810. (p) Paufique, L.; Papillon, J., and Guinet, P.: Roentgen Therapy of Edematous Exophthalmos Without Hyperthyroidism , J. radiol. et. electrol. 32:21, 1951. 811. (q) Salerno, P. R.; Mattis, P. A., and Friedell, H. L.: Administration of Pharmacological Agents as a Protective Measure Against Lethal Effects of X-Irradiation in Mice , Federation Proc. 11:387, 1952. 812. (r) Burnett, W. T., Jr.; Stapleton, G. E.; Morse, M. L., and Hollaender, A.: Reduction of X-Ray Sensitivity of Escherichia Coli B/r by Sulfhydryl Compounds, Alcohols, Glycols, and Sodium Hydrosulfite , Proc. Soc. Exper. Biol. & Med. 77:636, 1951. 813. (s) Kahn, J. B., Jr.: Modification of Sensitivity to X-Irradiation by Morphine Sulfate , Proc. Soc. Exper. Biol. & Med. 78:486, 1951. 814. (t) Jacobson, L. O., and Robson, M. J.: Factors Affecting X-Ray Inhibition of Antibody Formation , J. Lab. & Clin. Med. 39:169, 1952. 815. (u) Burn, J. H.; Kordik, P., and Mole, R. H.: The Effect of X-Irradiation on the Response of the Intestine to Acetyl Choline and on Its Content of Pseudo-Cholinesterase , Brit. J. Pharmacol. 7:58, 1952. 816. (v) Anderson, C. T.; Blaschko, H.; Burn, J. H., and Mole, R. H.: Influence of X-Irradiation on Response of the Intestine , Brit. J. Pharmacol. 6:342, 1951. 817. (w) Roberts, J. E.: Some Clinical Applications of Radioactive Isotopes , Arch. Middlesex Hosp. 1:219, 1951. 818. (x) Mitchell, J. S.: Practical Aspects of Radioactive Isotopes in Relation to Medical Treatment , Brit. M. J. 2:747, 1951. 819. (y) Wormall, A.: Theoretical Aspects of Isotopes in Relation to Medicine , Brit. M. J. 2:757, 1951. 820. (z) Duffy, B. F., Jr., and Howland, J. W.: Radiophosphorus (P-32) in Diagnosis and Treatment , New York J. Med. 52:551, 1952. 821. (a') Thomas, C. I.; Krohmer, J. S., and Storaasli, J. P.: Detection of Intraocular Tumors with Radioactive Phosphorus , A. M. A. Arch. Ophth. 47:276, 1952. 822. (b') Eisenberg, J.; Sklaroff, D.; Leopold, I. H., and Hallett, J.: Radioactive Isotopes in the Differential Diagnosis of Intraocular Tumors, read before the Monthly Wills Hospital Conference, February, 1952. 823. (c') Chou, S. N.; Aust, J. B.; Moore, G. E., and Payton, W. P.: Radioactive Iodinated Human Serum Albumin as Tracer Agent for Diagnosing and Localizing Intracranial Lesions , Proc. Soc. Exper. Biol. & Med. 77:193, 1951. 824. (d') Moore, G. E.; Caudill, C. M.; Marvin, J. F., and others: Clinical and Experimental Studies of Intracranial Tumors with Fluorescein Dyes: With an Additional Note Concerning the Possible Use of K42 and Iodine 133 Tagged Human Albumin , Am. J. Roentgenol. 66:1, 1951. 825. (a) Fitzgerald, P. J.: Radioautography in Cancer , Cancer 5:166, 1952. 826. (b) Mayneord, W. V.: Radiography of the Human Body with Radioactive Isotopes , Lancet 1:276, 1952. 827. Footnote deleted. 828. Kass, I.: Studies on the in Vitro Effects of Radioactive 1-131 Labeled 3,5 Diiodoparaminosalicylic Acid on the Tubercle Bacillus , Am. Rev. Tuberc. 65:316, 1952. 829. Schurr, P. H.: Angiography of the Normal Ophthalmic Artery and Choroidal Plexus of the Eye , Brit. J. Ophth. 35:473, 1951. 830. Falls, H. F.; Bassett, R. C., and Lamberts, A. E.: Ocular Complications Encountered in Intracranial Arteriography , A. M. A. Arch. Ophth. 45:623, 1951. 831. di Luca, G.: Observations of Sympathetic Ophthalmitis from the Clinical and Therapeutic Point of View with Special Reference to X-Ray Therapy , Boll. ocul. 33:54, 1951. 832. (a) Belz and Bouchel: Ultrasound Therapy in Hemorrhage of the Vitreous , Lyon Med. 184:187, 1951. 833. (b) Belz: Ultrasonics in Ophthalmology , Ann. ocul. 184:673, 1951. 834. (a) Hallermann, W.; Basch, A., and Ladeburg, H.: The Effect of Ultrasonic Waves on the Animal Eye , Klin. Monatsbl. Augenh. 119:401, 1951. 835. (b) Krusen, H.: Present Status of the Use of Ultrasonic Energy in Physical Medicine , South. M. J. 45:55, 1952.Crossref 836. Lavine, C.; Langenstrass, K. H.; Bowyer, C. M.; Fox, S. E.; Griffin, G. B., and Thaler, W.: Effect of Ultrasonic Waves on the Refractive Media of the Eye , A. M. A. Arch. Ophth. 47:204, 1952.Crossref 837. (a) Barraquer-Moner, J. I.: The Present State of Tissue Therapy in Ophthalmology , Arch. soc. oftal. hispano-am. 11:837, 1951. 838. (b) Lijó Pavia, J., and Arouh, J.: Biogeno-Therapy in Ophthalmology , Rev. oto-neuro-oftal. 26:73, 1951. 839. (c) Arouh, J., and Lijó Pavia, J.: Biogenic Treatment in Ophthalmology , Arch. oftal. Buenos Aires 26:131, 1951. 840. (d) Karaz, Z.: Tissue Therapy in Ophthalmology , Oto-neuro-oftal. 6:42, 1951. 841. (e) Kriz, R.: Our Experience with Placental Extract , Českoslov. Ofth. 7:105, 1951. 842. (f) Wei, C. H.; Pai, H. L., and Yamazaki: Final Report on Cases Treated with Tissue Therapy , Chinese J. Ophth. 1:184, 1951. 843. (g) LeGrand, J.: Limitations of Tissue Therapy , Bull. Soc. opht. France 1:92, 1951. 844. (h) LeGroux, R.: Acute Hypertony After Placental Implantations in a Case of Retinitis Pigmentosa , Bull. Soc. opht. France 1:46, 1951 845. (i) Placental Implants: Therapeutic Results , LeGroux Bull. Soc. opht. France 1:47, 1951. 846. (j) Oudot, N.: Tissue Therapy in Some Cases of Severe Keratitis , Bull. Soc. opht. France 1:88, 1951. 847. (k) Macki, E. G.: Placental Implantations for Retinitis Pigmentosa , Proc. Soc. Med. 44:977, 1951. 848. (l) Bourdier, F.: The Use of Reticuloendothelial Sero-Therapy in Ophthalmology , Ann. ocul. 184:769, 1951. 849. (m) Azzolini, U., and Faldi, S.: Oidiumycine-101 in Ocular Therapy , Arch. ottal. 55:285, 1951. 850. (n) Granirer, L. W.: Clinical Response of Rheumatoid Arthritis to Postpartum Plasma: A Two-Year Study , J. A. M. A. 146:995, 1951.Crossref 851. (o) Dillon, R. N., and Majnarich, J. J.: Placental Extract in Treatment of Rheumatoid Arthritis , Northwest Med. 56:77, 1951. 852. (p) Stewart, H. L., Jr.: Hormone Secretion by Human Placenta Grown in the Eyes of Rabbits , Am. J. Obst. & Gynec. 61:990, 1951. 853. (q) Gaba, V.; Skacel, J., and Sabata, J.: Treatment of Eye Diseases with Refrigerated Autogenous Blood , Českoslov. ofth. 7:271, 1951. 854. Opsahl, Long, and Fry.65c Tarantino.101w Opsahl and Long.101y Pelloja.101z Granirer.189n Dillon and Majnarich.189o Stewart.189p 855. Johnson, E. A.: Intravenous Morphine in Ocular Surgery , Canad. M. A. J. 64:429, 1951. 856. (a) Farquharson, H.: Curare with Local Anesthesia in Cataract Surgery , Am. J. Ophth. 34:554, 1951. 857. (b) Cordes, F. C., and Mullen, R. S.: The Use of Curare in Cataract Surgery , Am. J. Ophth. 34:557, 1951. 858. (c) Escuin Vera, J. M.: Curare: One Thousand Cases of Administration in Ocular Surgery , Día méd. 23:64, 1951. 859. (d) Barraquer Moner, J.: Curare in Ocular Surgery , Presse méd. 59:1078, 1951. 860. (e) Curare in Ophthalmic Surgery , Arch. Soc. oftal. hispano-am. 11:683, 1951. 861. (f) Patterson, R. L.: The Use of Muscle Relaxing Drugs in Anesthesia , Anesth. & Analg. 31:65, 1952. 862. Offenbach, B.: Trichlorethylene as an Analgesic in Ophthalmic Practice , Am. J. Ophth. 35:250, 1952. 863. Scharf, J., and Grethe, H.: The Use of Trichlorethylene for Inhalation Analgesia in Ophthalmology , Klin. Monatsbl. Augenh. 119:49, 1951. 864. Leffingwell, F. E.: Office Practice of Anesthesia , J. A. M. A. 148:1181, 1952. 865. Deming, M. N.: Agents and Techniques for Induction of Anesthesia in Infants and Young Children , Anesth. & Analg. 31:113, 1952. 866. Good, M. G.: Theory of Local Anesthesia , Anesth. & Analg. 31:120, 1952. 867. (a) Moore, D. C.: Pontocaine Solutions for Regional Analgesia Other Than Spinal and Epidural Block , J. A. M. A. 146:803, 1951. 868. (b) Bonica, J. J.: Use of Pontocaine for Regional Anesthesia , Anesth. & Analg. 30:76, 1951. 869. Sadove, M. S.; Wyant, G. M.; Gittelson, L. A., and Kretchmer, H. E.: Classification and Management of Reactions to Local Anesthesic Agents , J. A. M. A. 148:17, 1952. 870. Ludenna, F. P., and Hoppe, J. O.: Local Anesthetic Activity, Toxicity and Irritancy of 2-Alkoxy Analogs of Procaine and Tetracaine , J. Pharmacol. & Exper. Therap. 104:40, 1952. 871. Thiel, R.: Corneal Injury Through Misuse of Analgesics , Deutsche med. Wchnschr. 76:278, 1951. 872. Lane, C. G., and Luikart, R.: Dermatitis from Local Anesthetics , J. A. M. A. 146:717, 1951.Crossref 873. Weisel, W., and Tela, R. A.: Reaction to Tetracaine (Pontocaine) Used as a Topical Anesthetic in Bronchoscopy , J. A. M. A. 147:218, 1951.Crossref 874. Ireland, P. E.; Fergusson, J. K. W., and Stark, E. G.: Clinical and Experimental Comparison of Cocaine and Pontocaine as Topical Anesthetics in Otolaryngological Practice , Laryngoscope 61:767, 1951.Crossref 875. Young, P. A.: Duration of Cocaine Anesthesia in the Rabbit Cornea , Brit. J. Pharmacol. 60:73, 1951. 876. Tullar, P. E.: Local Anesthetic Studies with Procaine and Xylocaine , Federation Proc. 11:398, 1952. 877. Sadove, M. S.; Wynant, G. M.; Kretchmer, H. E., and Gittelson, L. A.: Procaine Amide: A Clinical Study , Anesth. & Analg. 31:45, 1952. 878. Fellows, E., and Mackoe, J. P.: Topical Anesthetic Activity of an Isoquinoline Compound , J. Pharmacol. & Exper. Therap. 103:306, 1951. 879. Cullen, S. C., and Gross, E. G.: The Anesthetic Properties of Xenon in Animals and Human Beings with Additional Observations on Krypton , Science 113:580, 1951. 880. Winter, C. A., and Flataker, L.: The Effect of Cortisone, Desoxycorticosterone and ACTH on the Response of Animals to Analgesic Drugs , J. Pharmacol. & Exper. Therap. 103:93, 1951. 881. Kalow, W.: Hydrolysis of Local Anesthetics by Human Serum Cholinesterase , J. Pharmacol. & Exper. Therap. 104:122, 1952. 882. Kennedy, R. J., and McGannon, W. J.: Stellate Ganglion Block in Retinitis Pigmentosa , A. M. A. Arch. Ophth. 47:287, 1952. 883. Coston.158 Scott. 159a Leriche.159b Editorial.159c 884. Pollin, I. M., and Deutsch, E. V.: Death Following Stellate Ganglion Block , Ann. Surg. 133:232, 1951. 885. Cohen, E. N., and Beecher, H. K.: Narcotics in Preanesthetic Medication , J. A. M. A. 147:1664, 1951. 886. (a) Freis, E. D.: Veratrum Viride and Hexamethonium in the Treatment of Severe Diastolic Hypertension , M. Ann. District of Columbia 20:297, 1951. 887. (b) Schroeder, A. A.: Effects of (1) Hydrazinophthalozine in Neurogenic Hypertension, read before the 24th Scientific Sessions of the American Heart Association, Atlantic City, June 8, 1951. 888. (c) Page, I. H.: Treatment of Essential Malignant Hypertension , J. A. M. A. 147:1311, 1951. 889. (d) Corcoran, A. C.; Taylor, R. D., and Page, I. H.: Controlled Observations on Effect of Low-Sodium Dieto-Therapy in Essential Hypertension , Circulation 3:1, 1951. 890. (e) Smirk, F. H.: Methonium Halides in High Blood Pressure , Science 114:4, 1951. 891. (f) Taylor, R. D.; Page, I. H., and Corcoran, A. C.: A Hormonal Neurogenic Vasopressor Mechanism , A. M. A. Arch. Int. Med. 88:1, 1951. 892. (g) Hormonal Cerebral Vasopressor Substance, editorial , J. A. M. A. 146:1326, 1951. 893. (h) Campbell, A. J. M.; Graham, J. G., and Maxwell, R. D. H.: Treatment of Hypertension by Oral Methonium Compounds , Brit. M. J. 1:251, 1952. 894. (i) Murphy, E. A.: Treatment of Hypertension with Hexamethonium Bromide , Lancet 2:899, 1951.Crossref 895. (j) Smirk, F. H., and Alstad, K. S.: Treatment of Arterial Hypertension by Penta- and Hexamethonium Salts , Brit. M. J. 1:1217, 1951.Crossref 896. (k) Peersson, I.: Treatment of Arterial Hypertension with Hexamethonium Bromide , Nord. med. 46:1564, 1951. 897. (l) Mackey, W. A., and Shaws, G. B.: Oral Hexamethonium Bromide in Essential Hypertension , Brit. M. J. 2:259, 1951.Crossref 898. (m) Shapiro, A. P., and Ferris, E. B.: The Effects of Intravenously Administered Veratrum Viride in Hypertension and Normotensive Subjects , Ann. Int. Med. 36:792, 1952.Crossref 899. (n) Anderson, W. B.: Fundus Changes Before and After the Rice Diet , Tr. Am. Acad. Ophth. 55:627, 1951. 900. (o) Rice, T. B.: Low-Sodium Diet: A Manual for the Patient , Philadelphia, Lea & Febiger, 1951. 901. (p) Loofbourow, D. G.; Callahan, D., and Palmer, R. S.: A Rice Diet in Ambulatory Patients with Essential Hypertension: A Two-Year Study of 105 Patients , New England J. Med. 244:577, 1951.Crossref 902. (q) Wolferth, C. C.; Jeffers, W. A.; Lukens, F. D. W., and others: Observations on Results of Subtotal Adrenalectomy in Treatment of Severe, Otherwise Intractable Hypertension and Their Bearing on Mechanism by Which Hypertension is Maintained , Ann. Int. Med. 35:8, 1951.Crossref 903. (r) Borsook, H., and Borsook, M. E.: Biochemical Basis of Betaine-Glycocyamine Therapy , Ann. West. Med. & Surg. 5:825, 1951. 904. (s) Graybiel, A., and Patterson, C. A.: Use of Betaine-Glycocyamine in Treatment of Patients with Heart Disease , Ann. West. Med. & Surg. 5:863, 1951. 905. (t) Feinberg, A. W., and Rosenberg, B.: Use of Carboxylic Cation Exchange Resins in Therapy of Congestive Heart Failure , Am. Heart J. 42:698, 1951. 906. (u) Wood, J. E., Jr.; Ferguson, D. H., and Lawrence, T.: Cation Exchange Resins as an Adjunct in Treatment of Heart Failure , J. A. M. A. 148:820, 1952. 907. (v) McChesney, E. W.; Dock, W., and Tainter, M. L.: Ion Exchange Resins in Edema , Medicine 30:183, 1951. 908. (w) Nickel, J. F.; Lowrance, P., and Leifer, E.: Effect of Sodium Depletion and Repletion on Renal Function and Body Fluids During Uremia , J. Clin. Invest. 30:664, 1951. 909. (x) Martz, B. L.; Kohlstaedt, K. G., and Heiner, O. M.: Use of a Combination of Anion and Cation Exchange Resins in the Treatment of Edema and Ascites , Circulation 5:524, 1952. 910. (y) Danowski, T. S.; Greenman, L.; Reters, J. H., and Mateer, F. M.: An Introduction to Experimental and Clinical Studies of Carboxylic Cation Exchange Resins , J. Clin. Invest. 30:979, 1951. 911. (z) Duncan, C. F.: Theory and Practice of Ion Exchange , Nature, London 169:22, 1952. 912. Lippman, R. W.: Cation Exchange Resin in Treatment of Nephrotic Syndrome , A. M. A. Arch. Int. Med. 88:9, 1951. 913. Chapman, D. W.; Pannill, F. C., Jr., and Skaggs, R. H.: New Cation Exchange Resins in Therapy of Edematous States , Am. Pract. & Digest. Treat. 2:945, 1951. 914. Emerson, K., Jr.; Conn, S. S.; Vester, J. W., and Nelson, K. P.: Oral Use of Cation Exchange Resins in Treatment of Edema , A. M. A. Arch. Int. Med. 88:605, 1951. 915. McChesney, E. W.; Dock, W., and Tainter, M. L.: Ion Exchange Resins in Edema , Medecine 30:183, 1951.Crossref 916. Flanagan, T. L.; Sax, M. F., and Heming, A. E.: Toxicity Studies on Amberlite XE-96, A Carboxylic Type Cation Exchange Resin , J. Pharmacol. & Exper. Therap. 103:215, 1951. 917. McChesney, E. W.: Studies on Cation Exchange Resins , J. Lab. & Clin. Med. 38:199, 1951. 918. Lee, R. E., and Holze, E. A.: Peripheral Vascular Hemodynamics in Bulbar Conjunctiva of Subjects with Hypertensive Vascular Disease , J. Clin. Invest. 30:539, 1951. 919. Schlezinger, N. S.: Present Status of Therapy in Myasthenia Gravis , J. A. M. A. 148:508, 1952. 920. Holmes Sellors, T.: Surgery of the Thymus Gland and Myasthenia Gravis , Arch. Middlesex Hosp. 2:1, 1952. 921. Kemp Harper, R. H.: The Investigation of Thymic Tumors in Myasthenia Gravis , J. Fac. Radiologists 3:164, 1952. 922. McKeever, G. E.: Myasthenia Gravis in a Mother and a Newborn Son , J. A. M. A. 147:320, 1951. 923. Botelho, S.; Deaterly, C. F., and Comroe, J. H., Jr.: Electromyogram from Orbicularis Oculi in Normal Persons and in Patient with Myasthenia Gravis , A. M. A. Arch. Neurol. & Psychiat. 67:348, 1952. 924. (a) Chaikoff, I. L., and Chernick, S. S.: Significance of Endogenous Cholesterol in Arteriosclerosis , Science 113:47, 1951. 925. (b) Blood Lipids in Atherosclerosis, editorial , J. A. M. A. 148:207, 1952. 926. (c) Keyes, A.: (Cholesterol Giant Molecules) in Atherosclerosis , J. A. M. A. 147:1514, 1951. 927. (d) McMahon, A.; Allen, H. N.; Weber, C. J., and Missey, W. C., Jr.: Hypercholesterolemia , South. M. J. 44:993, 1950. 928. (e) Stampler, J., and Katz, L. M.: Effect of Pancreatectomy on Lipemia, Tissue Lipidosis and Atherogenesis in Chicks , Circulation 4:255, 1951. 929. (f) Pollak, O. J., and Wadler, P.: Studies in Experimental Atherosclerosis , J. Gerontol. 6:217, 1951. 930. (g) Fredman, M.; Byers, S. O., and Rosenman, R. H.: Accumulation of Serum Cholate and Its Relationship to Hypercholesterinemia , Science 115:313, 1952. 931. (h) Wilmot, V. A., and Swank, R. L.: The Influence of Low-Fat Diet on Blood Lipid Levels in Health and in Multiple Sclerosis , Am. J. M. Sc. 223:25, 1952. 932. (i) Kellner, A.: Lipid Metabolism and Atherosclerosis , Bull. New York Acad. Med. 28:11, 1952. 933. (j) Priddle, W. W.: Hypercholesteremia , Ann. Int. Med. 35:836, 1951. 934. (k) Tuttle, E.: Dietary Cholesterol and Atherosclerosis , Geriatrics 7:37, 1952. 935. (1) Pollak, O. J.: Report on Current Trends in Arteriosclerosis Research , Geriatrics 7:59, 1952. 936. (m) Popkin, R. J.: Evaluation of Inositol in Treatment of Arteriosclerosis Obliterans , Angiology 2:398, 1951.Crossref 937. (n) Morrison, L. M.: Arteriosclerosis , J. A. M. A. 145:1232, 1951.Crossref 938. (o) Davidson, J. D.; Meyer, W., and Kendall, F. E.: Effect of Choline upon Experimental Canine Arteriosclerosis , Circulation 3:332, 1951.Crossref 939. (p) Gofman, J. W.; Lindgren, F. T.; Jones, H. B.; Lyon, T. P., and Strisower, B.: Lipoproteins and Atherosclerosis , J. Gerontol. 6:105, 1951.Crossref 940. (q) Gold, H.: Low Cholesterol Diet in the Treatment of Atherosclerosis , Am. J. Med. 12:357, 1952.Crossref 941. (r) Lindgren, F. T.; Elliott, H. H., and Gofman, J. W.: The Ultracentrifugal Characterization and Isolation of Human Blood Lipids and Lipoproteins with Applications to the Study of Atherosclerosis , J. Phys. & Colloid Chem. 55:80, 1951. 942. (s) Gofman, J. W., and Jones, H. B.: Obesity, Fat Metabolism and Cardiovascular Disease , Circulation 5:514, 1952. 943. (t) Pierce, F. I., Jr.: The Relationship of Serum Lipoproteins to Atherosclerosis in Cholesterol Fed Alloxanized Rabbit , Circulation 5:401, 1952. 944. (u) Steiner, A.; Kendall, F. E., and Mathers, J. A. L.: The Abnormal Serum Lipid Pattern in Patients with Coronary Arteriosclerosis , Circulation 5:605, 1952. 945. (v) Epstein, N. N.; Rosenman, R. H., and Gofman, J. W.: Serum Lipoproteins and Cholesterol Metabolism in Xanthelasma , A. M. A. Arch. Dermat. & Syph. 65:70, 1952. 946. (w) Van Itallie, B. T.; Waddell, W. R.; Geyer, R. P., and Stone, F. J.: Clinical Use of Fat Injected Intravenously , A. M. A. Arch. Int. Med. 89:353, 1952. 947. (x) Eggers, H.: Lipotropic Substances for the Absorption of Vitreous Opacities , New York. J. M. 51:2255, 1951. 948. Editorial.216b Kellner.216i Tuttle.216k Pollak.216l Gofman and others.216p Gold.216q Lindgren, Elliott, and Gofman.216r Gofman and Jones.216s Pierce.216t Steiner, Kendall, and Mathers.216u 949. Code, C. F.: Histamine in Blood , Physiol. Rev. 32:47, 1952. 950. Gaddum, J. H.: Metabolism of Histamine , Brit. M. J. 2:987, 1951. 951. Cuco, G.: Histamine and Permeability of the Blood-Eye Barrier , Ann. ottal. e clin. ocul. 77:118, 1951. 952. d'Ermo, F.: Ocular Changes in the Course of Anaphylactic Shock in the Guinea Pig and Rabbit , Acta allergol. 4:270, 1951. 953. Bowman, K. L.; Siegel, B. B., and Walzer, M.: Influence of a Single Dose of ACTH on the Atopic and Histamine Skin Reactions , J. Allergy 23:130, 1952. 954. Shure, N., and Harris, M. C.: Evaluation of Drugs Used in the Management of Allergy , M. Clin. North America 35:1543, 1951. 955. Azzolini, U., and Faldi, S.: Experimental Cataract Due to Synthetic Antihistaminic Drugs , Boll. ocul. 31:29, 1951. 956. (a) Leong Way, E., and Herbert, W. C.: Effect of Sodium Pentobarbital on the Toxicity of Certain Antihistaminics , J. Pharmacol. & Exper. Therap. 104:115, 1952. 957. (b) Wyngaarden, J. B., and Seevers, M. H.: Toxic Feature of Antihistaminics , J. A. M. A. 145:277, 1951. 958. (c) Lecks, H. I.: Acute Antihistamine Toxicity in Children , Quart. Rev. Pediat. 6:294, 1951. 959. Guerrant, J. L., and Hollifield, W. C.: Palpebral Dermatitis , Am. J. Ophth. 34:1318, 1951. 960. Komi, T.: Effect of Antihistaminic Drugs on the Rabbit Eye , Acta Soc. ophth. jap. 55:379, 1951. 961. d'Ermo, F., and Salvi, G. L.: Antihistaminic Drugs in the Eye , Boll. ocul. 30:3, 1951. 962. d'Ermo, F., and Santirocco, N.: Antihistaminic Drugs in the Eye , Boll. ocul. 30:99, 1951. 963. d'Ermo, F.: Antihistaminic Drugs in the Eye , Boll. ocul. 30:135, 1951. 964. Kulscher, A. H., and Chilton, H. W.: Effect of Antihistaminics on the Pain Threshold , Am. J. M. Sc. 223:239, 1952. 965. Moynahan, S. J.: Observations on the Effect of Antihistamine Drugs in the Reactions of the Skin Vessels to Carbaminoyl Choline , Brit. J. Dermat. 64:1, 1952. 966. Perry, D. T.; Hosmer, J. A., and Sternberg, T. H.: Urticarogenic Action of a Choline Ester Can be Modified or Obliterated by Antihistaminic Drugs , J. Invest. Dermat. 16:31, 1951. 967. (a) Chalmers, J. N. M.: Drug-Induced Blood Disease , Practitioner 168:235, 1952. 968. (b) Menzel, W., and Wilhoeft, I.: Hyperplastic Late Reaction of Blood-Forming Organs to Intoxication with Dichlor-Diethyl Sulfide (Mustard Gas) , Folia hæmat. 70:278, 1951. 969. (c) Modell, W., and Patterson, R.: Intestinal Bleeding Associated with Acetylsalicylic Acid , J. A. M. A. 147:124, 1951. 970. (d) Gelfand, M. L.: Visual Symptoms After Digitoxin Therapy , J. A. M. A. 147:1231, 1951. 971. (e) Cohen, B.: Digitalis Poisoning and Its Treatment , New England J. Med. 246:254 972. 225, 1952. 973. (f) Brooke, C., and Boggs, T.: Boric Acid Poisoning , A. M. A. Am. J. Dis. Child. 82:465, 1951. 974. (g) Slinger, W. N., and Hubbard, D. M.: Treatment of Seborrheic Dermatitis with a Shampoo Containing Selenium Sulfide , A. M. A. Arch. Dermat. & Syph. 64:41, 1951. 975. (h) Filatova, B. C.: Toxicity of Selenium Anhydride , Gigiena Sanit. 5:18, 1951. 976. (i) Ahlborg, G.: Hydrogen Sulfide Poisoning in Shale Oil Industry , A. M. A. Arch. Indust. Hyg. 3:247, 1951. 977. (j) Davidson, H. H.; Hingson, R. A., and Hellman, L. M.: Use of Various Plastic Catheters in the Subarachnoid and Peridural Spaces , A. M. A. Arch. Surg. 62:540, 1951.Crossref 978. (k) Ridley, H.: Intra-Ocular Acrylic Lenses: Recent Development in Surgery of the Cataract , Brit. J. Ophth. 36:113, 1952Crossref 979. (l) Tr. Ophth. Soc. U. Kingdom 71:617, 1951 980. (m) Intra-Ocular Acrylic Lenses After Cataract Extraction , Lancet 1:118, 1951. 981. (n) Vail, D.: Lint in the Anterior Chamber Following Intraocular Surgery , Am. J. Ophth. 34:1533, 1951. 982. (o) Enns, J. H.: Human Galactosemia Cataract , Am. J. Ophth. 34:1268, 1951. 983. (p) Reiter, C., and Lasky, M. A.: Galactose Cataractogenesis , Am. J. Ophth. 35:69, 1952. 984. (q) Falls, H. F.; Lowrey, G. H.; Anderson, W., and Glayton, C., Jr.: Galactosemia Cataract , Am. J. Ophth. 34:1271, 1951. 985. (r) Bellows, J.: Lens and Vitreous , A. M. A. Arch. Ophth. 47:516, 1952.Crossref 986. (s) Daily, L., Jr.; Zeller, E. A.; Wakin, J. G.; Herrick, J. F., and Benedict, W. L.: Microwaves and the Lens , Am. J. Ophth. 34:1301, 1951. 987. (t) Morillas, D.: Spastic Paraparesis and Bilateral Cataract Following an Electric Shock , Actas luso-españ. neurol. y psiquiat. 10:69, 1951. 988. (u) Habenberger: Change in the Fundus After a Lesion Due to a High-Frequency Current , Wien. klin. Wchnschr. 63:209, 1951. 989. (v) Lijo Pavia, J.: Radiations and the Ocular Alterations They Produce , Rev. oto-neuro-oftal. 26:25, 1951. 990. (w) Sykowski, P.: Ethylene Glycol Toxicity , Am. J. Ophth. 34:1599, 1951. 991. (x) di Ferdinando, R.: Lead Poisoning with Optic Neuritis Due to the Morocco Leather of the Patient's Hat , Gior. ital. oftal. 4:344, 1951. 992. (y) Roda, E.: Iritis of Unknown Cause Treated with Nitrogen Mustard , Arch. Soc. oftal. hispano-Am. 11:645. 1951. 993. (z) Jimenez Diaz, C.: Treatment of Dysreaction Diseases with Nitrogen Mustards , Ann. Rheumat. Dis. 10:144, 1951.Crossref 994. (a') Mitchell, R. G.: Laburnum Poisoning in Children , Lancet 2:57, 1951.Crossref 995. (b') Fink, A. I.: Carbon Monoxide Asphyxia with Visual Sequelae , Am. J. Ophth. 34:1024, 1951. 996. (c') Krejek, F.; Marlo, Z., and Soucek, B.: Experimental Carbon Disulfide Poisoning , Praktyka Lekanska, 1951, p. 124. 997. (d') Esente, I.: Ocular Manifestations in Acute Barbiturate Poisoning , Gior. ital. oftal. 4:162, 1951. 998. (e') Pagliarani, N.: Neuroocular Complications Due to Antirabic Vaccination , Riv. oto-neuro-oftal. 26:200, 1951. 999. (f') Sarkies, J. W. R.: Ophthalmoplegia Following a Scorpion Bite , Brit. J. Ophth. 35:502, 1951.Crossref 1000. (g') Roberts, A. E.: Platinosis: Five-Year Study of Effects of Soluble Platinum Salts on Employees in Platinum Laboratory and Refinery , A. M. A. Arch. Indust. Hyg. 4:549, 1951. 1001. Duffy, T. L., and Drehl, A. M.: Ferrous Sulfate Poisoning , J. Pediat. 40:1, 1952.Crossref 1002. Deichmann, W. B.; Pugliese, W., and Cassidy, J.: Effects of Dimethyl and Diethyl Paranitrophenyl Thiophosphate on Experimental Animals , A. M. A. Arch. Indust. Hyg. 5:44, 1952. 1003. Hamblin, D. O., and Marchand, J. F.: Parathion Poisoning , Am. Pract. & Digest Treat. 2:1, 1951. 1004. Bidstrup, P. L., and Payne, D. J. H.: Poisoning by Dinitro-Ortho-Cresol , Brit. M. J. 2:16, 1951. 1005. Aldridge, W. N., and Barnes, J. M.: Some Problems in Assessing Toxicity of the Organo-Phosphorus Insecticides Toward Mammals , Nature, London 169:345, 1952. 1006. Bergman, B. B.: Tetryl Toxicity , A. M. A. Arch. Indust. Hyg. 5:10, 1952. 1007. Morris, G. E.: Condensation Plastics , A. M. A. Arch. Indust. Hyg. 5:37, 1952. 1008. Schiff, B. L.: Contact Dermatitis Caused by Bamboo , A. M. A. Arch. Dermat. & Syph. 64:66, 1951. 1009. Van Ordstrand, H. S.: Beryllium Poisoning , Ann. Int. Med. 35:1203, 1951. 1010. White, M. R.; Finkel, A. J., and Schubert, J.: Protection Against Experimental Beryllium Poisoning of Aurin Tricarboxylic Acid , J. Pharmacol. & Exper. Therap. 102:88, 1951. 1011. Sterner, J. H., and Eisenbud, M.: Epidemiology of Beryllium Intoxication , A. M. A. Arch. Indust. Hyg. 4:123, 1951. 1012. Curtis, G. H.: Cutaneous Hypersensitivity Due to Beryllium , A. M. A. Arch. Dermat. & Syph. 64:470, 1951. 1013. Ginsberg, J. E., and Becker, L. A.: Silicon Granuloma of Skin Due to Traumatic Sand Inoculation , J. A. M. A. 147:751, 1951. 1014. Capri, A., and Alagna, G.: Action of Leucotaxin on the Cornea , Arch. ottal. 55:7, 1951. 1015. Leepton, C. H.: Treatment of Burns , J. Internat. Coll. Surgeons 17:354, 1952. 1016. Curtis, R. M.; Brewer, J. H., and Rose, I. W., Jr.: New Technique for Local Treatment of Burns , J. A. M. A. 147:741, 1951. 1017. Cruithirds, A. E.: Sulfhydryl Therapy in Ophthalmology: Progress Report , Ann. West. Med. & Surg. 5:554, 1951. 1018. McLaughlin, R. S.: Chemical Burns of the Eye , South. M. J. 44:446, 1951Crossref 1019. Hydrosulphosol as a Treatment of Chemical Burns of the Eye , Am. J. Ophth. 35:21, 1952. 1020. Harley, R. D.: An Experimental Study on the Evaluation of Hydrosulphosol in the Treatment of Ocular Injuries Due to Chemical Burns , Tr. Am. Ophth. Soc. 49:557, 1951. 1021. Strauss, J. S., and Rosenberg, E. J.: BAL Therapy of Gold Intoxication , Proc. Inst. Med. Chicago 18:330, 1951. 1022. Denny-Brown, D., and Porter, H.: Effect of BAL on Hepatolenticular Degeneration , Tr. Am. Neurol. A. , 1951. 1023. Cummings, J. N.: Effects of BAL in Hepatolenticular Degeneration , Brain 74:10, 1951.Crossref 1024. (a) Flaxman, N.: Drug Fatalities , J. A. M. A. 147:337, 1951. 1025. (b) The Use of New Drugs, editorial , Flaxman J. A. M. A. 147:62, 1951. 1026. Dunham, C. L.; Cronkite, E. P.; Leroy, G. V., and Warren, S.: Atomic Bomb Injury: Radiation, Council on National Emergency Medical Service , J. A. M. A. 147:50, 1951.Crossref 1027. Cady, L. D., and Miller, J. E.: A Symposium on Effects of Atomic Explosions , Mil. Surgeon 110:165, 1952. 1028. (a) Szewzzky, S. T.: Retrolental Fibroplasia: Etiology and Prophylaxis , Am. J. Ophth. 34:1649, 1951 1029. (b) Retrolental fibroplasia , Szewzzky Am. J. Ophth. 35:301, 1952. 1030. (c) Ingalls, T. H.; Tedeschi, C. G., and Helpern, M. M.: Malformations Induced by Maternal Anoxia , Am. J. Ophth. 35:311, 1952. 1031. (d) Ryan, H.: Retrolental Fibroplasia , Am. J. Ophth. 35:329, 1952. 1032. (e) Campbell, K.: Intensive Oxygen Therapy as a Possible Cause of Retrolental Fibroplasia , M. J. Australia 2:48, 1951. 1033. (f) Lelong, N.; Renard, G.; Rossier, A.; Lemasson, C., and Michelin, J.: The Retinopathy of Premature Infants , Presse. méd. 59:705, 1951. 1034. Lodato, G.: Experimental Retinitis Pigmentosa Due to Sodium Iodate in Albino Rabbits , Gior. ital. oftal. 4:226, 1951 1035. Experimental Pigmentary Degeneration of the Retina in Rabbits Undergoing Filatov's Treatment , Lodato Gior. ital. oftal. 4:125, 1951. 1036. Harrell, G. T., Jr., and Aikawa, J. K.: Alterations in Permeability of Membranes During Infections , J. A. M. A. 147:232, 1951.Crossref 1037. Trevor-Roper, T. D.: Present Status of Physiotherapy in Ocular Disease , Brit. J. Ophth. 35:583, 1951.Crossref 1038. Hoffmann, W.: A Lamp for the Ultraviolet Irradiation of the Anterior Segment of the Eye , Klin. Monatsbl. Augenh. 119:41, 1951. 1039. Paufique, L., and Rougier, J.: Treatment with Beta Rays in Ocular Disease , Ann. ocul. 184:577, 1951. 1040. Cutler, S. S.; Burbank, B., and Marzullo, E. R.: Hypocoagulability of Certain Irradiated Plasmas , J. A. M. A. 143:1057, 1950.Crossref 1041. Kaplan, S. R., and Freedman, I. A.: Effects of Ultraviolet Ray Irradiation on Clotting Mechanism of Plasma , J. A. M. A. 147:229, 1951.Crossref 1042. Rhoades, A. L.: Uveitis , Jackson Clin. Bull. 13: (Nov.) , 1951. 1043. Farmer, D. F.; Sullivan, C. P., and Sullivan, W. B.: The Use of Hemoirradiation (Knott Technique) in Eye Infections, at a meeting of the American Blood Irradiation Society, Atlantic City, N. J., June 9, 1951. 1044. (a) Wild, J. J., and Neal, D.: Use of High Frequency Ultrasonic Waves for Detecting Changes of Texture in Living Tissues , Lancet 1:655, 1951Crossref 1045. (b) Experimental Application of Ultrasonics to the Localization of Brain Tumors , J. Neurosurg. 8:198, 1951.Crossref 1046. (c) Ultrasonics in Diagnosis, editorial , J. A. M. A. 146:1033, 1951.Crossref 1047. Belz and Bouchel.186a Belz.186b Hallermann and others.187a Krusen.187b Lavine.188 1048. (a) Stuart, E. G.: Accelerating Effect of Pyromen in Contrast to Inhibitory Effect of Cortisone on Arthus Phenomenon in Rabbits , Federation Proc. 10:133, 1951 1049. (b) Accelerating Effect of Pyromen in Contrast to Inhibitory Effect of Cortisone on Arthritis Phenomenon in Rabbits , Am. J. M. Sc. 221:470, 1951.Crossref 1050. (c) Clemente, C. D.; Chambers, W. W.; Greene, L. C.; Mitchell, S. Q., and Windle, W. F.: Regeneration of the Transected Spinal Cord of Adult Cats , Anat. Rec. 109:280, 1951. 1051. (d) Zindler, G. A.: Pyromen therapy in the Treatment of Food Allergy , Ann. Allergy 9:494, 1951. 1052. (e) Wittich, F. W.: Pyromen in the Treatment of Perennial Respiratory Allergies , Ann. Allergy 9:502, 1951. 1053. (f) Clemente, C. D.: Production of Periods of Leukocytosis and Tolerance of Consecutive Oral Administration of Different Bacterial Pyrogens , Federation Proc. 10:27, 1951. 1054. (g) Soylemezogou, B., and Wells, J. A.: Comparison of Leukocyte Response to ACTH and Bacterial Pyrogen , Proc. Soc. Exper. Biol. & Med. 77:43, 1951. 1055. Alvis, V. Y.: The Role of Hyperpyrexia in the Management of Ocular Inflammatory Disease , Am. J. Ophth. 34:1741, 1951. 1056. Newell, F.: Foreign Protein Therapy in Ophthalmology , Am. J. Ophth. 34:1189, 1951. 1057. Wolffersdorff, H. V.: "Pyrifer" Therapy in Different Optic Nerve Affections in the Period 1939-1950 , Klin. Monatsbl. Augenh. 119:271, 1951. 1058. (a) Huck, H.: Usefulness of Fluorescein in Testing the Permeability of the Lachrymal Passage , Ophthalmologica 121:110, 1951. 1059. (b) Hager, H.: A Simple Apparatus for Fluorescein Measurements in the Anterior Chamber , Klin. Monatsbl. Augenh. 119:81, 1951. 1060. (c) Miller, S. J. H., and Swanljung, H.: Appearance of Fluorescein in the Aqueous of Glaucomatous Eyes , Brit. J. Ophth. 35:356, 1951. 1061. (a) Woods, A. C.: The Ocular Changes of Hyperthyroidism , West. J. Surg. 59:288, 1951. 1062. (b) Medine, M. M.: Malignant Exophthalmos , Am. J. Ophth. 34:1587, 1951. 1063. (c) Beierwaltes, W. H.: Irradiation of the Pituitary in Treatment of Malignant Exophthalmos , J. Clin. Endocrinol. 11:512, 1951.Crossref 1064. (d) Van Manen, J. G.: Exophthalmic Ophthalmoplegia , Ophthamologica 122:207, 1951.Crossref 1065. (e) Hermann, K.: Pituitary Exophthalmos: An Assessment of Methods of Treatment , Brit. J. Ophth. 36:1, 1952.Crossref 1066. (f) Cope, O.: Diseases of the Thyroid , New England J. Med. 246:408; 368; 451, 1952.Crossref 1067. (g) Wing, E. S., and Asper, S. P., Jr.: Propyl Thiouracil in Hyperthyroidism , Bull. Johns Hopkins Hosp. 92:1, 1952. 1068. (h) Mann, I.: A Further Report on Exophthalmic Ophthalmoplegia and Its Relation to Thyrotoxicosis , Am. J. Ophth. 34:960, 1951. 1069. (i) Weekers, R., and Dedoyard, J.: Endocrine Exophthalmos , Boll. Soc. belge opht. 97:122, 1951. 1070. Asboe-Hansen, G., and Iversen, K.: Influence of Thyrotropic Hormone on Connective Tissue: Pathogenetic Significance of Mucopolysaccharides in Experimental Exophthalmos , Acta endocrinol. 8:90, 1951. 1071. Duffy, B. J., Jr., and Howland, J. W.: Radio-Iodine Principles of Diagnosis and Treatment of Thyroid Disease , New York J. Med. 51:1399, 1951. 1072. Portmann, U. V.; Hayes, R. A.; McCullagh, E. P., and Richards, C. E.: Experiences in Treatment of Diseases of Thyroid with Radioactive Iodine , Am. J. Roentgenol. 66:179, 1951. 1073. Scott, W. G.; Seaman, W. B.; MacBryde, C., and others: Observations and Results in Treatment of Hyperthyroidism with Radioactive Iodine (I-131) , Am. J. Roentgenol. 66:171, 1951. 1074. Crile, G., Jr., and McCullagh, E. B.: Treatment of Hyperthyroidism , Ann. Surg. 134:18, 1951.Crossref 1075. Barnum, D. I.; De Takets, G., and Dolkart, R. E.: Periarteritis Following Thiouracil Therapy of Hyperthyroidism , Angiology 2:256, 1951.Crossref 1076. Astwood, E. B.: Use of Antithyroid Drugs During Pregnancy , J. Clin. Endocrinol. 11:1045, 1951.Crossref 1077. Catz, B. D.; Petit, D. W., and Starr, P.: Sodium 5-Iodo-2-Thiouracil in Treatment of Hyperthyroidism , J. Clin. Endocrinol. 11:978, 1951.Crossref 1078. D'Angelo, S. A.; Paschkis, K. E.; Gordon, A. S., and Cantarow, A.: Thyroid-Thyrotropic Hormone Balance in the Blood of Normal and Endocrinopathic Individuals , J. Clin. Endocrinol. 11:1237, 1951.Crossref 1079. Okie, M. B.; Denee, H. B., and Daley, W.: Estradiol Implants and Postoperative Pituitary Exophthalmos , J. Internat. Coll. Surgeons 16:98, 1951. 1080. Francois, J.: Estrogen Therapy in Graves' Disease , Bull. Soc. belge opht. 97:194, 1951. 1081. Deziewiatowski, D. D.: Chondroitin Sulfate , J. Biol. Chem. 189: (a) 187 1082. (b) 717, 1951. 1083. Campbell, D. A.; Hay, K. M., and Tonks, E. M.: An Investigation of the Salt and Water Balance in Migraine , Brit. M. J. 2:1424, 1951.Crossref 1084. Simidu, S.: (a) On Treatment of True Migraine , Acta Soc. Ophth. Jap. 55:121, 1951 1085. (b) Migraine Therapy, Department of Pharmacy, Philadelphia College of Pharmacy and Science , Philadelphia Med. 47:905, 1952. 1086. Campbell, Hay, and Tonks.272 Simidu.273a Editorial.273b 1087. (a) Nettleship, A.: Chemotherapeutics of Cancer , Current M. Dig. 19:46, 1952. 1088. (b) Code, J.: Chemotherapy in the Treatment of Malignant Disease , Brit. M. J. 2:1193, 1949.Crossref 1089. (c) Haddow, A.: The Chemotherapy of Cancer , Practitioner 167:36, 1951. 1090. (d) Udupa, K. N.: Present Status of Chemotherapy in Certain Malignant Diseases , Antiseptic 49:126, 1952. 1091. (e) Inactive Compounds in Tumor Chemotherapy, Announcement , Cancer Res. 12:241, 1952. 1092. (f) Golden, A.; Greenspan, E. M., and Schoenbach, E. B.: Studies on the Mechanism of Action of Chemotherapeutic Agents in Cancer , Cancer 5:153, 1952.Crossref 1093. (g) Iversen, K., and Meulengracht, E.: Oral Treatment of Polycythema Vera with Beta-Naphthyl-Di-2-Chloroethylamine (R48) , Brit. M. J. 2:510, 1951.Crossref 1094. (h) Buckley, S. M.; Stock, C. C.; Crossley, M. L.; Rhoads, C. P.; Patti, J., and Sata, E. S.: Inhibition of Crocker Mouse Sarcoma , Cancer 5:142, 1952.Crossref 1095. (i) Bayrd, E. D.; Stickney, J. M.; Hall, B. E., and Watkins, C. H.: Clinical Observations on the Use of Triethylenemelamine , Cancer 5:336, 1952.Crossref 1096. (j) Karnofsky, D. H.; Burchenal, J. H.; Armistead, G. C., Jr.; Southam, C. M.; Bernstein, J. L.; Craver, L. F., and Rhoad, C. P.: Triethylene Melamine in the Treatment of Neoplastic Disease , A. M. A. Arch. Int. Med. 87:477, 1951.Crossref 1097. (k) Meyer, L. M.; Beyers, M. R.; Sawitsky, A.; Brahn, C., and Ritz, N. D.: Treatment of Lymphomata with Triethylene Melamine , Cancer Res. 11:268, 1951. 1098. (l) Nathanson, I. T., and Kelley, R. M.: Hormonal Treatment of Cancer , New England J. Med. 246:180, 1952Crossref 1099. 135, 1952. 1100. (m) Luttgens, W. F., and Bayard, E. D.: Treatment of Multiple Myeloma with Urethane , J. A. M. A. 147:824, 1951.Crossref 1101. (n) Silverberg, J. H., and Dameshek, W.: Use of Triethylene Melamine in Treatment of Leukemia and Leukosarcoma , J. A. M. A. 148:1015, 1952.Crossref 1102. (o) Oncolytic Action of Epinephrine, editorial , Silverberg J. A. M. A. 147:578, 1951. 1103. (p) Lewis, M. R., and Aptekman, P. M.: Inhibitory Action of Adrenal on Growth of Rat Sarcoma , Science 113:557, 1951.Crossref 1104. (a) Morrell, C., and Weinberg, J. A.: Streptokinase and Streptodornase in Suppurative Lesions , West. J. Surg. 59:524, 1951. 1105. (b) Mienster, J. T.; Fiance, I. J., and Sweeney, B.: Treatment of Unresolved Pneumonia with Streptokinase and Streptodornase , Am. J. Med. 12:376, 1952.Crossref 1106. (c) Sherry, S., and Tillett, W. S.: The Local Use of Streptokinase and Streptodornase in Chronic Refractory Areas of Suppuration with Draining Sinuses , Ann. Surg. 135:479, 1952.Crossref 1107. (d) Wright, L. T.; Smith, D. H.; Rothman, M.; Metzger, W. I., and Quash, E. T.: Use of Streptokinase-Dornase in Certain Surgical Conditions , J. Internat. Coll. Surgeons 15:286, 1951. 1108. (e) McVay, L. V., Jr., and Sprunt, D. H.: Streptokinase and Streptodornase in the Treatment of Diabetic Gangrene , A. M. A. Arch. Int. Med. 87:551, 1951.Crossref 1109. (f) Hubbard, W. M., Jr.: Systemic Toxic Responses of Patients to Treatment with Streptokinase, Streptodornase , J. Clin. Invest. 30:1171, 1951.Crossref 1110. (g) Adie, G. C., and Childress, W. G.: Experiences with Streptokinase and Streptodornase , Ann. Surg. 134:659, 1951.Crossref 1111. (h) Jukofsky, S. L.: A New Technique in the Treatment of Hyphemia , Am. J. Ophth. 34:1692, 1951. 1112. (i) Prevention of Operative Adhesions, editorial , J. A. M. A. 145:1138, 1951. 1113. Fastier, L. B.: Failure of Hyaluronidase to Influence Growth of Pr 8 Virus in Chick Embryos , J. Immunol. 66:1, 1951. 1114. Di Caprio, J. M.; Rantz, L. A., and Randall, E.: Studies on Streptococcal Hyaluronidase and Antihyluronidase , A. M. A. Arch. Int. Med. 89:374, 1952.Crossref 1115. Glassman, J. M.; Blumenthal, A.; Beckfield, W. J., and Seifter, J.: Effect of Hyaluronidase in Inflammatory Response to Primary Irritants , Federation Proc. 11:348, 1952. 1116. Ende, M.: Use of Hyaluronidase in Chronic Ulcers , South. M. J. 44:661, 1951.Crossref 1117. Dunnington, J. H., and Regan, E. F.: Ocular Wound Healing , Am. J. Ophth. 35:167, 1952. 1118. Tassman, I.; DeLong, and Hallett: Fibrin and Thrombin in Ocular Wound Healing: Histological Study, read before the Fourth Wills Clinical Conference, March 20, 1952. 1119. De Berardinis, E., and Bonavolontá, G.: Healing Activity of Some Amino Acids on Experimental Corneal Lesions and Their Influence on Corneal Metabolism , Gior. ital. oftal. 4:86, 1951. 1120. Swan, K. C.: Symposium: Corneal Diseases: Treatment , Tr. Am. Acad. Ophth. 55:387, 1951. 1121. Hind, H. W., and Goyan, F. M.: New Concept of the Role of Hydrogen Ion Concentration and Buffer Systems in Preparations of Ophthalmic Solutions , J. Am. Pharm. A. (Scient. Ed.) 36:33, 1947.Crossref 1122. Mims, J. L.: Methyl Cellulose Solution for Ophthalmic Use , A. M. A. Arch. Ophth. 46:644, 1951.Crossref 1123. Bell, R. P., Jr.: A New Ophthalmic Irrigating Solution , Am. J. Ophth. 34:1321, 1951. 1124. Schiller, A. A.: Rutin-Potientation of Epinephrine , Am. J. Physiol. 165:293, 1951. 1125. Ambrose, A.; Robbins, D. J., and DeEds, F.: Comparative Toxicities of Quercetin and Quercitrin , J. Am. Pharm. A. (Scient. Ed.) 41:119, 1952.Crossref 1126. Griffith, J. Q., Jr., and Couch, J. F.: Inhibition by Rutin of Capillary Injury by Alpha-Radiation in Rats , Blood 6:552, 1951. 1127. Arriga Cantullera, J.: Rutin and Bishydroxycoumarin in Ophthalmology , Arch. Soc. oftal. hispano-am. 11:373, 1951. 1128. Gördüren, S., and Tangun, A.: Rutin in Ophthalmology , Gáz. Klin. 9:55, 1951. 1129. Palmer, L. J.; Flaherty, N. F.; Crampton, J. H., and Johnson, R. H.: Influence of Rutin upon Diabetic Retinitis , Northwest Med. 56:69, 1951. 1130. Joslin, E. P.: Status of Living Diabetics with Onset Under 40 Years of Age , J. A. M. A. 147:209, 1951.Crossref 1131. Wilson, J. L.; Root, H. F., and Marble, A.: Prevention of Degenerative Vascular Lesions in Young Patients by Control of Diabetes , Am. J. M. Sc. 221:479, 1951.Crossref 1132. Lawrence, R. D.; Scott, G. I.; Ashton, N.; Whittington, T. H.; Martin, M. M., and Oakley, W. G.: Discussion on Diabetic Retinopathy , Proc. Roy. Soc. Med. 44:742, 1951. 1133. Sherrill, J. W.: Diabetic Retinitis , Bull. Scripps Metabolism Clinic 2: 1951. 1134. Spoont, S.; Dyer, W. W.; Day, R., and Balzer, H.: Incidence of Diabetic Retinopathy Relative to the Degree of Diabetic Control , Am. J. M. Sc. 221:490, 1951.Crossref 1135. Bell, E. T.: A Postmortem Study of 1,214 Diabetic Subjects with Special Reference to Vascular Lesions , Proc. Am. Diabetes A. 10:62, 1950. 1136. Sheppard, L. B.: Diabetic Retinopathy , Quart. Rev. Ophth. 7:3, 1951. 1137. Kennedy, R. J., and Kirschbaum, F. M.: Ocular Fundus Findings in 133 Cases of Diabetes Mellitus , Cleveland Clin. Quart. 18:134, 1951.Crossref 1138. Post, L. T., and Stickle, A. W., Jr.: Fundus Changes in Juvenile Diabetics , Am. J. Ophth. 34:1119, 1951. 1139. Panepinto, V.: Clinical and Anatomical Considerations in the Problem of Diabetic Retinopathy , Ann. ottal. e clin. ocul. 77:233, 1951. 1140. (a) Gronberg, A., and Svanteson, G.: Diabetic Retinopathy Improved by Gonadotrophic Hormones , Svenska läk-tidning. 48:2005, 1951. 1141. (b) Desvignes, P., and Sadoughi, G.: Trial of Treatment of Diabetic Retinitis with Lipocaic Hormone , Bull. Soc. opht. France 2:126, 1951. 1142. Saskin, E.; Waldman, S., and Pelner, L.: Diabetic Retinopathy , Am. J. Ophth. 34:613, 1951. 1143. Cholst, M. R.; Schilback, H. F.; Handelsman, M. B., and Levitt, L. M.: Response of Retinal Vessels to Priscoline in Various Vascular Conditions , Am. J. Ophth. 35:191, 1952. 1144. Cholst, M. R.; Schilback, H. F.; Handelsman, M. B., and Levitt, L. M.: Response of the Retinal Vessels to Priscoline in Diabetes Mellitus , Am. J. Ophth. 35:375, 1952 1145. Zubrod, C. G.; Eversole, S. L., and Dana, G. W.: Amelioration of Diabetes and Striking Rarity of Acidosis in Patients with Kimmelsteil-Wilson Lesions , New England J. Med. 245:518, 1951.Crossref 1146. Swallow, K. A., and Chute, A. L.: NPH Insulin , Canad M. A. J. 65:23, 1951. 1147. Jameson, M.; Lacey, A. H., and Fisher, A. M.: NPH Insulin , Canad M. A. J. 65:20, 1951. 1148. Rodriquez, R. R.: Influence of Diet and Insulin on the Incidence of Cataracts in Diabetic Rats , Yale J. Biol. & Med. 24:103, 1952. 1149. Hanbold, H.; Lackner, F., and Schmidt-Lecker: New Therapeutic Experiences with Emulsified Vitamin A , Med. Klin. 46:30, 1951. 1150. Niedermeier, S.: Medicinal Effect on Night Vision , Deutsche med. Wchnsch. 76:210, 1951. 1151. Dekking, H. M.: Chemical Influence of Retinal Functions , Acta physiol. et pharmacol. neerl. 2:141, 1951. 1152. Bair, G.: Chronic Vitamin A Poisoning , J. A. M. A. 146:1573, 1951. 1153. Sulzberger, M. B., and Lazar, M. P.: Hypervitaminosis, A , J. A. M. A. 146:788, 1951. 1154. Naz, J. F., and Edwards, W. M.: Hypervitaminosis A , New England J. Med. 246:87, 1952. 1155. Gribetz, D.; Silverman, S. H., and Sobel, A. E.: Vitamin A Poisoning , Pediatrics 7:372, 1951. 1156. Ojers, G. W., and Alfano, J.: Band Keratopathy in Disturbances of Calcium Metabolism , A. M. A. Arch. Ophth. 46:531, 1951. 1157. Chetwood, W. R., and Moore, C. D.: Anaphylactic Shock Following Intravenous Administration of Vitamin B Complex , J. A. M. A. 148:461, 1952. 1158. Pohlman, M. E., and Ritter, E. F., Jr.: Observations on Vitamin Deficiency , Am. J. Ophth. 35:228, 1952. 1159. Guha, G. S.: Role of Vitamins A, B and C in Affections of the Eye , Indian M. J. 45:949, 1951. 1160. Moren, A., and Pola, G.: Vitamin Therapy in Ophthalmology , Medicamenta 9:395, 1951. 1161. Bagnall, H. H., and Slock, F. G.: A Critical Account of the Spectrophotometric Estimation of Vitamin A , J. Pharm. & Pharmacol. 4:81, 1952. 1162. Simkova, M.: Influence of Local Treatment of Diseases of the Cornea with Vitamin B1 and B2 , Českoslov. ofth. 7:37, 1951. 1163. Edgerton, M. T.; Hanahan, E. M., and Davis, W. B., Use of Vitamin E in Treatment of Keloids , Plast. & Reconstruct. Surg. 8:224, 1951. 1164. Laupus, W., and Bousquet, F.: Retrolental Fibroplasia , A. M. A. Am. J. Dis. Child. 81:617, 1951. 1165. Dancis, J.; Lewis, J. M., and Guy, L. P.: Retrolental Fibroplasia: Statistical Study with Particular Reference to the Effect of Vitamin A , New England J. Med. 245:402, 1951. 1166. Kramer, B.; Gordon, S. M.; Berger, H. M., and Sobel, A. E.: Aqueous Dispersions of Vitamins A and D in Premature Infants , A. M. A. Am. J. Dis. Child. 82:17, 1951. 1167. Kinsey, V. E., and Crisholm, J. F.: Retrolental Fibroplasia: Evaluation of Several Changes of Dietary Supplements of Premature Infants with Respect to the Incidence of the Disease , Am. J. Ophth. 34:1259, 1951. 1168. Malatesta, C.: Histopathological Changes in the Eye in Experimental Avitaminosis E in Rats , Boll. ocul. 35:31, 1951. 1169. Stormont, R. T.: Pyridoxine Hydrochloride Vitamin B6 , J. A. M. A. 147:322, 1951. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png A.M.A. Archives of Ophthalmology American Medical Association

Loading next page...
 
/lp/american-medical-association/pharmacology-and-toxicology-f1GlJCgs9D
Publisher
American Medical Association
Copyright
Copyright © 1952 American Medical Association. All Rights Reserved.
ISSN
0096-6339
DOI
10.1001/archopht.1952.00920010168007
Publisher site
See Article on Publisher Site

Abstract

References 1. (a) Wilson, R. H.; Deeds, F., and Rather, L. J.: Toxicity Studies on Subtilin , Proc. Soc. Exper. Biol. & Med. 78:517, 1951. 2. (b) Sacks, L. E.: Subtilin Considered as a Germicidal Surface Active Agent , Antibiotics & Chemother. 2:79, 1952. 3. (c) Kaiser, E.: Über die Wirkung von Subtilin und Subtilin Tyrothricin Kombination in Vivo et in Vitro , Wien. med. Wchnschr. 101: 254, 1951. 4. (d) Quinn, L.: Globicin, a New Antibotic from Bacillus Subtilis , Antibotics & Chemother. 2:215, 1952. 5. (e) Micks, D. W.; Whitney, D. M., and Anigstein, L.: Effect of Sanguinin, an Antibacterial Agent from Blood, on Streptococcal Infection in Mice , Proc. Soc. Exper. Biol. & Med. 78:573, 1951. 6. (f) Davisson, J. W.; Tanner, F. W., Jr.; Finlay, A. C., and Solomons, I. A.: Rimocidin , Antibotics & Chemother , 1:289, 1951. 7. (g) Wachter, R. F.; Bohonos, N., and Quakenbusch, F. W.: Xanthellin: An Antibiotic with Anti-Brucella Activity , Antibotics & Chemother 1:399, 1951. 8. (h) Kenner, B. A., and Murray, F. J.: Gliotoxin Studies , Antibotics & Chemother 1:509, 1951. 9. (i) Berger, J.; Rachlin, A. I.; Scott, W. E.; Sternbach, L. H., and Goldberg, M. W.: Antibiotics from Streptomyces , J. Am. Chem. Soc. 73:5295, 1951. 10. (j) Dimick, K. P.: Hemolytic Action of Gramicidin and Tyrocidin , Proc. Soc. Exper. Biol. & Med. 78:782, 1951. 11. (k) Hall, E. A.; Kavanagh, F., and Asheshov, I. N.: Action of 45 Antibacterial Substances on Bacterial Viruses , Antibiotics & Chemother. 1:369, 1951. 12. (l) Paul, H. E.; Harrington, C. M.; Bender, R. C., and Briggs, W. P.: Resistance and Cross Resistance of Bacteria to Nitrofurans , Proc. Soc. Exper. Biol. & Med. 79:199, 1952. 13. (m) Asnis, R. E.; Cohen, F. B., and Gots, J. S.: Studies on Bacterial Resistance to Furacin , Antibiotics & Chemother. 2:123, 1952. 14. (n) Bender, R. C., and Paul, H. E.: Metabolism of the Nitrofurans , J. Biol. Chem. 191:217, 1951. 15. (o) Asnis, R. E., and Gots, J. E.: Studies on the Action of Nitrofurans on Bacterial Enzyme Systems , Arch Biochem. 30:35, 1951. 16. (p) Pritikin, R. I., and Duchon, M. L.: Eye Conditions Similar to Those Produced by Modern Warfare , Mil. Surgeon 109:706, 1951. 17. (q) Mierecki, G. P.: Bacteriological Examination of Eye Ointments , Klin. Monatsbl. Augenh. 110:606, 1951. 18. (r) Raper, K. P.: The Progress of Antibiotics , Scient. Am. 186:49, 1952. 19. (s) Hull, F. E.: Management of Eye Casualties in the Far East Command During the Korean Conflict: A Preliminary Report , Tr. Am. Acad. Ophth. 50:885, 1951. 20. (t) Wheat, R. P.; Zuckerman, A., and Rautz, L. H.: Infection Due to Chromobacteria , A. M. A. Arch. Int. Med. 88:461, 1951. 21. (u) Killough, J. H. M.; Magill, G. B., and Smith, R. C.: Treatment of Amebiasis with Fumagillin , Science 115:71, 1952.Crossref 22. (v) McCowen, M. C.; Callender, M. E., and Lawlis, J. F., Jr.: Fumagillin (H-3), a New Antibiotic with Amebicidal Properties , Science 113:202, 1951.Crossref 23. (w) Raubitscheck, F.; Acker, R. F., and Waksman, S. A.: Production of an Antifungal Agent of the Fungicidin Type by Streptomyces Aureus , Antibiotics & Chemother. 2:179, 1952. 24. (x) Hazen, E. L., and Brown, R.: Fungicidin, an Antibiotic Produced by a Soil Actinomycete , Proc. Soc. Exper. Biol. & Med. 76:93, 1951. 25. (y) Takano, Y.: The Therapeutic Value of Guanofuracin in Various Diseases of the Outer Eye , Acta Soc. ophth. Jap. 55:399, 1951. 26. (z) Dubois-Poulsen, A.; Dubois-Verlière, and Tibi, A.: The Salts of Propionic Acid in External Affections of the Eye , Ann. ocul. 184:894, 1951. 27. (a′) Melodia, C.: Sodium Propionate in the Treatment of External Ocular Infections , Ann. ottal. e clin. ocul. 77:359, 1951. 28. (b′) Heatley, N. G.; Kelly, B. K., and Smith, N.: Assay of Micrococcin, an Almost Insoluble Antibiotic , J. Gen. Microbiol. 6:30, 1952. 29. (c′) Wilson, A. T., and Rosenblum, H.: The Antistreptococcal Property of Milk , J. Exper. Med. 95:25, 1952. 30. (a) Novak, M., and Taylor, W.: Prophylactic Treatment of Tetanus with Procaine Penicillin , Proc. Inst. Med. Chicago 18:61, 1950. 31. (b) Pelner, L., and Waldman, S.: Sodium Dehydrocholate , Postgrad. Med. 2:49, 1952. 32. (c) Dailsir, G., and Weinstein, L.: Streptococcal Bacteriostatic Antibody in Patients Treated with Penicillin , Proc. Soc. Exper. Biol. & Med. 78:160, 1951. 33. (d) Weinberg, E. D.: Influence of Various Sources of Nitrogen on the Activity of Antibiotics , Antibiotics & Chemother. 2:130, 1952. 34. (e) Elias, W.; Price, A., and Merrianon, H. J.: A New Repository Form of Penicillin , Antibiotics & Chemother. 1:491, 1951. 35. (f) Longacre, A. B.: Compenamine , Antibiotics & Chemother. 1:223, 1951. 36. (g) Siegal, S.: Allergy to Penicillin-O in Management of Penicillin Sensitivity , Am. J. Med. 11:196, 1951. 37. (h) Díaz-Rivera, R. S.; Ramirez, E.; Pons, E. R., and Torregrosa, M. V.: Management of Tetanus , J. A. M. A. 147:1635, 1951. 38. (i) Burnell, J. M., and Kirby, W. M. M.: Effectiveness of a New Compound, Benemid, in Elevating Serum Penicillin Concentrations , J. Clin. Invest. 30:697, 1951. 39. (j) Harkavy, J.: Cardiovascular Allergy Due to Penicillin, Sulfadiazine and Bacterial Sensitization , J. Allergy 23:104, 1952. 40. (k) Spring, M.: Purpura and Nephritis After Administration of Procaine Penicillin , J. A. M. A. 147:1139, 1951. 41. (l) Adair, C. V.; Woodin, W. G., and Bunn, P. A.: Clinical and Pharmacological Studies with Allyl Mercaptomethyl Penicillin (Penicillin-O) , Am. J. Med. 11:188, 1951.Crossref 42. (m) Epstein, M. M., and Allen, J. R.: Treatment of Neurosyphilis with Penicillin Combined with Artificial Fever Therapy , A. M. A. Arch. Dermat. & Syph. 63:419, 1951. 43. (n) Robinson, H. M., and Robinson, H. M., Jr.: Antibiotics in Early Syphilis , A. M. A. Arch. Dermat. & Syph. 63:687, 1951. 44. (o) Hahn, R. D.: Treatment of Neurosyphilis with Penicillin and with Penicillin Plus Malaria , Am. J. Syph. 35:433, 1951. 45. (p) Lepper, M. H.; Rodriguez, J.; Blatt, N., and Spies, H. W.: Use of Dibenzylethylenediamine Penicillin , Antibiotics & Chemother. 2:175, 1952. 46. (q) Flippen, H.; Matteucci, W. V.; Schimmel, N. H.; Bartholomew, E. L., and Boger, W.: The Hydroiodide of Diethylaminoethyl Ester of Penicillin-G, Neo-Penil , Antibiotics & Chemother. 2:208, 1952. 47. (r) Kadison, E. R.; Ishihara, S. J., and Waters, T.: A New Form of Penicillin with Antiallergic Properties , Am. Pract. & Digest Treat. 2:411, 1951. 48. (s) Jensen, K. A.; Dragsted, P. J.; Nielsen, E. J., and Fredrickson, E: Leocillin , Acta path. et microbiol. scandinav. 28:407, 1951. 49. (t) Jensen, K. A.; Dragsted, P. J.; Møller, P., and Kaier, I.: Investigations on Penicillin Preparations and Dosage , Ugesk. læger 112:1075, 1950. 50. (u) Tada, H.: Comparison of Various Bases for Penicillin Ointment , Acta Soc. ophth. jap. 55:405, 1951. 51. (v) Kennedy, R. J., and Vogel, A. W.: Intraocular Inflammation with the Gas-Forming Bacillus Clostridium Welchii , A. M. A. Arch. Ophth. 45:528, 1951. 52. (a) Sorsby, A.; Ungar, J., and Bailey, M. L.: Streptomycin in Ophthalmology , Brit. M. J. 1:19, 1952. 53. (b) Bignell, J. L.: Infection of the Cornea with B-Pyocyaneus , Brit. J. Ophth. 35:419, 1951. 54. (c) Kmonicek, J.: Interesting Complication in the Streptomycin Treatment of Iridocyclitis , Ceskoslov. Ofth. 7:343, 1951. 55. (d) Payne, H. G.; Spencer, J. N., and Schultz, F. H., Jr.: Oral Toxicity of Bacitracin , Antibiotics & Chemother. 1:387, 1951. 56. (e) Eggers, H.: Clinical Experience with Bacitracin , Am. J. Ophth. 34:1706, 1951. 57. (f) Leopold, I. H.: Pharmacology and Toxicology , A. M. A. Arch. Ophth. 46:159, 1951. 58. (h) Birge, H. L.: The Diagnosis of Ocular Mycotic Infection , A. M. A. Arch. Ophth. 46:225, 1951. 59. (i) Emerson, R.: Molds and Men , Scient. Am. 186:28, 1952. 60. (i) Longacre, A. B., and Waters, R. M.: Parenteral Bacitracin in Surgical Infections , Am. J. Surg. 81:599, 1951 61. (k) Observations on Absorption of Bacitracin , Surg. Gynec. & Obst. 92:913, 1951. 62. (l) Friedberg, C. K., and Bader, M. E.: Acute Staphylococcic Endocarditis Cured with Aid of Bacitracin , J. A. M. A. 147:46, 1951. 63. (m) Kadison, E. R., and Borovsky, M. P.: The Treatment of Infantile Diarrhea with a New Combination of Antibiotics , J. Pediat. 38:576, 1951. 64. (a) Killough, V. H.: Aureomycin in Tropical Disease , Proc. Roy. Soc. Med. 45:109, 1952. 65. (b) Karp, A., and Snyder, J. C.: In Vitro Effect of Aureomycin, Terramycin and Chloramphenicol on Typhus Rickettsiae , Proc. Soc. Exper. Biol. & Med. 79:216, 1952. 66. (c) Snelling, C. E., and Johnson, R.: Aureomycin in Cross Infection , Canad. M. A. J. 66:6, 1952. 67. (d) Furth, F. W.; Coulter, M. P., and Howland, J. W.: Effect of Aureomycin and Terramycin on the X-Radiated Rat , Am. J. Path. 28:185, 1952 68. Effect of Aureomycin on the Radiation Syndrome in Dogs , Furth Am. J. Path. 28:25, 1952. 69. (e) Rosenthal, S. M.; Lillie, R. D., and Vender, E.: Influence of Chemotherapy on the Delayed Deaths Following Extensive Burns in Mice , Federation Proc. 11:387, 1952. 70. (f) Schoenbach, E. B.; Spencer, H. C., and Monnier, J.: Treatment of H. Influenzae Meningitis with Aureomycin and Chloramphenicol , Am. J. Med. 12:263, 1952. 71. (g) McVay, L. V., Jr., and Carroll, D. S.: Aureomycin in the Treatment of Systemic North American Blastomycosis , Am. J. Med. 12:289, 1952. 72. (h) Reiches, A. J.: Antibiotic Sensitivity and Moniliasis , A. M. A. Arch. Int. Med. 64:604, 1951. 73. (i) Ayre, J. E.: Regression of Anaplastic Lesions of the Cervix Using Aureomycin , Antibietics & Chemother. 1:339, 1951. 74. (j) Brainerd, H. D.; Bruin, H. P.; Meikeljohn, G., and O'Gara, L.: Studies on the Clinical Pharmacology of Aureomycin , Antibietics & Chemother. 1:447, 1951. 75. (k) Forbes, S. D.: Retinal Detachments, Spontaneous Reattachments Following Aureomycin Therapy , Am. J. Ophth. 34:1597, 1951. 76. (l) Pritkin, R. I., and Duchon, M. L.: Herpes Zoster Ophthalmicus , Am. J. Ophth. 34:893, 1951. 77. (m) McVay, L. B., Jr., and Sprunt, D. H.: Study of Moniliasis and Aureomycin Therapy , Proc. Soc. Exper. Biol. & Med. 78:759, 1951. 78. (n) Biscay, V. M., and Carbonell, A. F.: Brucellosis Laboratory Autoinfection , Rev. méd. cubana 62:151, 1951. 79. (o) McVay, L. V., Jr.; Guthrie, F., and Sprunt, D. H.: Aureomycin in Treatment of Actinomycosis , New England J. Med. 245:91, 1951. 80. (p) Rais, D. B.: Aureomycin in the Koch-Weeks Conjunctivitis , Bull. Soc. ophth. France 1:34, 1951. 81. (q) Murty, K. K.: Aureomycin and Streptomycin in Ophthalmic Practice , Indian M. Guide 4:195, 1951. 82. (r) Mercier, A.: Aureomycin in Ocular Therapy , Bull. Soc. ophth. France 1:101, 1951. 83. (s) Trope, R. A.: Topical Aureomycin in Ophthalmology , Sind M. J. 24:117, 1951. 84. (t) Manheim, S. D.: Anorectal Complications of Aureomycin, Terramycin and Chloromycetin Therapy , New York J. Med. 51:2759, 1951. 85. (a) Lloyd, E. L.: Aplastic Anemia Due to Chloramphenicol , Antibiotics & Chemother. 2:1, 1952. 86. (b) Clarke, P. S.: Chloramphenicol in Treatment of Cutaneous Anthrax , Brit. M. J. 86:1952. 87. (c) Burnell, J. M., and Kirby, W. M. M.: Serum Concentrations of Chloramphenicol Following Intravenous and Intramuscular Administration , J. Lab. & Clin. Med. 38:234, 1951. 88. (d) Usadek, H. E.; Curtis, W. P., and Mill, E. J.: Skin Eruption Due to Chloramphenicol , A. M. A. Arch. Dermat. & Syph. 64:217, 1951. 89. (e) Romansky, M. J.; Olansky, S.; Taggert, S. R.; Landmen, G. S., and Robin, E. D.: Chloromycetin in the Treatment of Various Types of Syphilis , Am. J. Syph. 35:234, 1951. 90. (f) White, J. S.: The Newer Antibiotics with Special Reference to Chloromycetin , South African M. J. 25:527, 1951. 91. (g) Doggart, J. H.: Chemotherapy in Ophthalmology , Practitioner 1:66, 1951. 92. (h) Berens, C., and Gulyash, J.: Recent Advances in the Use of Antibiotics and Steroids in Ophthalmology , Quart. Rev. Ophth. 7:1, 1951. 93. (i) Brown, S. R.: Hodgkin's Disease Controlled by Chloromycetin , Hawaii M. J. 10:356, 1951. 94. (j) Kelley, R. S.; Hunt, A. D., Jr., and Tashman, S. G.: Studies on the Absorption and Distribution of Chloramphenicol , Pediatrics 8:362, 1951. 95. (k) van Gelderen, F. T.: Experiences with Chloromycetin , Maandschr. kindergeneesk. 19:172, 1951. 96. (l) Littman, N. L.; Paul, J. S., and Fusillo, M. H.: Treatment of Pulmonary Actinomycosis with Chloramphenicol , J. A. M. A. 148:608, 1952. 97. (m) Tomaszewski, W.: Findings on Lingual Scrapings Taken During Treatment with Chloramphenicol and Aureomycin , J. Clin. Path. 4:393, 1951. 98. (n) Roberts, W.: Chloramphenicol in Ocular Infections , Am. J. Ophth. 34:1081, 1951. 99. (o) Willcox, R. R.: Chloromycetin in the Treatment of Chancroid , Brit. M. J. 1:509, 1951. 100. (a) Gustafson, G. E., and Kaletsky, S.: Effect of Oral Terramycin Prior to Whole Body Irradiation , Proc. Soc. Exper. Biol. & Med. 78:489, 1951. 101. (b) Reiss, E.; Pulaski, E. J.; Artz, C. P., and Schaeffer, J. R.: Terramycin in Treatment of Peritonitis , A. M. A. Arch. Surg. 64:5, 1952. 102. (c) Miura, Y.; Nakamura, Y.; Matsudaira, H., and Komeiji, T.: The Mode of Action of Terramycin , Antibiotics & Chemother. 2:152, 1952. 103. (d) Greene, H.: Terramycin in the Treatment of Trichomonas , Antibiotics & Chemother. 2:119, 1952. 104. (e) Castaneda, M. R., and Ibarra, G. G.: Terramycin in the Treatment of Human Brucellosis , Antibiotics & Chemother. 2:86, 1952. 105. (f) Ruiz-Sanchez, F.; Casillas, J.; Paredes E, M.; Velasquez, J., and Riebeling, R.: Terramycin in the Treatment of Malaria , Antibiotics & Chemother. 2:51, 1952. 106. (g) Caffery, E. L.; Alford, B. H., and Musselman, M. M.: Levels of Terramycin in the Serum After Administration of Terramycin Base , Antibiotics & Chemother. 2:72, 1952. 107. (h) Hall, H. E.; Hightower, J. A.; Diaz Rivera, R.; Byrne, R. J.; Smadel, J. E., and Woodward, T. E.: Evaluation of Antibiotic Therapy in Human Leptospirosis , Ann. Int. Med. 35:981, 1951. 108. (i) Wolman, B., and Hozel, A.: Terramycin in Infections of Infants and Children , Brit. M. J. 1:419, 1952. 109. (j) Mitsui, Y.; Tanaka, C.; Iwashige, Y., and Yamashita, K.: Terramycin in Ophthalmology , Antibiotics & Chemother. 1:253, 1951. 110. (k) Luttermoser, G. W.; Haskins, W. T.; Coleman, N., and Jumper, J. R.: Experimental Endamoeba Histolytica Infections in Rabbits with Reference to Chemotherapy , Am. J. Trop. Med. 1:162, 1952. 111. (l) Lepri, G.: The Action of Terramycin in Some Ocular Infections , Rass. ital. ottal. 20:15, 1951. 112. (m) Town, A. E.: Ophthalmic Use of Terramycin , Am. J. Ophth. 34:725, 1951. 113. (n) Azzolini, A., and Foldi, S.: Researches on the Tolerance and on the Action of Terramycin in the Eye , Gior. ital. oftal. 4:114, 1951. 114. (o) Linnen, H. J.: Experimental Research in Animal Eyes with Crystalline Terramycin Hydrochloride , Klin. Monatsbl. Augenh. 118:561, 1951. 115. (p) Liebowitz, D., and Schwartz, H.: Leptospiral Infection Treated with Terramycin , J. A. M. A. 147:122, 1951. 116. (q) Frisk, A. R., and Tunevall, G.: In Vitro Activity, Absorption and Excretion of Terramycin , Scandinav. J. Clin. & Lab. Invest. 3:175, 1951. 117. (r) Poure, A. M.; Snyder, M. J., and Minor, J. U., Jr.: Use of Terramycin in Rocky Mountain Spotted Fever , Bull. Johns Hopkins Hosp. 89:30, 1951. 118. (s) Willcox, R. R.: Anorectal Syndrome and Other Mild Side-Effects of Terramycin , Lancet 2:154, 1951. 119. (t) Miyamura, S., and Kanazawa, Y.: Cup Assay of Terramycin , Antibiotics J. 4:470, 1951. 120. (u) Lepri, G., and Capalbi, S.: Influence of Terramycin on the Course of Experimental Ocular Tuberculosis , Brit. J. Ophth. 36:75, 1952. 121. (v) Lepri, G., and Sicca, G. T.: Observations on the Penetration of Terramycin into the Aqueous Humor Following Local Administration , Arch. ottal. 55:383, 1951. 122. (w) Cannon, E. J.; Nichols, A. C., and Leopold, I. H.: Studies on the Intraocular Penetration and Toxicity of Terramycin , A. M. A. Arch. Ophth. 47:344, 1952.Crossref 123. (x) Douvas, N. G.; Featherstone, R. M., and Braly, A. E.: Role of Terramycin in Ophthalmology , A. M. A. Arch. Ophth. 46:57, 1951.Crossref 124. (y) Sandusky, W. R.; Keeble, C. F.; Wharton, W. P., and Taylor, R. N.: Prophylactic Use of Terramycin in Experimental Clostridii welchii Infection , Surgery 31:365, 1952. 125. (z) Cannon, E. J., and Leopold, I. H.: Effectiveness of Terramycin and Other Antibiotics Against Experimental Bacterial Keratitis , A. M. A. Arch. Ophth. 47:426, 1952.Crossref 126. (a) Florestano, H. J., and Bahler, M. E.: Antifungal Properties of the Polymyxins , Proc. Soc. Exper. Biol. & Med. 79:141, 1952. 127. (b) Light, A.; Tornaben, J. A., and De Beer, E. J.: A Comparison of the Renal Effects of Polymyxin A, Aerosporin, and a Mercurial Diuretic , Antibiotics & Chemother. 2:63, 1952. 128. (c) Jackson, D. M.; Lowbury, E. J. L., and Topley, E.: Pseudomonas Pyocyanea in Burns , Lancet 2:137, 1951. 129. (d) Brownlee, G.; Bushby, S. R. M., and Short, E. I.: The Chemotherapy and Pharmacology of the Polymyxins , Brit. J. Pharmacol. 7:170, 1952. 130. (e) Lieberman, D., and Jawetz, E.: Treatment of Chronic Shigella Infection in Children with Oral Polymyxins , Pediatrics 8:249, 1951. 131. (f) Jawetz, E.: Infections with Pseudomonas Aeruginosa Treated with Polymyxin B , A. M. A. Arch. Int. Med. 89:90, 1952. 132. (g) Keating, S. B.: A Note on the Use of Antibiotics in the Treatment of Infections with Gram-Negative Bacilli , M. J. Australia 2:709, 1951. 133. (a) Hambre, D. M.; Pansy, F. E.; Lapedes, D. N.; Perlman, D.; Bayou, A. P., and Donovick, R.: Some Characteristics of the Neomycins , Antibiotics & Chemother. 2:135, 1952. 134. (b) Dutcher, J. D.; Hosansky, N.; Donin, M. N., and Wintersteiner, O.: Neomycin B and C and Some of Their Degradation Products , J. Am. Chem. Soc. 73:1384, 1952. 135. (c) McVay, L., Jr.; Laird, R. L., and Stern, T. N.: Neomycin in Treatment of Human Amebiasis , Am. J. M. Sc. 223:20, 1952. 136. (d) Livingood, C. S.; Nilasena, S.; King. W. C.; Stevenson, R. A., and Mullins, J. F.: Pyogenic Infection Treated with Neomycin , J. A. M. A. 148:334, 1952. 137. (e) Kile, R. L.; Rockwell, E. M., and Schwarz, J.: Use of Neomycin in Dermatology , J. A. M. A. 148:339, 1952. 138. (f) Vogel, A. W.; Leopold, I. H., and Nichols, A.: Neomycin: Ocular Penetration and Toxicity , Am. J. Ophth. 34:1357, 1951. 139. (g) Forbes, A. M.: A Clinical Evaluation of Neomycin in Different Bases , South. M. J. 45:235, 1952. 140. (h) Ditkowsky, S.; Goldman, A., and Goldin, M.: Pseudomonas Meningitis Treated with Neomycin , Pediatrics 9:101, 1952. 141. (a) Collier, H. D. J., and Waterhouse, P. O.: The Activities of Some 2-4-Diaminopteridines and Sulphathiazole Against Streptococcus Foecalis and Staphylococcus Aureus , Brit. J. Pharmacol. 7:161, 1952. 142. (b) Quinn, L. H., and Burnside, R. M.: Gantrisin , Eye, Ear, Nose & Throat Month. 30:81, 1951. 143. (c) Hagerman, D. D., and Franzblau, S. A.: Gantrisin® (Sulfisoxazole)-Induced Granulocytopenia , J. A. M. A. 147:1657, 1951. 144. (d) Hawking, F., and Laurence, J. S.: The Sulfonamides , New York, Grune & Stratton Inc., 1951. 145. (e) Findlay, G. M.: Recent Advances in Chemotherapy , Ed. 3, Philadelphia, The Blakiston Company, 1950. 146. (f) Hatschek, G.: Further Contributions to the Subjunctival Use of Prontosil , Klin. Monatsbl. Augenh. 118:629, 1951. 147. (g) Reiser, K. A.: Studies on Sulfonamide Therapy , Klin. Monatsbl. Augenh. 118: 508, 1951. 148. (h) Belousova, R. V.: Complications of the Eye During the Administration of Disulfone , Vestnik. oftal. 30:42, 1951. 149. (i) Kahan, A., and Torok, E.: Functional Intoxication of the Retina by Sulfonamides , Szemészet ophth. Hungary 88:85, 1951. 150. (j) Klinvanskaya, A. A.: The Toxic Influence of the Sulfonamide Drugs on the Eye , Vestnik. oftal 30:32, 1951. 151. (k) Leskowitz, S.; Fox, C. L., Jr., and Raymond, S.: Isolation and Identification of Para-Aminobenzoic Acid Produced by Staphylococci Resistant to Sulfonamides , J. Exper. Med. 95:247, 1952. 152. (a) Bacterial Versatility, editorial , Ann. Int. Med. 36:185, 1952. 153. (b) Miller, C. P.: New Problems in the Treatment of Infectious Disease , Ann. Int. Med. 35:763, 1951. 154. (c) Waisbren, B. A.; Carr, C., and Struxness, D.: Role of Inhibitors and Mutations in Antibiotic Resistance of Escherichia Coli , Antibiotics & Chemother. 1:54, 1951. 155. (d) Bacterial Resistance in Chemotherapy, editorial , Brit. M. J. 425:1952. 156. (e) Mitchison, D. A.: Segregation of Streptomycin-Resistant Variants of Mycobacterium Tuberculosis into Groups with Characteristic Levels of Resistance , J. Gen. Microbiol. 5:596, 1951. 157. (f) Eagle, H.: Further Observations on the Zone Phenomenon in the Bactericidal Action of Penicillin , J. Bact. 62:663, 1951. 158. (g) Kaipainen, W. J.: Relationship of Bacteria to Streptomycin , Ann. Med. exper. et biol. fenniae 29, (Supp. 1) , 1951. 159. (h) Gocke, E. M., and Finland, H.: Cross Resistance to Antibiotics , J. Lab. & Clin. Med. 38:719, 1951. 160. (i) Chandler, C. A.; Davidson, V. Z.; Long, P. H., and Monnier, J. J.: Studies on Resistance of Staphylococci to Penicillin , Bull. Johns Hopkins Hosp. 89:81, 1951. 161. (j) Monnier, J. J., and Schoenbach, E. B.: Resultant Sensitivity of Microorganisms to Various Antibiotics , Antibiotics & Chemother. 1:472, 1951. 162. (k) Superinfections During Antibiotic Treatment, editorial , Brit. M. J. 1:537, 1952. 163. (l) Bierman, H. R., and Jawetz, E.: Effect of Prolonged Administration of Antibiotics on the Human Fecal Flora , J. Lab. & Clin. Med. 37:394, 1951. 164. (m) Abbott, J. D.; Fernando, H. V. J.; Gurling, K., and Meade, B. W.: Pulmonary Aspergillosis Following Post-Influenza Bronchopneumonia Treated with Antibiotics , Brit. M. J. 1:523, 1952. 165. (n) Tomaszewski, T.: Side-Effects of Chloramphenicol and Aureomycin with Special Reference to Oral Lesions , Brit. M. J. 1:388, 1951. 166. (o) Garrod, L. P.: Reactions of Bacteria to Chemotherapeutic Agents , Brit. M. J. 1:205, 1951.Crossref 167. (p) Pappenfort, R. B., and Schnall, E. S.: Moniliasis in Patients Treated with Aureomycin , A. M. A. Arch. Int. Med. 88:729, 1951.Crossref 168. (q) Ainslie, D.: Treatment of Blepharitis , Brit. M. J. 2:582, 1951.Crossref 169. (r) Keefer, C. S.: Alterations in Normal Bacterial Flora of Man and Secondary Infections During Antibiotic Therapy , Am. J. Med. 11:665, 1951.Crossref 170. (s) Editorial: Sensitivity of Bacterial Antibiotics , New England J. Med. 245:868, 1951.Crossref 171. (t) Heatherman, N. E., and Clapper, W. E.: Relation Between Resistance to Chemotherapeutic Agents and other Biochemical Properties of Some Viridans Streptococci and Enterococci , J. Lab. & Clin. Med. 38:881, 1951. 172. (u) Lemke, C. E., and Gates, L. E.: Distribution and Antibiotic Sensitivity in 55 Strains of Klebsiella Pneumoniae , J. Lab. & Clin. Med. 38:899, 1951. 173. (v) Dowling, H. F.: Antibiotics , Illinois M. J. 100:992, 1951. 174. (w) Metabolic Aspects of Streptomycin Resistance, editorial , J. A. M. A. 147:1361, 1951. 175. (x) English, A. R., and McCoy, E.: Gross Comparison of Streptomycin Sensitive and Streptomycin Resistant Micrococcus Pyogenes , J. Bact. 62:19, 1951. 176. (y) Clancy, C. F.: The Sensitivity of Freshly Isolated Bacteria to Neomycin , J. Bact. 61:715, 1951. 177. (z) Cross Resistance to Antibiotics, editorial , J. A. M. A. 148:470, 1952. 178. (a′) Gezon, H. M., and Fasan, D. M.: Cross Resistance of Streptococci to Five Streptomyces Antibiotics , Science 114:422, 1951. 179. (b′) Fusillo, M. H., and Romansky, M. J.: The Simultaneous Increase in Resistance of Bacteria to Aureomycin and Terramycin , Antibiotics & Chemother. 1:107, 1951. 180. (c′) Reiss, E.; Pulaski, E. J.; Amspischer, W. H., and Contreras, A. A.: Penicillin Sensitivity of Staphylococci , New England J. Med. 246:611, 1952. 181. (d′) Summero, G. A. C.: Penicillin-Resistant Staphylococci , Lancet 1:135, 1952. 182. (e′) Sherris, J. C., and Florey, M. E.: Relation of Penicillin Sensitivity in Staphylococci to Clinical Manifestation of Infection , Lancet 1:309, 1951. 183. (f′) Lepnik, M. J.; Kligman, A. M., and Strauss, R.: Antibiotics and Fungous Infections , J. Invest. Dermat. 18:247, 1952. 184. (a) Miles, C. P.; Coleman, V. R.; Gunnison, J. B., and Jawetz, E.: Antibiotic Synergism , Proc. Soc. Exper. Biol. & Med. 78:738, 1951. 185. (b) Shlaes, W. H.; Volini, I. F.; Felsenfeld, O., and Burbridge, E.: The Antibacterial Action of Combinations of Penicillin and Sulfonamides , Antibiotics & Chemother. 2:21, 1952. 186. (c) Pratt, R., and Dufrenoy, J.: Mechanism of Antibiotic Action and Trends in Antibiotic Chemotherapy , Texas Rep. Biol. & Med. 9:76, 1951. 187. (d) Gunnison, J. P.: Speck, R. S., and Bruff, J. A.: Studies on Antibiotic Synergism and Antagonism , Antibiotics & Chemother. 1:259, 1951. 188. (e) Bliss, E. A.; Warth, P. T., and Long, P. H.: Studies on Combinations of Antibiotics , Bull. Johns Hopkins Hosp. 91:49, 1952. 189. (f) Jawetz, E.; Gunnison, J. P.; Speck, R. S., and Coleman, B. R.: Studies on Antibiotic Synergism and Antagonism , A. M. A. Arch. Int. Med. 87:349, 1951. 190. (g) Armstrong, C. W. J., and Larner, A. E.: The Effect of Combinations of Antibiotics , J. Lab. & Clin. Med. 37:584, 1951. 191. (h) Robbins, W. C., and Tompsett, R.: Results of Combined Therapy with Penicillin and Streptomycin , Am. J. Med. 10:278, 1951. 192. (i) Spink, W. W.; Hall, W. H., and Magoffin, R.: Follow-up Study of Therapy in 48 Culturally Proved Cases of Brucellosis: Streptomycin, Sulfadiazine, Aureomycin and Chloramphenicol , A. M. A. Arch. Int. Med. 88:419, 1951. 193. (j) Wallach, R., and Pomerantz, N.: Combined Antibiotic Therapy , A. M. A. Arch. Int. Med. 88:840, 1951. 194. (k) Jawetz, E., and Gunnison, J. B.: Studies on Antibiotic Synergism and Antagonism: A Scheme of Combined Antibiotic Action , Antibiotics & Chemother. 2:243, 1952. 195. (l) Wellman, W. E.: Combinations of Antibiotics in Treatment of Infectious Disease , Minnesota Med. 34:537, 1951. 196. (m) Panzardi, D., and Pasca, G.: The Action of Bacitracin and Streptomycin Associated with Penicillin on the Bacterial Flora of the Conjunctiva , Boll. ocul. 31:79, 1951. 197. (n) Antibiotic Combinations, Editorial ; New England J. Med. 245:989, 1951. 198. (o) Finland, M.; Jackson, G. G.; Kass, E. H.; Haight, T. H., and Womack, C. R.: Some Recent Observations of Staphylococcal Infections in Relation to Antibiotic Therapy , Tr. A. Am. Physicians 64:343, 1951. 199. (p) Hugo, D.: Infections in and About the Eye and Their Treatment by the Antibiotics , Proc. Transvaal Mine and Med. Officers' A. 31:17, 1951. 200. (q) Jawetz, E.: Gunnison, J. B., and Speck, R. S.: Antibiotic Synergism and Antagonism , New England J. Med. 245:966, 1951. 201. (r) Antibiotic Antagonism, Editorial , J. A. M. A. 147:513, 1951. 202. (s) Speck, R. S.; Jawetz, E., and Gunnison, J. B.: Studies on Antibiotic Synergism and Antagonism , A. M. A. Arch. Int. Med. 88:168, 1951. 203. (t) Meleney, F. L.; Johnson, B. A., and Teng, P.: The Importance of Laboratory Data in the Treatment of Surgical Infections by Antibiotics, with Particular Reference to the Synergistic Action of Penicillin and Bacitracin , J. Mt. Sinai Hosp. 18:257, 1952. 204. (u) Lepri and Capalbi: Influence of Terramycin on Course of Ocular Tuberculosis , Brit. J. Ophth. 36:75, 1952. 205. Ghanahy, S. S.: Ophthalmia Neonatorum , Antiseptic 48:626, 1951. 206. Clark, S. G., and Culler, A. M.: Aureomycin as Prophylaxis Against Ophthalmia Neonatorum , Am. J. Ophth. 34:840, 1951. 207. Leff, N.: Prevention of Ophthalmia Neonatorum by Flushing with Sterile Water , West. J. Surg. 59:176, 1951. 208. Toth, Z.: Is the Crede Method in Ophthalmia Neonatorum Untimely and Superfluous? Klin. Monatsbl. Augenh. 118:613, 1951. 209. Prophylaxis of Ophthalmia Neonatorum, editorial , J. A. M. A. 148:122, 1952.Crossref 210. O'Brien, D.: Terramycin in the Prophylaxis of Ophthalmia Neonatorum , Lancet 1:347, 1952.Crossref 211. Culler, A. M., and Clark, S. G.: Aureomycin as Prophylaxis Against Ophthalmia Neonatorum , Am. J. Ophth. 9:82, 1951. 212. Lehrfeld, L.: Prophylaxis of Ophthalmia Neonatorum , Eye, Ear, Nose & Throat Month. 30:367, 1951. 213. (a) Geller, H. O., and Thygeson, P.: Aureomycin, Chloromycetin, Terramycin in Experimental Herpes Simplex Virus Infections , Am. J. Ophth. 34:165, 1951. 214. (b) Polemann, G.: Inoculation Vaccinia: Treatment with Aureomycin , Med. Welt 20:2747, 1951. 215. (c) Holmes, W. J.: An Epidemic of Conjunctivitis in Hawaii , Hawaii M. J. 11:94, 1951. 216. (d) Benedek, P.: Herpes Zoster Ophthalmicus Treated with Aureomycin , Mil. Surgeon 108:481, 1951. 217. (e) Ciotola, G.: Urea in the Treatment of Herpes Keratitis , Boll. ocul. 34:17, 1951. 218. (f) Latte, B., and Pino, G.: Experimental Infection of the Human Conjunctiva by the Virus of Newcastle Disease in Volunteers , Boll. ocul. 30:553, 1951. 219. (g) Voisin, J.; Dismut, G.; Reboul, R., and Garcie-Bouran: Aureomycin in Herpes Zoster , Bull. Soc. ophth., France 1:29, 1951. 220. (h) Schaeffer, G., and Svendsen, I. B.: Herpes Zoster Healed with Aureomycin and Chloramphenicol , Ugesk. læger 113:1537, 1951. 221. (i) Hallett, J. W.; Leopold, I. H.; Vogel, A. W.; Cannon, E. J., and Steinmetz, C. C.: Treatment of Experimental Herpes Simplex Keratitis in the Rabbit , A. M. A. Arch. Ophth. 46:33, 1951. 222. (j) Bubbage, N. F.: Therapy of Herpes Zoster with Chloromycetin , M. J. Australia 1:399, 1951. 223. (k) Kass, E. H.; Aycock, R. R., and Finland, M.: Chemical Evaluation of Aureomycin and Chloramphenicol in Herpes Zoster , New England J. Med. 246:167, 1952. 224. (l) Carter, A. B.: Investigation into Effects of Aureomycin and Chloramphenicol in Herpes Zoster , Brit. M. J. 1:987, 1951. 225. (m) Eaton, M. D.; Levenson, C. G., and Perry, M.: Inhibition of the Growth of Viruses in the Chick Embryo by Aromatic Diamidines , J. Immunol. 68:1, 1952. 226. (a) Waccache, R.: Clinical Trial of Aureomycin in Trachoma , Am. J. Ophth. 34:1591, 1951. 227. (b) Pasca, G., and Altier, I. A.: Contribution to Tracheoma Therapy with Chloramphenicol , Día méd. 23:1866, 1951. 228. (c) Vautien, P.: Trial of Aureomycin in Trachoma , Rev. internat trachome 28:202, 1951. 229. (d) Zeppa, R.: High Doses of Penicillin in Trachoma , Riv. ital. tracoma 3:23, 1951. 230. (e) Tani, M.: The Mass Treatment of Trachoma by the Internal Use of Sulfathiazole and Its Late Effect , Acta Soc. ophth. Jap. 55:38, 1951. 231. (f) Mazalan, T.: Recurrences of Trachoma Treated with Sulfonamides , Českoslov. ofth. 7:149, 1951. 232. (g) Benmussa, A.: A Trial of Collective Antitrachoma Treatment , Rev. internat. trachome 28:344, 1951. 233. (h) Berkovitch, M. E.: A Course of Treatment for Trachoma , Vestnik. oftal 30:21, 1951. 234. (i) Thygeson, P.: The Trachoma Psittacosis, Lymphogranuloma Venereum Group of Viruses, the Chlamydozoaceae , Am. J. Ophth. 34:7, 1951. 235. (j) Siniscal, A. A.: The Sulfonamides and Antibiotics in Trachoma , J. A. M. A. 148:637, 1952.Crossref 236. (k) Andrade, L. D.: Trachoma Diagnosis and Treatment , Brit. J. Ophth. 35:601, 1951.Crossref 237. (l) Sztrilich, L.: Modern Treatment of Trachoma , Szemészet ophth. Hungary 88:148, 1951. 238. (m) Marin Amat, M.: Present State of the Treatment of Trachoma with Sulfonamides and Antibiotics , Arch. Soc. oftal. hispano-am. 11:641, 1951. 239. (n) Otian, R. G.: Treatment of Trachoma in Children with Hypodermic Injections of 0.5% Sulfidone , Vestnik. oftal. 30:15, 1951. 240. (o) Pavkovic-Burgarski, D.: Treatment of Trachoma with Sulfonamides and Penicillin , Srpski Arhiv. celok. lek. 49:145, 1951. 241. (p) Sakon, H.; Kohn, M., and Raphael, R.: Results Obtained with Aureomycin and Chloramphenicol in the Treatment of Trachoma , Rev. internat. trachoma 28:309, 1951. 242. (q) Ching, R.: Aureomycin in the Treatment of Trachoma , A. M. A. Arch. Ophth. 45:657, 1951.Crossref 243. (r) Beauvieux, J.; Julien, R. J., and Chabot, J.: Pure Florid Trachoma Treated by Aureomycin , Rev. internat trachome 28:269, 1951. 244. (s) Sarkies, J. W. R.: Aureomycin in Trachoma , Brit. J. Ophth. 35:549, 1951.Crossref 245. (t) Ng-van-hieu: Trial of Treatment of Granular Trachoma in Its Different Stages with Aureomycin Drops and Ointment , Ann. ocul. 184:938, 1951. 246. (u) Lavat: Aureo- mycin in the Treatment of Trachoma , Semaine Méd. 27:899, 1951. 247. (v) del Rio Cabanes, J. L.: Aureomycin in Trachoma , Arch. Soc. oftal. hispano-am. 11:635, 1951. 248. (w) Marin Enciso, E.: A Contribution to the Treatment of Trachoma with Aureomycin , Arch. Soc. oftal. hispano-am. 11:628, 1951. 249. (x) Geraci, P.: A Preliminary Note in the Use of Terramycin in Trachoma and Other Ocular Diseases , Riv. ital. tracoma 2:55, 1951. 250. (y) Choumakov, M. P.; Fradkin, M. Y.; Schlykova, B. D.; Avakyan, A. A., and Zaytzeva, N. S.: A New Method of Treatment of Trachoma with Chloromycin® and Syntomycin , Vestnik. oftal. 30:3, 1951. 251. (z) Bierent, P.: Treatment of Trachoma with Aromatic Diamidines , Rev. internat, trachome 28:324, 1951. 252. (a′) Sezer, F. N.: Tarsitis as a Cause of Sulfonamide Resistance in Trachoma , Am. J. Ophth. 34:1508, 1951. 253. (b′) Mitsui, Y.: Tanaka, C.; Toya, H.; Iwashige, Y., and Yamashita, J.: Terramycin in the Treatment of Trachoma , A. M. A. Arch. Ophth. 46:235, 1951.Crossref 254. (c′) Cosgrove, K. W.: The Control of Trachoma , South. M. J. 45:152, 1952.Crossref 255. (a) Straub, W.: Experiences with Ocular Toxoplasmosis , Klin. Monatsbl. Augenh. 118:43, 1951. 256. (b) Wilder, H. C.: Toxoplasma Chorioretinitis in Adults , A. M. A. Arch. Ophth. 47:425, 1952.Crossref 257. (c) Gingrich, W. D., and Darrow, E. M.: Effect of Endochin on Experimental Toxoplasmosis , Am. J. Trop. Med. 31:12, 1951. 258. (d) Kass, E., and Steen, E.: Aureomycin in Treatment of Acute Experimental Toxoplasmosis in Rabbits , Acta path. et microbiol. Scandinav. 28:165, 1951.Crossref 259. (a) Ross, E. J.: Transfer of Non-Electrolytes Across the Blood-Aqueous Barrier , J.: Physiol. 112:229, 1951. 260. (b) Langham, M.: Affecting the Penetration of Antibiotics into the Aqueous Humor , Brit. J. Ophth. 35:614, 1951.Crossref 261. (c) Leopold, I. H.; Nichols, A., and Vogel, A. W.: Penetration of Chloramphenicol into the Eye , A. M. A. Arch. Ophth. 44:22, 1950.Crossref 262. (d) Leopold, I. H.: Clinical Trial with Chloramphenicol in Ocular Infections , A. M. A. Arch. Ophth. 45:44, 1951.Crossref 263. (a) Gurta, S. P.: Modern Therapy in Ophthalmic Diseases , Antiseptic 49:95, 1952. 264. (b) Duca, C. J.; Rothlauf, M. V., and Saidi, J. V.: Studies on Experimental Tuberculosis , Antibiotics and Chemother. 2:16, 1952. 265. (c) Grunberg, E., and Leiwant, B.: Antitubercular Activity in Vivo of Nicotinaldehyde Thiosemicarbazone and Its Isomers , Proc. Soc. Exper. Biol. & Med. 77:47, 1951. 266. (d) Cruickshank, A. H., and Mitchell, G. W., Jr.: Myocardial, Hepatic and Renal Damage Resulting from Para-Aminobenzoic Acid Therapy , Bull. Johns Hopkins Hosp. 88:211, 1951. 267. (e) Hoggarth, E., and Martin, A. R.: Thiosemicarbazones in the Chemotherapy of Tuberculosis , Brit. J. Pharmacol. 6:454, 1951. 268. (f) Hasegawa, S.: Cepharanthine , Jap. J. Exper. Med. 20:69, 1949. 269. (g) Ebina, T.; Kanho, I., and Yamasaki, T.: Cepharanthine , Tohoku J. Exper. Med. 52:67, 1949. 270. (h) Steel, S. J.: Acquired Sensitivity to Para-Amino-Salicylic Acid , Brit. M. J. 1:415, 1952.Crossref 271. (i) Oatway, W. H., and Reding, F.: An Expanded Use of Streptomycin and PAS , Arizona Med. 8:26, 1951. 272. (j) Lorker, J.: Streptokinase in Tuberculous Meningitis , Lancet 1:1334, 1951. 273. (k) New Antituberculosis Drugs, editorial , J. A. M. A. 148:1034, 1952.Crossref 274. (l) Grunberg, E., and Schnitzer, R. J.: Studies on the Activity of Hydrazine Derivatives of Isonicotinic Acid in the Experimental Tuberculosis of Mice , Quart. Bull. Sea View Hosp. 13:3, 1952. 275. (m) Bernstein, J.; Lott, W. A.; Steinberg, P. A., and Yale, H. L.: Chemotherapy of Experimental Tuberculosis: Isonicotinic Acid Hydrazide and Related Compounds , Am. Rev. Tuberc. 65:357, 1952. 276. (n) Stenken, W., Jr., and Wolinsky, E.: Antituberculous Properties of Hydrazines of Isonicotinic Acid , Am. Rev. Tuberc. 65:365, 1952. 277. (o) Zieper, I., and Lewis, R. A.: Tuberculosis in a Macacus Rhesus Treated with Isonicotinyl Hydrazide , Quart. Bull. Sea View Hosp. 13:12, 1952. 278. (p) Robitzek, E. H.; Selikoff, I. J., and Ornstein, G. G.: Chemotherapy of Human Tuberculosis with Hydrazine Derivatives of Isonicotinic Acid , Quart. Bull. Sea View Hosp. 13:27, 1952. 279. (q) Bosworth, D. M.; Wright, H. A., and Fielding, J. W.: Marsillid in the Treatment of Tuberculosis Orthopedic Lesions , Quart. Bull. Sea View Hosp. 13:52, 1952. 280. (r) Elmendorf, B. F., Jr.; Cawthon, M. V.; Muschenheim, C., and McDermott, W.: Absorption, Distribution, Excretion and Short-Term Toxicity of Isonicotinic Acid Hydrazide in Man , Am. Rev. Tuberc. 65:429, 1952. 281. (s) Selikoff, I. J.; Robitzek, E. H., and Ornstein, G. G.: Toxicity of Hydrazine Derivatives of Isonicotinic Acid in the Chemotherapy of Human Tuberculosis , Quart. Bull. Sea View Hosp. 13:17, 1952. 282. (t) Rubin, B.; Hassert, G. L., Jr.; Thomas, B. G. H., and Burke, J. C.: Pharmacology of Isonicotinic Acid Hydrazide , Am. Rev. Tuberc. 65:392, 1952. 283. (u) Sykowski, P.: Streptomycin in Eales's Disease , Am. J. Ophth. 34:889, 1951. 284. (v) Hughes, F. J.; Mardis, R. E.; Dye, W., and Temple, C. W.: Combined Intermittent Regimens in Treatment of Nonmiliary Pulmonary Tuberculosis , Dis. Chest 21:1, 1952.Crossref 285. (w) Glorig, A.: Effect of Dihydrostreptomycin Hydrochloride in Auditory Mechanism , Ann. Otol. Rhin. & Laryng. 63:27, 1951. 286. (x) Adair, C. V.; Drobeck, B., and Bunn, P. A.: Use of Antituberculous Agents in Tuberculosis , Am. Rev. Tuberc. 64:207, 1951. 287. (y) Lepri, G.: The Effect of Hyaluronidase on the Diffusion of Experimental Tuberculous Infection of the Eye , Gior. ital. oftal. 4:373, 1951. 288. (z) Wegner, W., and Lintz, R.: Experiences with Chemotherapy in Ocular Tuberculosis , Klin. Monatsbl. Augenh. 119:350, 1951. 289. (a′) Gandolfi Morpurgo, F.: Thiosemicarbazone in the Treatment of Ocular Tuberculosis , Arch. ottal. 55:293, 1951. 290. (b′) Belgorou, H. E.; Alexander, H.; Meidt, C. E., and McGaley, J.: Tibione in Treatment of Tuberculosis , Dis. Chest 20:1, 1951.Crossref 291. (c′) Volini, I. F.; Kadison, E. R., and Felsenfeld, O.: New Antibiotics in Treatment of Tuberculosis , Dis. Chest 20:19, 1951.Crossref 292. (d′) O'Connor, J. B.; Christie, F. J., and Howlett, K. J., Jr.: Hemotoxicity of Dihydrostreptomycin , Am. Rev. Tuberc. 63:312, 1951. 293. (e′) Finley, A. C.: Viomycin , Am. Rev. Tuberc. 63:1, 1951. 294. (f′) Bartz, O. R.: Viomycin , Am. Rev. Tuberc. 63:4, 1951. 295. (g′) Ehrlich, L.: Viomycin , Am. Rev. Tuberc. 63:7, 1951. 296. (h′) Harvey, G. L.: Viomycin , Am. Rev. Tuberc. 63:17, 1951. 297. (i′) Warring, F. C., Jr., and Howlett, K. J., Jr.: Allergic Reactions to Para-Aminosalicylic Acid , Am. Rev. Tuberc. 65:235, 1952. 298. (j′) Marsh, K.: Drugs Employed in Chemotherapy of Tuberculosis , Antibiotics & Chemother. 1:318, 1951. 299. (k′) Fabrizio, A. M.: Effect of Purified Fractions of Tuberculin on Leucocytes from Normal and Tuberculous Animals in Tissue Cultures , Am. Rev. Tuberc. 65:250, 1952. 300. (l′) Gaby, W. L.; Black, J., and Bondi, A., Jr.: A Study of Tuberculins by the Hemaglutination Procedure , Am. Rev. Tuberc. 65:272, 1952. 301. (m′) Meddlebrook, G., and Dubos, R. J.: Specific Serum Agglutinations of Erythrocytes Sensitized with Extracts of Tubercle Bacilli , J. Exper. Med. 88:521, 1948. 302. (n′) Kass, I.: Studies on the in vitro Effects of Radioactive I-131 Labeled 3,5 Diiodo Pas on the Tubercle Bacillus , Am. Rev. Tuberc. 65:316, 1952. 303. (o′) Perry, T. L.: Failure of Neomycin as an Adjunct to Streptomycin in Tuberculous Meningitis , Am. Rev. Tuberc. 65:325, 1952. 304. (p′) Sykowski, P.: Streptomycin in Miliary Choroidal Tuberculosis , Am. J. Ophth. 35:414, 1952. 305. (q′) Gross, G., and Haase, A.: Experimental Investigations of the Effect of Thiosemicarbazone and Paraaminosalicylic Acid on the Course of Intraocular Tuberculosis in Guinea Pigs , Klin. Monatsbl. Augenh. 118:573, 1951. 306. (r′) Bunn, P. A., and Drobeck, B.: Use of Rabbit Eye as Tissue to Study Tuberculosis , Am. Rev. Tuberc. 64:197, 1951. 307. (s′) Mendenhall, E., and Shaw, R. R.: Recent Trends in Treatment of Pulmonary Tuberculosis , J. A. M. A. 148:595, 1952.Crossref 308. (t′) James, J. A.; Sides, L. J.; Dye, W. E., and Dyke, V. F.: Intermittent Streptomycin Regimens , Am. Rev. Tuberc. 63:275, 1951. 309. (u′) Horne, N. W., and MacAskill, J.: Effect of Para-Aminosalicylic Acid (PAS) Alone and in Association with Streptomycin in Experimental Ocular Tuberculosis , Brit. J. Ophth. 35:459, 1951.Crossref 310. (v′) Irradiated Tuberculosis Vaccine, editorial , J. A. M. A. 146:931, 1951. 311. (w′) Myers, J. A.: Immunity in Tuberculosis , J. A. M. A. 146:1492, 1951.Crossref 312. (x′) Dahlstrom, G., and Difs, H.: The Efficacy of BCG Vaccination: A Study on Vaccinated and Tuberculin-Negative, Unvaccinated Conscripts , Acta tuberc. scandinav. 25:1, 1951. 313. (y′) Damato, F. J.: BCG Vaccine in Phlyctenular Conjunctivitis , Brit. J. Ophth. 35:416, 1951.Crossref 314. (z′) Don, C., and Gregory, J.: Toxicity of Dihydrostreptomycin Sulfate for the Auditory Nerve , Lancet 1:72, 1952.Crossref 315. (a″) Pitts, T. W., and Tempel, C. W.: Antimicrobial Treatment of Pulmonary Tuberculosis , Journal-Lancet 72:180, 1952. 316. (b″) Hirsch, J. G., and Dubos, R. J.: The Effect of Spermine on Tubercle Bacilli , J. Exper. Med. 95:191, 1952.Crossref 317. (c″) Progress in the Treatment of Tuberculosis, editorial , New England J. Med. 246:468, 1952.Crossref 318. (d″) Shane, S. J.; Laurie, J. H.; Riley, C., and Boutilier, M.: Effect of Combined Therapy on the Emergence of Streptomycin Resistant Strains of Tubercle Bacilli , New England J. Med. 246:132, 1952.Crossref 319. (e″) Bavin, E. M.; Brach, A. S.; Falconer, R., and Friedman, R.: Nisin in Experimental Tuberculosis , Lancet 1:127, 1952.Crossref 320. (f″) Viellard, R.: Treatment of Tuberculoma of the Iris with Streptomycin , Bull. Soc. ophth. France 2:214, 1951. 321. (g″) Palich-Szanto, O.: Toxicity of Paraaminosalicylic Acid , Orvosi-hetil. 92:1329, 1951. 322. (h″) Sykowski, P.: Streptomycin Causing Optic Neuritis , Am. J. Ophth. 34:1446, 1951. 323. (i″) Linhart, W. O.: Induced Ocular Tuberculosis , A. M. A. Arch. Ophth. 46:271, 1951.Crossref 324. (j″) Woods, A. C.; Wood, R. M., and Naquin, H. A.: Studies in Experimental Ocular Tuberculosis , A. M. A. Arch. Ophth. 45:546, 1951.Crossref 325. (k″) Woods, A. C., and Wood, R. M.: Studies in Experimental Ocular Tuberculosis , A. M. A. Arch. Ophth. 47:477, 1952.Crossref 326. (l″) Mitzukawa, T., and Nakayama, H.: Studies on the Appearance of Tuberculous Eye Allergy , Acta Soc. ophth. Jap. 55:367, 1951. 327. (m″) Irvine, K. W.: The Present Position of B.C.G. Vaccination , Postgrad. M. J. 28:211, 1952.Crossref 328. (a) Lind, H. E., and Swanton, E.: Routine Bacteriologic Sensitivity , Antibiotics & Chemother. 2:25, 1952. 329. (b) Eisenberg, G. M.: Bacterial Susceptibility to Antibiotics: Concept of Bacterial Inhibition , J. Philadelphia Gen. Hosp. 2:127, 1951. 330. (c) Laboratory Control of Antibiotic Therapy, editorial , J. A. M. A. 147:1360, 1951. 331. (d) Patrick, W. C.; Craig, G. H., and Bachman, F. C.: Diameter of Inhibition Zones Correlated with Tube Sensitivities Using Six Antibiotics , Antibiotics & Chemother. 1:133, 1951. 332. (e) Theodore, F. H.: Contamination of Ocular Solutions , J. A. M. A. 147:1381, 1951. 333. (f) Gray, J. P.: Status of Antibiotics , Rhode Island M. J. 34:474, 1951. 334. (g) Marshall, A. K.: The Dosage Schedule of Chemotherapeutic Agents , Pharmacol. Rev. 4:85, 1952. 335. (h) Long, P. H.: Clinical Use of Antibiotics , A. M. A. Arch. Ophth. 46:360, 1951. 336. (i) Leopold, I. H.: Principles of Antibiotic Therapy in Ophthalmology , A. M. A. Arch. Ophth. 46:360, 1951. 337. (j) Braley, A. E.: Antibiotics in External Eye Disease , Am. J. Ophth. 34:1046, 1951. 338. (k) Sorsby, A.; Bailey, N. L.; Joseph, R., and Ainsley, D.: Discussion of the Newer Antibiotics in Ophthalmology , Proc. Roy. Soc. Med. 44:737, 1951. 339. (l) Swan, K. C.: Some Contemporary Concepts of Scleral Disease , A. M. A. Arch. Ophth. 45:630, 1951. 340. (m) Wooldridge, W. E.: Antifungal Antibiotics of Clinical Significance , South. M. J. 45:351, 1952. 341. (n) Brownlee, G.: The Most Recent Antibiotic Agents , Postgrad. M. J. 28:139, 1952. 342. (o) Douvas, N. G.: Recent Developments in Ocular Therapeutics , J. Iowa M. Soc. 42:54, 1952. 343. (p) Spaulding, E. H., and Anderson, T. G.: Selection of Antimicrobial Agents by Laboratory Means , J. A. M. A. 147:1336, 1951. 344. (q) Nelson, W. E.: Clinical Basis for Selection of Patients for Antimicrobial Therapy , J. A. M. A. 147:1340, 1951. 345. (r) Laboratory Control of Antibiotic Therapy, editorial , Nelson J. A. M. A. 147:1360, 1951. 346. (s) Jackson, G. G., and Finland, M.: Comparison of Methods for Determining Sensitivity of Bacteria in Vitro , A. M. A. Arch. Int. Med. 88:446, 1951.Crossref 347. (t) Matthew, W. B.: Occupational Injuries to the Eye and Their Treatment , J. Internat. Coll. Surgeons 17:187, 1952. 348. (u) Leopold, I. H.: Therapy of Infection Associated with Intraocular Surgery or Trauma, Read at the Annual Meeting of the Ophthalmology Section of American College of Surgeons, Atlantic City, N. J. Feb. 11-12, 1952. 349. (v) Meleney, F. L.; Johnson, B. A., and Teng, P.: The Importance of Laboratory Data in the Treatment of Surgical Infections by Antibiotics , J. Mt. Sinai Hosp. 18:257, 1952. 350. Micks, Whitney, and Anigstein.1e Davisson and others.1f Wachter and others.1g Kenner and Murray.1h McCowen, Callender, and Lawlis.1v Raubitscheck, Acker, and Waksman.1w 351. Elias, Price, and Merrianon.2e Longacre.2f Siegal.2g Adair, Woodin, and Bunn.2l Epstein and Allen.2m Kadison, Ishihara, and Waters.2r 352. Longacre.2f Jensen and others.2t 353. Grunberg and Leiwant.17c Hoggarth and Martin.17e Wegner and Lintz.17z Gandolfi Morpurgo.17a′ Belgorou and others.17b′ Volini, Kadison, and Felsenfeld.17c′ Marsh.17j′ Gross and Haase.17q′ Bunn and Drobec.17r′ 354. Gurta.17a Cruickshank and Mitchell.17d Steel.17h Hughes and others.17v Adair, Drobeck, and Bunn.17x Lepri.17y Wegner and Lintz.17z Volini, Kadison, and Felsenfeld.17c′ Warring and Howlett.17i′ Marsh.17j′ Gross and Haase.17q′ Bunn and Drobeck.17r′ Mendenhall and Shaw.17s′ Horne and MacAskill.17u′ Pitts and Tempel.17a″ Editorial.17c″ Shane and others.17d″ 355. Lepri and Capalbi.6u Gurta.17a Duca, Rothlauf, and Saidi.17b Oatway and Reding.17i Sykowski.17u Hughes and others.17v Glorig.17w Adair, Drobeck, and Bunn.17x Wegner and Lintz.17z Volini, Kadison, and Felsenfeld.17c′ O'Connor, Christie, and Howlett.17d′ Bartz.17e′ Finley.17e′ Ehrlich.17g′ Harvey.17h′ Marsh.17j′ 356. Hughes and others.17v Mendenhall and Shaw.17s′ James and others.17t′ 357. Marsh.17j′ Woods, Wood, and Naquin.17j″ Woods and Wood.17k″ 358. Geller and Thygeson.13a Ciotola.13e Hallett and others.13i 359. Benedek.13d Voisin and others.13g Schaeffer and Svendsen.13h Bubbage.13j Kass, Aycock, and Finland.13k Carter. 13l 360. Wilson, Deeds, and Rather.1a Sacks.1b Kaiser.1c Quinn.1d Micks, Whitney, and Anigstein.1e Davisson and others.1f Wachter, Bohonos and Quakenbusch.1g Kenner and Murray.17h Berger and others.1i Dimick.1j Takano.1y Dubois-Poulsen, Dubois-Verlière, and Tibi.1z Siegal2g Harkavy.2j Spring.2k Adair, Woodin, and Bunn.2l Kmonicek.3c Payne, Spencer, and Schultz.3d Eggers.3e Reiches.4h Ayre.4i McVay and Sprunt.4m Mercier.4r Usadek, Curtis, and Mill.5d Berens and Gulyash.5h van Gelderen.5k Roberts.5n Willcox.6s Cannon, Nichols, and Leopold.6w Douvas, Featherstone, and Braly.6x Brownlee, Bushby, and Short.7d Hambre and others.8a Vogel, Leopold, and Nichols.8f Hagerman and Franzblau.9c Cruickshank and Mitchell.17d Steel.17h Editorial.17k Selikoff, Robitzek, and Ornstein.17s O'Connor, Christie, and Howlett.17d′ Warring and Howlett.17i′ 361. Dubois-Poulsen, Dubois-Verlière, and Tibi.1z Melodia.1a′ 362. Lepri and Sicca.6v Cannon, Nichols, and Leopold.6w Douvas.6x Frisk and Tunevall.6q 363. Selye, H.: Annual Report on Stress , Montreal, Canada, Acta, Inc., Medical Publishers, 1951. 364. (a) Pentini, G.: The Eye and the General Adaptation Syndrome , Ann. ottal. e clin ocul. 77:287, 1951. 365. Romani, J. D.: Malignant Postoperative Fevers , Semaine hôp. Paris 27:1951. 366. Blair, J. R.: Dimitroff, J. M., and Hingeley, J. A.: Acquired Resistance to Cold Exposure in the Rabbit and the Rat , Federation Proc. 10:15, 1951. 367. Daniels, F., Jr.; Fainer, D. C.; Bommarito, C. L., and Bass, D. E.: The Climatization to Cold in Man , Federation Proc. 10:32, 1951. 368. Miline, R., and Kosak, O.: Effect of Noise and Vibration on the Neuroendocrine System , Med. Preg. , 1951, No. (9) . 369. Bean, J. W.: Adrenal Alteration Induced by Oxygen at High Pressure , Federation Proc. 10:11, 1951. 370. Henri, F., and Mast, H.: Behavior of the White Blood Picture, Especially of the Eosinophiles in Rats After Administration of Dibenamine and of Hydergin,® Ztschr. klin. Med. 148:143, 1951. 371. Sawyer, C. H., and Parkerson, G. R., Jr.: ACTH Release in Response to Stress Is Partially Prevented by an Adrenergic Blocking Agent, SKF 501 , Federation Proc. 10:119, 1951. 372. Patrono, D.: Streptomycin and the Adrenal Cortex, Quad. Sc. 1o Smeraldo, Rome, 1950. 373. Tomitti, E., and Matzner, K. H.: Neurotropic Toxic Effect of Penicillin , Klin. Wchnschr. 28:560, 1950.Crossref 374. Barnard, R. D.: Corticotherapeutic Equivalents of Terramycin , New York J. Med. 50:1852, 1950. 375. Salicylates and Cortisone in Rheumatic Diseases , Lancet 1:780, 1951. 376. (a) Cohen, S. J.: A Comparison of Hydrolytic Procedures for Conjugated Urinary Corticoids , Federation Proc. 10:173, 1951. 377. (b) Jacobson, R. P., and Pincus, G.: The Chemical Nature and Sythesis of Cortisone in the Chemistry of Adrenal Steroids , Am. J. Med. 10:531, 1951.Crossref 378. (c) Venning, E. H.: Enzymatic Hydrolysis of the Urinary Corticoids, Program of the 33d Meeting of The Association for the Study of Internal Secretions, Atlantic City, N. J. 1951, p. 43. 379. Wick, A. M.; Hillyard, L., and MacKay, E. M.: Method for Measuring the Effect of Adrenocorticotropic Hormone on Lipoid Soluble Reducing Substances of Rabbit Plasma , Endocrinology 148:137, 1951.Crossref 380. (a) Chen, C., and Tewell, H. E., Jr.: Corticosteroid Determination with Blue Tetrazolium , Federation Proc. 10:377, 1951. 381. (b) Mader, W. J., and Buck, R. R.: Colorimetric Determination of Cortisone: Use of Blue Tetrazolium , Analyt. Chem. 24:666, 1952.Crossref 382. Burton, R. B.; Zaffaroni, A., and Kentman, E. H.: Paper Chromatography of Steroids , J. Biol. Chem. 188:763, 1951. 383. Hoffman, H., and Standinger, H.: Paper Chromatographical Separation and Determination of the Adrenal Cortex, Hormones , Naturwissenschaften 9:213, 1951.Crossref 384. Kretchewsky, D., and Kirk, M. R.: Detection of Steroids in Paper Chromatography , Arch. Biochem. 36:346, 1952.Crossref 385. Best, W. R., and Samter, M.: Variations That Occur in Eosinophil Counts of Blood and Bone Marrow , Blood 6:61, 1951. 386. Proti, F. T.; Clayton, A. B. E., and McSwiney, R. R.: Comparison of Human Bioassay of ACTH with Adrenal Ascorbic Acid Depletion and Inhibition of Tissue Responses , Endocrinology 7:22, 1951. 387. Reinhardt, W. O.; Hungerford, G. F., and Li, C. H.: Eosinopenic Response of Mice to ACTH, Protein and Peptide , Federation Proc. 10:109, 1951. 388. Reinhardt, W. O., and Li, C. H.: Apparent Discrepancies in the Evaluation of Adrenocorticotropic Hormone (ACTH) Activity by two Bioassay Methods , Proc. Soc. Exper. Biol. & Med. 77:229, 1951. 389. Gordon, E. S.; Kelsey, C., and Meyer, E. S.: Adrenal Stimulation by Intravenous ACTH , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 30. 390. Kanee, A.: Corticotropin (ACTH) administered Intravenously , A. M. A. Arch. Dermat. & Syph. 65:95, 1952. 391. Jelliffe, A. M.; Steward, P. A., and Beaumont, G. E.: ACTH by Intravenous Infusion , Lancet 1:1260, 1951. 392. Mandel, W.; Singer, M. J.; Gudmundson, H. R.; Meister, L., and Modern, F. W. S.: Intravenous Use of ACTH , J. A. M. A. 146:546, 1951. 393. Renold, A. E.; Forsham, P. H.; Maisterrena, J., and Thorn, G. W.: Intravenously Administered ACTH , New England J. Med. 244:796, 1951. 394. Forsham, P. H.; Renold, A. E., and Frawley, T. F.: Nature of ACTH Resistance, Program of the Association for the Study of Internal Secretions, 33d Meeting, Atlantic City, N. J., 1951, p. 20. 395. Rohm, E. N., Jr., and Hollander, J. L.: Allergy to ACTH in the Use of Beef ACTH , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 391. 396. (a) McLester, J. G.: Physiologic Effects, Contraindications, Dosage and Control of ACTH and Cortisone Therapy , J. M. A. Alabama 20:319, 1951. 397. (b) Proctor, E. L., and Rawson, E. J.: Adrenocortical Failure Following Treatment with Cortisone and ACTH , Am. J. Clin. Path. 21:158, 1951. 398. (c) Parmer, L. G.; Katonah, F., and Angrist, A. A.: Comparative Effects of ACTH, Cortisone, Corticosterone, Desoxycorticosterone, Pregnenolone, on Growth and Development of Infant Rats , Proc. Soc. Exper. Biol. & Med. 77:215, 1951. 399. (d) Frawley, T. F.: Recognition and Prevention of Complications of ACTH and Cortisone Therapy , A. M. A. Arch. Indust. Hyg. 3:587, 1951. 400. (e) Sulzberger, M.: Effects of ACTH and Cortisone on Certain Skin Diseases , J. Invest. Dermat. 6:323, 1951. 401. (f) Lourel, F. C.; Franklin, W.; Beale, H. D., and Scheller, I. W.: Occurrence of Convulsive Seizures During Treatment of Asthma with Cortisone Acetate , New England J. Med. 244:49, 1951. 402. (g) Dorfman, A.: Status Epilepticus Coincident with the Use of Pituitary Adrenocorticotropic Hormone , J. A. M. A. 146:25, 1951. 403. (h) Morrison, J. F.; Eimor, A. H.; Bazeley, P. L., and Thayer, J. H.: Antigenic Properties of Growth Hormone and ACTH , Nature, London , 169:28, 1952. 404. (i) Boland, E. W., and Headley, M. E.: Results of Long Continued Cortisone Administration in Rheumatoid Arthritis , California Med. 74:416, 1951. 405. (j) Engleman, E. P.; Kunkel, P.; Welsh, J. E., Jr., and Molyneaux, M. G.: Experiences with Cortisone Given Orally , California Med. 75:1, 1951. 406. (k) Krupp, M. A.; Saier, M., and Keddie, F.: Experience with Cortisone and ACTH in Private Clinic , California Med. 75:6, 1951. 407. (l) Rowe, A., Jr.; Lamb, G. R.; Taylor, F. B., and Kinsel, L. W.: Experience with ACTH and Cortisone in Private Practice , California Med. 75:11, 1951. 408. (m) Cosgriff, S. W.: Thrombo-Embolic Complications Associated with ACTH and Cortisone Therapy , J. A. M. A. 147:924, 1951.Crossref 409. Engelman, E. P.; Krupp, M. A., and Kunkel, P.: The Oral Use of Cortisone Suspension in Syrup , J. A. M. A. 145:402, 1951.Crossref 410. Boland, E. W., and Headley, N. E.: The Oral Use of Cortisone Acetate , J. A. M. A. 145:8, 1951.Crossref 411. (a) Smith, R. W., Jr., and Steffensen, E. H.: ACTH and Cortisone in the Treatment of Arthritic Disease , New England J. Med. 245:972, 1951.Crossref 412. (b) McDonald, P. R.; Leopold, I. H.; Vogel, A., and Mulberger, R.: Evaluation of Compound F in Ocular Disease, Read at the Fourth Wills Hospital Clinical Conference, Philadelphia, March 22, 1952. 413. Hollander, J. L.; Brown, E. M.; Jessar, R. A., and Brown, C. Y.: Hydrocortisone and Cortisone Injected into Arthritic Joints , J. A. M. A. 147:629, 1951. 414. Fraser, F. C.: Experimental Production of Congenital Anomalies , Canad. M. A. J. 64:270, 1951. 415. Experimental Production of Congenital Anomalies with Cortisone, editorial , J. A. M. A. 148:206, 1952. 416. Fraser, F. C., and Fainstat, T. D.: Production of Congenital Defects in the Offspring of Pregnant Mice Treated with Cortisone: Progress Report , Pediatrics 8: 527, 1951. 417. Silverman, W. A.; Day, R. L., and Blodi, F. C.: Inhibition of Growth and Othei Effects of ACTH in Premature Infants , Pediatrics 8:177, 1951. 418. Wilson, R., and Rowe, R.: Some Special Problems in the Use of ACTH and Cortisone Therapy in Children , J. Pediat. 40:164, 1952.Crossref 419. Locke, W.; Talbot, N. B.; Jones, H. S., and Worcester, J.: Studies of the Combined Use of Measurements of Sweat Electrolyte Composition and Rate of Sweating as an Index of Adrenal Cortical Activity , J. Clin. Invest. 30:325, 1951.Crossref 420. Conn, J. W.; Louis, L. H., and Fajans, S. S.: Probability That Compound F Is the Hormone Produced by the Normal Human Adrenal Cortex , Science 113:713, 1951.Crossref 421. Forsham, P. H.; Renold, A. E., and Lesh, J. B.: Metabolic Effects of Small Molecular ACTH: A Preliminary Report , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 7. 422. Payne, R. W.; Rosenberg, I. N.; Raben, M. S.; Cleroux, A. P., and Astwood, E. B.: Effectiveness of Corticotropin Suspension, Program of the 43d Meeting of the American Society for Clinical Investigation, 1951, p. 44. 423. Shulman, L. E.; Harvey, A. M. G.; Howard, J. A., and Schoenrich, E. H.: Clinical Studies with ACTH in Bronchial Asthma , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 401. 424. (a) Wolfson, W. Q.; Thompson, R. E.; Robinson, W. D.; Duff, I. F.; Cohn, C.; Lewis, L., and Hunt, H. D.: Development, Evaluation and Clinical Use of Long-Acting ACTH Preparations , in Mote, P. R.: Proceedings, Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 1. 425. (b) Wolfson, W. Q.; Thompson, R. E.; Robinson, W. D.; Duff, I. F.; Cohn, C., and Lewis, L.: An Excellent Tolerated, Heat-Stable, Long-Acting ACTH Preparation Suitable for Prolonged and Ambulatory Treatment, Program of the 33d Meeting of the Association for the Study of Internal Secretions, Atlantic City, 1951, p. 80. 426. Mason, H. L.; Hoehn, W. N., and Kendall, E. C.: Chemical Studies of the Suprarenal Cortex , J. Biol. Chem. 124:459, 1938. 427. Perera, G. A.; Ragan, C., and Werner, S. C.: Clinical and Metabolic Study of 17-Hydroxycorticosterone (Kendall Compound F): Comparison with Cortisone , Proc. Soc. Exper. Biol. & Med. 77:326, 1951. 428. Thorn, G. W.: Adrenals in Health and Disease , Tr. & Stud. Coll. Physicians, Philadelphia 19:95, 1952. 429. Mason, H. L.: Isolation of Adrenal Cortical Hormones from Urine , J. Biol. Chem. 182:131, 1950. 430. Mason, H. L.; Nelson, D. H.; Reich, H., and Samuels, L. D.: Isolation of Steroid Hormone from the Adrenal Vein Blood of Dogs , Science 111:578, 1950. 431. Boland, E. W., and Headley, M. E.: Compound F Used Orally in Patients with Rheumatoid Arthritis , J. A. M. A. 148:981, 1952. 432. Jacobsen, R. P., and Pincus, G.: The Chemistry of Adrenal Steroids , Am. J. Med. 10:531, 1951. 433. Perera, G. A.; Ragan, C., and Werner, S. C.: Clinical and Metabolic Study of 17-Hydroxycorticosterone (Kendall's Compound F): Comparison with Cortisone , Proc. Soc. Exper. Biol. & Med. 77:326, 1951. 434. Thorn, G. W.; Renold, A. P.; Wilson, D. L.; Frawley, F. F.; Jenkins, D.; Garcia-Reyes, J., and Forsham, P. H.: Clinical Studies on the Activity of Orally Administered Cortisone , New England J. Med. 245:549, 1951.Crossref 435. Conn, J. W.; Louis, L. H.; Fajans, S. S.; Johnson, B. J.; Barott, G. W.; Hogg, L. W.; Blood, J. P., and Weiss, M.: Metabolic Effects in Man of Orally and Parenterally Administered Compound F and Compound F Acetate , Proc. Centr. Soc. Clin. Res. 24:23, 1951. 436. (a) Shechmeister, I. L., and Pond, P. P.: Response of Mice to Inoculation with Certain Avirulent Bacteria After Exposure to Sublethal Total Body X-Ray , Federation Proc. 10:418, 1951. 437. (b) Rebuck, J. W.; Smith, R. W., Jr., and Margulis, R. P.: ACTH and Leukocytic Performance in Windows in Man , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 460. 438. (c) Opsahl, J. C.; Long, C. N. H., and Fry, E. G.: Chorionic Gonadotropin, ACTH and Adrenal Hyaluronidase Relationship , Yale J. Biol. & Med. 23:399, 1951. 439. (d) Menkin, V.: Effect of Commercial Cortisone Acetate Suspension on Capillary Permeability , Am. J. Physiol. 164:294, 1951. 440. (e) Martin, S. P.; Bennett, I. L., and Chaudhuri, S.: The Effect of a Series of Bacteria and Their Products on the Human Leukocyte, Program of the 43d Meeting of the American Society Clinical Investigation, 1951, p. 38. 441. (f) Anderson, G. E.; Wiesel, L. L.; Hillman, R. W., and Stump, W. N.: Sulfhydryl Inhibition as a Mechanism in the Effects of ACTH and Cortisone , Proc. Soc. Exper. Biol. & Med. 76:825, 1951. 442. (g) Smith, D. T., and Reinmuth, O. M.: Effect of ACTH on Pneumonia Induced with Tuberculin in Lungs of Sensitized Rabbits , Federation Proc. 10:4, 1951. 443. (h) Garmuth, F. G., Jr.; Nedcel, G. A.; Ottinger, B., and Oyama, J.: Anatomic and Histologic Changes in Rabbits with Experimental Hypersensitivity Treated with Compound E and ACTH , Proc. Soc. Exper. Biol. & Med. 76:177, 1951. 444. (i) O'Neill, G. Q.; Ford, R. T.; Dughi, D. N., and Faddis, E.: A Critique of Laboratory Methods for the Evaluation of Agents for Use in Collagen Diseases , Federation Proc. 10:328, 1951. 445. (j) Sutliff, W. D., and Norman, S. L.: Adrenocorticotropic Hormone in Cutaneous and Systemic North American Blastomycosis , in Mote, J. R.: Proceedings Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 391. 446. (k) Ungar, G., and Damgaard, E.: Studies on Fibrinolysin-Antifibrinolysis System in Serum: Action of Anterior Pituitary, Adrenal Cortex and Spleen , J. Exper. Med. 93:89, 1951. 447. (l) Ungar, G.; Damgaard, E., and Weinstein, H. P.: Anaphylactic Arthritis in Guinea Pigs and Its Hormonal Control , Federation Proc. 10:422, 1951. 448. (m) Selye, H.: Role of Somatotropic Hormone in the Production of Malignant Nephrosclerosis, Periarteritis Nodosa, and Hypertensive Disease , Brit. M. J. 1:263, 1951 449. (n) The Effects of the Local Injection of Electrophoretically Pure Somatotropic Hormone , Rev. canad. biol. 9:476, 1951 450. (o) The Physiology and Pharmacology of the 11-Desoxysteroids, Program of the Steroid Hormone Conference, México, D. F., Philadelphia, The Blakiston Company, 1951. 451. (p) Reid, E.: Assay of Diabetogenic Pituitary Preparations , J. Endocrinol. 7:120, 1951. 452. (q) Selye, H.: Influence of STH, ACTH and Cortisone upon Resistance to Infection , Canad. M. A. J. 64:49, 1951. 453. (r) Adams, F. H.; Berglund, E.; Balkan, S. G., and Chisholm, P.: Pituitary Adrenocorticotropic Hormone in Severely Burned Children , J. A. M. A. 146:31, 1951. 454. (s) Adams, F. H.; Berglund, E., and Tamerin, J. A.: ACTH in Burns , J. A. M. A. 145:925, 1951. 455. (t) Whitelaw, M. J.: Physiological Reaction to Pituitary Adrenocorticotropic Hormone (ACTH) in Severe Burns , J. A. M. A. 145:85, 1951. 456. (u) Frawley, T. F.; Roche, N.; Jenkins, D., and Thorn, G. W.: The Role of the Pituitary Adrenocortical System in the Response to Anoxia, Program of the 43d Meeting of the American Society for Clinical Investigation, 1951, p. 17. 457. Selye, footnotes 65 m, n, o, q. 458. Lanman, J. T.; Guy, L. P., and Dancis, L.: Adrenocorticotropic Hormone in the Therapy of Retrolental Fibroplasia , Pediatrics 9:27, 1952. 459. Finland, M.; Kass, E. H., and Ingber, S. H.: Further Observations on the Effects of ACTH , in Mote, J. R.: Proceedings of Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 478. 460. Kass, E. H., and Finland, M.: Role of Adrenal Steroids in Infection and Immunity , New England J. Med. 244:464, 1951. 461. Woods, A. C., and Wood, R. M.: Studies in Experimental Ocular Tuberculosis , A. M. A. Arch. Ophth. 47:477, 1952.Crossref 462. Svedberg, B.; Dahlstrom, B., and Luft, R.: Effect of Adrenocorticotropic Hormone (ACTH) on Experimental Tuberculosis in Mice: Preliminary Report , Acta endocrinol. 60:50, 1951. 463. Smith, G. H., and Opsahl, J. C.: The Adrenal Hyaluronidase Relationship in Infection , Yale J. Biol. & Med. 23:361, 1951. 464. (a) Edelmann, A., and Katsh, S.: Survival of Rats Adrenalectomized After X-Ray Irradiation , Federation Proc. 10:38, 1951. 465. (b) Katsh, S., and Edelmann, A.: Adrenal Cortical Requirements of Adrenalectomized X-Ray Irradiated Rats , Federation Proc. 10:73, 1951. 466. Abernathy, R.: Effect of Cortisone on Experimental Brucellosis, Program of the 43d Meeting of the American Society Clinical Investigation, 1951, p. 5. 467. Mogabgab, W. J., and Lewis, T.: Effects of Cortisone on Bacterial Infection , J. Lab. & Clin. Med. 39:271, 1952. 468. Lemaistre, C. A.; Tompsett, R.; Muschenheim, C., and others: Effect of Adrenocorticotropic Hormone and Cortisone in Patients with Tuberculosis , J. Clin. Invest. 30:445, 1951. 469. Kleinschmidt, R. F., and Johnston, J. M.: Miliary Tuberculosis in Cortisone-Treated Patient: Case Report with Autopsy , Ann. Int. Med. 35:694, 1951. 470. ACTH and Cortisone in Infection, Editorial , New England J. Med. 245:75, 1951. 471. Deleterious Effects of ACTH and Cortisone in Tuberculosis, Editorial , New England J. Med. 245:662, 1951. 472. Lemaistre, C., and Tompsett, R.: Emergence of Pseudotuberculosis in Rats Given Cortisone , J. Exper. Med. 95:393, 1952. 473. Swartzman, G., and Fisher, A.: Alteration of Experimental Poliomyelitis Infection in the Syrian Hamster with the Aid of Cortisone , J. Exper. Med. 95:347, 1952. 474. Boyer, F., and Chedid, L.: Antitoxic Action of Cortisone , Compt. rend. Acad. Sc. 233:1232, 1951. 475. Kirk, J. E.: Steroid Hormones and Aging , J. Gerontol. 6:253, 1951. 476. Cunmun, P.: Action of Cortisone and of Desoxycorticosterone on Dinitrophenol Fever , Rev. canad. biol. 9:426, 1951. 477. Douglas, W. W., and Paton, W. D. M.: The Hypothermic and Antipyretic Effect of Preparations of ACTH , Lancet 1:342, 1952. 478. Hahn, E. O.; Houser, H. B.; Rammelkamp, G. H., Jr.; Denny, M. W., and Wanamaker, L. W.: Effect of Cortisone on Acute Streptococcal Infections and Post-Streptococcal Complications , J. Clin. Invest. 30:274, 1951. 479. Kohler, V., and Munich, W.: Effect of Synthetic Adrenal Cortex Hormone Desoxycorticosterone on the Blood Sugar During a Short Fast , Endokrinologie 28:60, 1951. 480. Pentini, G., and Formaro, L.: The Eye in the General Adaptation Syndrome , Folia endocrinol. 3:893, 1951. 481. (a) Rich, A. R.; Bennett, I. L.; Cochran, T. H.; Griffith, P. C., and McGoon, D. C.: Effect of ACTH and Cortisone upon Experimental Anaphylactic Glomerulonephritis , Bull. Johns Hopkins Hosp. 88:189, 1951. 482. (b) Sheltar, M. R.; Schmidt, H. L.; Lincoln, R. B.; DeVore, J. K.; Bullock, J. A., and Hellbaum, A. A.: Response of Serum Polysaccharide Fractions and Protein Fractions Following Cortisone Treatment , J. Lab. & Clin. Med. 39:372, 1952. 483. (c) Balmain, J. H.; Folley, S. J., and Glascock, R. F.: Inhibition of Fatty Acid Synthesis in Rat Mammary Gland Slices by Cortisone in Vitro and Its Antagonism by Insulin , Nature, London , 169:447, 1952. 484. (d) Layton, L. L.: Effects of Cortisone upon Chondroitin Sulphate Synthesis by Animal Tissues , Proc. Soc. Exper. Biol. & Med. 76:596, 1951. 485. (e) Adams, F. H.; Kelley, B. G.; Dwan, P. F., and Glick, D.: Response to Serum Hyaluronidase Inhibitor and Mucoproteins to Adrenocorticotropic Hormone in Rheumatic States , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 572 486. (f) Response of the Serum Hyaluronidase Inhibitor and Mucoproteins to Adrenocorticotropic Hormone in Rheumatic States: Mucolytic Enzyme Systems, 15 , Pediatrics 7:472, 1951. 487. Meyer, K., and Rappaport, T. M.: The Mucopolysaccharides of the Brown Substance of Connective Tissue , Science 113:596, 1951. 488. Steen, A. S.: Effect of Cortisone on Tissue Cultures , Brit. J. Ophth. 35:741, 1951. 489. Maumenee, E.: Influence of Donor Recipient Sensitization of Corneal Grafts , Am. J. Ophth. 34:142, 1951. 490. Newell, F. W., and Dixon, J. M. Effect of Subconjunctival Cortisone upon the Immediate Union of Experimental Corneal Grafts , Am. J. Ophth. 34:977, 1951. 491. Baxter, H.; Schiller, C.; Whiteside, J. H., and Straith, R. E.: Effect of ACTH on Survival of Homografts in Man , Plastic & Reconstruct. Surg. 7:492, 1951. 492. (a) Baxter, H.; Schiller, C.; Whiteside, J. H., and Straith, R. E.: Influence of Cortisone on Skin and Wound Healing in Experimental Animals , Plast. & Reconstruct. Surg. 7:24, 1951 493. (b) Influence of ACTH on Wound Healing in Man , Baxter Plast. & Reconstruct. Surg. 7:85, 1951. 494. (c) Upton, A. C., and Coon, W. W.: Effects of Cortisone and Adrenocorticotropic Hormone on Wound Healing in Normal and Scorbutic Guinea Pigs , Proc. Soc. Exper. Biol. & Med. 77:153, 1951. 495. Findlay, C. W., Jr., and Howes, E. L.: Combined Effect of Cortisone and Partial Protein Depletion on Wound Healing , New England J. Med. 246:597, 1952. 496. Fornaro, L.: Influence of Desoxycorticosterone and of Corticotropic Hormone on the Process of Healing of Corneal Wounds , Rass. ital. ottal. 20:90, 1951. 497. Fornaro, L.: The Eye in the General Adaptation Syndrome , Rass. ital. ottal. 21:28, 1951. 498. Conway, H., and Stark, R. B.: ACTH in Plastic Surgery , Plast. & Reconstruct. Surg. 8:354, 1951. 499. Spain, D. M.; Molomut, N., and Haber, A.: Studies of the Cortisone Effects on the Inflammatory Response , J. Lab. & Clin. Med. 39:383, 1952. 500. Conway, H., and Stark, R. B.: Corticotropin (ACTH) in Treatment of Keloids , A. M. A. Arch. Surg. 64:47, 1952. 501. Billingham, R. E.; Krohn, P. L., and Medawar, P. M.: Effect of Locally Applied Cortisone Acetate on Survival of Skin Homografts in Rabbit , Brit. M. J. 2:1049, 1951. 502. Skin Homografts in Clinical Practise, editorial Billingham Brit. M. J. 2:1073, 1951. 503. (a) Tompkins, E. H.: The Response of Monocytes to Adrenal Cortical Extract , J. Lab. & Clin. Med. 39:365, 1952. 504. (b) Schulman, I.; Lanman, J. T.; Laxdal, O. E., and Holt, L. E., Jr.: Effects of ACTH and Cortisone on Leukemia in Childhood , Pediatrics 8:34, 1951. 505. (c) Dobriner, K.: Adrenal Function in Steroid Excretion in Disease , in Symposium on Steroids in Experimental and Clinical Practice , Philadelphia, The Blakiston Company, 1951, p. 130. 506. (d) Burton, R. B.; Zaffaroni, A.; Izzo, A. J., and Kutmann, E. H.: Studies on the Nature of the Adrenal Cortical Excretion in Patients with Malignancy, Program of the 43d Meeting American Society Clinical Investigation, 1951, p. 11. 507. (e) Funk, C.; Tomashefsky, P.; Soukup, R., and Ehrlich, A.: Effect of the Hormonal Factors on Growth of a Transplanted Rat Tumor , Federation Proceedings 10:185, 1951. 508. (f) Alpert, L. K.; Zimmerman, J., and Cherr, E. H.: Effects of ACTH, Cortisone and Nitrogen Mustard on Malignant Diseases , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 235. 509. (g) Farber, S.; Downing, V.; Schwachman, H.; Toch, R.; Appleton, R.; Held, F.; King, J. P., and Feriozi, D.: Action of ACTH and Cortisone on Children with Disseminate Cancer , in Mote, J. R.: Proceedings Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 226 510. (h) The Action of ACTH and Cortisone in Acute Leukemia , in Mote, J. R.: Proceedings Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 251. 511. ( i) Cummings, M. M.; Drummond, M. C.; Michael, M., Jr., and Bloom, W. L.: Influence of Cortisone on Artificially Induced Peritoneal Exudates , Bull. Johns Hopkins Hosp. 90:185, 1952. 512. (j) Pillers, E. N. K.; Burchenal, J. H.; Eliel, L. P., and Pearson, O. H.: Resistance to Corticotropin Cortisone, and Folic Acid Antagonists in Leukemia , J. A. M. A. 148:907, 1952. 513. (a) Adlersberg, D.; Schaefer, E., and Drachman, S. R.: Development of Hypercholesteremia During Cortisone and ACTH Therapy , J. A. M. A. 144:969, 1950 514. (b) Studies on Hormonal Control of Serum Lipid Partition in Man , J. Clin. Endocrinol. 11:67, 1951. 515. (c) Bloom, B., and Pierce, F. T., Jr.: Relationship of ACTH and Cortisone to Serum Lipoproteins in Atherosclerosis in Humans , Metabolism 1:155, 1952. 516. (d) Pierce, F. T., Jr., and Bloom, B.: Relationship of ACTH and Cortisone to Serum Lipoproteins of the Rabbit , Metabolism 1:163, 1952. 517. (e) Stanler, J.; Pick, R., and Katz, L. N.: Effects of Desoxycorticosterone Acetate on Cholesterolemia, Blood Pressure and Atherogenesis in Chicks , Circulation 4:262, 1951. 518. DeVries, J.: The Effect of ACTH on Circulating Antibody Levels , J. Immunol. 65:119, 1950. 519. (b) Bjørneboe, M.; Fischel, E. E., and Stoerk, H.: Effect of Cortisone and ACTH on the Concentration of Circulating Antibodies , J. Exper. Med. 93:37, 1951. 520. (c) Mirick, G. S.: Effects of ACTH and Cortisone on Antibodies in Humans , Bull. Johns Hopkins Hosp. 88:332, 1951. 521. (d) Hahn, E. O.; Houser, H. B.; Rammelkamp, C. H., Jr.; Denny, F. W., and Wanamaker, L. W.: Effect of Cortisone on Acute Streptococcal Infections and Post-Streptococcal Complications , J. Clin. Invest. 30:274, 1951. 522. (a) Kass, R. H., and Finland, N.: Role of Adrenal Steroids in Infection and Immunity , New England J. Med. 244:464, 1951. 523. (b) Sprague, R. G.: Cortisone and ACTH: A Review of Certain Physiologic Effects and Their Clinical Implications , Am. J. M. Sc. 10:567, 1951. 524. (c) Witlow, N. J.: Treatment of Severe Burns with ACTH , in Mote, J. R.: Proceedings of Second Clincial ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 322. 525. (d) Ebert, R. H., and Wissler, R. W.: In Vivo Observations of the Effects of Cortisone on the Vascular Reaction to Large Doses of Horse Serum, Using the Rabbit Ear Chamber Technique , J. Lab. & Clin. Med. 38:499, 1951. 526. (e) Elliott, K. A. C., and Yrarrazaval, S.: An Effect of Adrenalectomy and Cortisone on Tissue Permeability in Vitro , Nature, London 169: 460, 1952. 527. (g) States, editorial, ACTH, Cortisone and Hypersensitive Disease Ann. Int. Med. 36:911, 1952. 528. (h) Wedgewood, R. J.; Ajwn, C. B. Z., and Janeway, C. A.: The Mechanism of Action of ACTH in Experimental Nephritis Due to a Foreign Protein , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 108. 529. (i) Grob, D.; Schoenrich, E. H.; Winkenwerder, W. C., and Harvey, A. M.: Influence of ACTH on the Reactivity of the Bronchial Tree, Skin and Secretory Glands to Specific Antigens, Histamine and Mecholyl in Bronchial Asthma , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 1, p. 499. 530. (j) Grace, H. W.; Frank, L., and Wyse, R. J.: Effect of Cortisone upon Hypersensitivity Due to Lymphogranuloma Venereum , A. M. A. Arch. Dermat. & Syph. 65:348, 1952. 531. (k) Ehrich, W. E.: The Nature of Collagen Diseases , Am. Heart J. 43:121, 1952.Crossref 532. (l) Rantz, L. A.; Creger, W. C., and Choy, S. H.: Immunological Hyperreactivity in the Pathogens of Rheumatic Fever and Other Diseases , Am. J. Med. 12:115, 1952.Crossref 533. (m) Holman, J., and Goth, A.: Histamine Release in the Human Skin and the Effect of Cortisone , Federation Proc. 11:358, 1952. 534. (n) Winter, C. A., and Flataker, L.: Cortisone and Related Hormones: Effect on Response to Analgesic Drugs , J. Pharmacol. & Exper. Therap. 103:93, 1951. 535. (o) Goth, A.; Holman, J., and Copenhaver, J. H.: Mechanism of Action of Cortisone in Experimental Hypersensitivity , Federation Proc. 11:349, 1952. 536. (p) Thomas, L., and Good, R. A.: The Effect of Cortisone on the Schwartzman Reaction , J. Exper. Med. 95:409, 1952. 537. (q) Goldman, L.; Preston, R., and Rockwell, E.: The Local Effect of 17-Hydroxycorticosterone 21-Acete in the Diagnostic Patch Test Reaction , J. Invest. Dermat. 18:89, 1952. 538. (r) Ebert, R. H., and Wissler, R. W.: The in Vivo Observations of Vascular Reactions to Large Doses of Horse Serum Using Rabbit Ear Chamber Technique , J. Lab. & Clin. Med. 38:511, 1951. 539. (a) Woods, A. C.: The Present Status of ACTH and Cortisone in Clinical Ophthalmology , Am. J. Ophth. 34:945, 1951. 540. (b) Dickey, R. L.: Cortisone and ACTH in the Treatment of Diseases of the Eye , Delaware M. J. 23:11, 1951. 541. (c) Henderson, J. W., and Hollenhorst, R. W.: Clinical Observations on the Use of Cortisone in Ophthalmic Diseases , Tr. Am. Acad. Ophth. 55:543, 1951. 542. (d) Moutinho, H., and Vasto, O. P.: Ocular Therapy with Local Applications of Cortisone , A. M. A. Arch. Ophth. 11:241, 1951. 543. (e) Berens, C., and Girard, L. J.: ACTH and Cortisone , J. Florida M. A. 37:695, 1951. 544. (f) McLean, J. M.: Present Status of ACTH and Cortisone in Treatment of Eye Diseases , Sight-Saving Rev. 21:67, 1951. 545. (g) Hill, H. F.; Dennis, R. H., and Shannon, E. G.: ACTH and Cortisone in Ophthalmology , J. Maine M. A. 42:47, 1951. 546. (h) Krupp, M. A.; Saier, M.; Keddie, F.; Tanner, R., and Snell, A. M.: Experience with Cortisone and ACTH in a Private Clinic , California Med. 75:6, 1951. 547. (i) Rowe, A., Jr.; Lamb, G. R.; Taylor, F. B., and Kinsell, L. W.: Experience with ACTH and Cortisone in Private Practice , California Med. 75:11, 1951. 548. (j) Paich-Szanto, O.: The Intermittent Form of Sympathetic Ophthalmitis and Its Therapy , Klin. Monatsbl. Augenh. 118:499, 1951. 549. (k) Laws, H. W., and Howard, R. P.: Sympathetic Ophthalmia Treated Successfully with ACTH , Canad. M. A. J. 64:530, 1951. 550. (l) Vesterdal, E.: ACTH in the Treatment of Sympathetic Ophthalmia , Acta ophth. 29:239, 1951. 551. (m) Haik, G. M.; Waugh, R. L., Jr., and Lyda, W.: Sympathetic Ophthalmia , A. M. A. Arch. Ophth. 47:437, 1952.Crossref 552. (n) Lavery, F. S.; Werner, L. E.; O'Donoghue, S.; Guinan, P. M., and MacDougald, J.: Use of Cortisone in Diseases of the Eye , Brit. M. J. 1:1285, 1951.Crossref 553. (o) Barrious, R. R., and Barrière, R. B.: Cortisone in Ophthalmology , Arch. Soc. oftal. hispano-am. 11:276, 1951. 554. (p) McLean, J. M.; Gordon, D. M., and Koteen, H.: Clinical Experience with ACTH and Cortisone in Ocular Disease , Tr. Am. Acad. Ophth. 55:565, 1951. 555. (q) MacCaslin, M. F.: Cortisone and ACTH in Ophthalmology , Rev. brasil. oftal. 9:207. 556. (r) Fog, T.: Corticotropin (ACTH) Treatment of Disseminated Sclerosis , Nord. med. 46:1742, 1951. 557. (s) Lerner, M.: Dendritic Ulcer Treated with Cortisone , Brit. J. Ophth. 35:435, 1951.Crossref 558. (t) Koch, F. P.: ACTH and Cortisone in Ophthalmologic Practice , New York J. Med. 51:2411, 1951. 559. (u) Hogan, M. J.: Engelman, E. P.; Thygeson, P., and Krupp, M.: Effect of ACTH and Cortisone on Ocular Disease , Am. J. Ophth. 34:73, 1951. 560. (v) Duke-Elder, S.: The Clinical Value of Cortisone, ACTH in Ocular Disease , Brit. J. Ophth. 35:637, 1951.Crossref 561. (w) Duke-Elder, S.; Duthie, O. M.; Foster, J.; Law, F. W.; Lister, A.; Reid, A. M.; Scott, G. I.; Zorab, E. C., and Goldsmith, A. J. B.: A Series of Cases Treated Locally by Cortisone , Brit. J. Ophth. 35:672, 1951.Crossref 562. (x) Duke-Elder, S., and Ashton, N.: Action of Cortisone on Tissue Reactions of Inflammation and Repair with Special Reference to the Eye , Brit. J. Ophth. 35:695, 1951.Crossref 563. (y) Garcianocito, P. F.: Ocular Diseases and Cortisone , Semana méd. 99:531, 1951. 564. (z) Guinan, P. M.: Recurrent Choroiditis Treated with Cortisone , Brit. J. Ophth. 35:431, 1951.Crossref 565. (a') Pinkerton, O. D.: Cortisone in Interstitial Keratitis , Am. J. Ophth. 34:1746, 1951. 566. (a) Lavat: Cortisone in the Treatment of Phlyctenular Keratoconjunctivitis , Semana méd. 27:1000, 1951. 567. (b) Horne, G. O.: Topical Treatment of Cortisone in Syphilitic Ocular Disease , Brit. M. J. 2:1289, 1951.Crossref 568. (c) Lavery, F. S.; Werner, L. E., and O'Donoghue, D.: Use of Cortisone in Diseases of Eye , Brit. M. J. 2:1285, 1951.Crossref 569. (d) Thygeson, P.: Etiology and Treatment of Phlyctenular Keratoconjunctivitis , Am. J. Ophth. 34:1217, 1951. 570. (e) Siltzbach, L. E.: Effect of Cortisone in Sarcoidosis , Am. J. Med. 12:139, 1952.Crossref 571. (f) Gindel, B. R.; Young, J. M., and Greiner, D. J.: Sarcoidosis , Am. J. Med. 12:205, 1952.Crossref 572. (g) Siltzbach, L. E.; Posner, A., and Medine, M. M.: Cortisone Therapy in Sarcoidosis , J. A. M. A. 147:927, 1951.Crossref 573. (h) Small, M. J.: Favorable Response of Sarcoidosis to Cortisone Treatment , J. A. M. A. 147:932, 1951.Crossref 574. (i) Lovelock, F. J., and Stone, D. J.: Cortisone Therapy of Boeck's Sarcoid , J. A. M. A. 147:930, 1951.Crossref 575. (j) Small, M. J.: Pulmonary Sarcoidosis , J. A. M. A. 147:932, 1951.Crossref 576. (k) Kierland, R. R.; O'Leary, P. A.; Brunsting, L. A., and Didcoct, J. W.: Cortisone and Corticotropin (ACTH) in Dermatology , J. A. M. A. 148:23, 1952.Crossref 577. (l) Maddin, S., and Danto, J. L.: Results of Topical Application of Cortisone in Congenital Syphilitic Interstitial Keratitis , A. M. A. Arch. Dermat. & Syph. 64:437, 1951. 578. (m) Freedlander, A. S.: Observations on Use of ACTH and Cortisone in Treatment of Asthma, Hay Fever and Other Allergic Conditions , Ann. Allergy 9:588, 1951. 579. (n) Sharnoff, J. G.; Carideo, H. L., and Stein, I. D.: Cortisone-Treated Scleroderma: Report of a Case with Autopsy Findings , J. A. M. A. 145:1230, 1951. 580. (o) Ormsby, H. L.; Shirley, B. Y.; Aikenhead, J. F., and Murray, R. G.: ACTH and Cortisone in Eye Disease , Canad. M. A. J. 66:62, 1952. 581. ( p) Beerman, H.; Ford, W. T.; Nicholas, L., and Katzenstein, L.: Syphilis , A. M. A. Arch. Int. Med. 89:309 582. 464, 1952. 583. (q) Cortisone in Interstitial Keratitis, Editorial , Am. J. Syph. 35:88, 1951. 584. (r) Vesterdal, E.: ACTH in the Treatment of Sympathetic Ophthalmia , Acta ophth. 29:239, 1951 585. (s) Acute Fibrinous Iridocyklitis , Vesterdal Acta ophth. 29:509, 1951. 586. (t) Lawrence, H. G., Jr.: Value of ACTH and Cortisone in Ocular Inflammations , South. M. J. 45:65, 1952. 587. (u) Crawford, H. E.: Cortisone in Secondary Glaucoma , Am. J. Ophth. 34:1320, 1951. 588. (v) Mundy, M. L.; Howard, R. M.; Stillman, P. H., and Bevans, M.: Cortisone Therapy in a Case of Rheumatoid Nodules of the Eye in Chronic Rheumatoid Arthritis , A. M. A. Arch. Ophth. 45:531, 1951. 589. (w) Kellerman, L.: Pregnenolone Therapy in Uveitis , A. M. A. Arch. Ophth. 46:419, 1951. 590. (x) Thiel, R.: Cortisone Therapy in Eye Disease , Klin. Monatsbl. Augenh. 119:161, 1951. 591. (y) Schwarz, F.: Cortisone Therapy in Ophthalmic Disease , Kresge Eye Inst. Bull. 2:59, 1951. 592. (z) Arruga, H.: Cortisone in Ophthalmology , Arch. Soc. oftal. hispano-am. 11:585, 1951. 593. (a') Perera, C. A., and McLean, J.: Use of ACTH and Cortisone , A. M. A. Arch. Ophth. 46:105, 1951.Crossref 594. (a) Rama, G.: Cortisone and Corticostimulants in Ophthalmology , Arch. ottal. 55: 461, 1951. 595. (b) Offret, G., and Forest,: Cortisone in Local Application , Bull. Soc. opht. France 1:20, 1951. 596. (c) Olson, B. G.: Evaluation of ACTH and Cortisone in Eye Disease , Bull. Univ. Minnesota Hosp. 22:398, 1951. 597. (d) Polan, C. M.: ACTH and Cortisone Therapy of Ocular Conditions , West Virginia M. J. 47:285, 1951. 598. (e) Paufique, L.; Chavanne, H., and Rougier, J.: First Trials of Cortisone in Ocular Therapeutics , Bull. Soc. opht. France 2:184, 1951. 599. (f) Bohringer, H. R., and Wettler, H.: Experiences with Local Cortisone Therapy , Von Graefes Arch. Ophth. 152:89, 1951.Crossref 600. (g) Southgate, P. T.: ACTH in Acute Recurrent Choroiditis , Eye, Ear, Nose & Throat Month. 30:47, 1951. 601. (h) Rubino, A., and Tiberi, G. F.: Cortisone and Corticotropin Therapy in Ophthalmology , Gior. ital. oftal. 4:329, 1951. 602. (i) Rouher, F.: Cortisone Instillation in Some Ocular Infections , Bull. Soc. opht. France 2:130, 1951. 603. (j) Meiffret, A.: A Case of Sympathetic Ophthalmitis Treated and Cured with ACTH , Bull. Soc. opht. France 2:189, 1951. 604. (k) Moutinho, H.: Inflammatory Ocular Lesions of Ethmoidal or Cryptogenic Origin: Surgical Therapeutics and Cortisone , Bol. Soc. port. oto-neuro-oftal. 1:19, 1951. 605. (l) Smith, V. L.: Bilateral Transverse Optic Neuritis: Report of Two Cases with Cortisone Therapy , A. M. A. Arch. Ophth. 46:363, 1951. 606. (m) Wammock, V. S.; Biderman, A. A., and Jordan, R. S.: Erythema Multiforme Exudativum (Stevens-Johnson Syndrome) , J. A. M. A. 147:637, 1951. 607. (n) Kristensen, H. P. O.: Case of Temporal Arteritis Treated with ACTH , Ugesk. læger 113:1353, 1951. 608. (o) Appelmans, M.; Michiels, J., and van Assche, E.: Rheumatic Polyarthritis and Keratoconjunctivitis Sicca and Cortisone , Ophthalmologica 122:337, 1951. 609. (p) Lavat: Cortisone in the Treatment of Phlyctenular Keratoconjunctivitis Semana méd. 27:1000, 1951. 610. (q) Irvine, S. R., and Irvine, M. D.: Effect of Cortisone on the Primary and Secondary Aqueous and on Corneal Vascularization in Rabbits , Bull. Johns Hopkins Hosp. 89:288, 1951. 611. (r) Ripps, J. H.: Cortisone for Canine Eye Infections , J. Am. Vet. M. A. 118:304, 1951. 612. (s) Hallett, J. W.; Leopold, I. H.; Vogel, A. W.; Cannon, E. J., and Steinmetz, C. C.: Treatment of Experimental Herpes Simplex Keratitis in the Rabbit , A. M. A. Arch. Ophth. 46:33, 1951.Crossref 613. (t) Hallett, J. W.; Leopold, I. H., and Steinmetz, C. C.: Effect of Systemic Cortisone and Corticotropin on Experimental Herpes Simplex Keratitis , A. M. A. Arch. Ophth. 46: 268, 1951.Crossref 614. (u) Thygeson, P.; Geller, H. O., and Schwartz, A.: Cortisone in Experimental Herpes Simplex Keratitis , Am. J. Ophth. 34:885, 1951. 615. (v) Ormsby, H. L.; Dempster, G., and Van Rooyen, C. E.: Effect of Cortisone on Experimental Induced Herpetic Keratitis in the Rabbit , Am. J. Ophth. 34:1687, 1951. 616. (w) Potter, W. B.: Cortisone Therapy in Anterior Segment Inflammation , Am. J. Ophth. 34:1650, 1951. 617. (x) Agatston, H.: Use of Cortisone in Ocular Conditions , Am. J. Ophth. 34:1655, 1951. 618. (y) Steffensen, E. H., and Kukora, J.: ACTH, Intermedin and Cortisone in the Treatment of Retinitis Pigmentosa , Am. J. Ophth. 34:1655, 1951. 619. (z) Johnsson, S., and Högberg, B.: Observations on the Connexion Between Intermedin and Adrenocorticotropic Hormone , Nature, London , 169:286, 1952.Crossref 620. (a) Gordon, D. M.; McLean, J. M.; Koteen, H.; Bousquet, F. P.; McCusker, W. D.; Baras, I.; Wetsig, P., and Norton, E. W. D.: Use of ACTH and Cortisone in Ophthalmology , Am. J. Ophth. 34:1670, 1951. 621. (b) Millikan, C. H., and Eaton, L. M.: Clinical Evaluation of ACTH and Cortisone in Myasthenia Gravis , Neurology 1:145, 1951.Crossref 622. (c) Torda, C., and Wolff, H. G.: Effects of Administration of Adrenal Corticotropic Hormone (ACTH) on Patients with Myasthenia Gravis , A. M. A. Arch. Neurol. & Psychiat. 66:163, 1951. 623. (d) Baggenstoss, A. H.; Shick, R. M., and Polley, H. F.: Cortisone in Periarteritis Nodosa , Am. J. Path. 25:537, 1951. 624. (e) Simpson, W. G.; Rosenblum, B. F.; Wood, C. E., and Stammer, E. L.: Local Cortisone Acetate Therapy in Congenital Syphilitic Interstitial Keratitis , J. Ven. Dis. Inform. 32:116, 1951. 625. (f) Torda, C., and Wolff, H. G.: Effects of Administration of ACTH on Patients with Myasthenia Gravis , in Mote, J. R.: Proceedings of the Second Clinical ACTH Conference , Philadelphia, The Blakiston Company, 1951, Vol. 2, p. 126. 626. (g) Smelser, G. K., and Ozanics, V.: Relation of Steroid Hormones to Development of Experimental Exophthalmos , Am. J. Ophth. 34:87, 1951. 627. (h) Fritz, A.: Action of Cortisone on the Ocular Capillaries , Bull. Soc. Beige opht. 97:160, 1951. 628. (i) Bourquin, J. B.: Effect of Cortisone on Experimental Inflammation of the Rabbit Anterior Chamber Caused by Sterile Talc Powder , Experientia 7:221, 1951. 629. (j) Goldman, L., and Richfield, D. F.: Effect of Corticotropin and Cortisone on Development and Progress of Pigmented Nevi , J. A. M. A. 147:941, 1951. 630. (k) Bottino, C.: The Blood-Aqueous Barrier and Luminous Stimuli , Ann. ottal. e clin. ocul. 77: 281, 1951. 631. (l) Ashton, N., and Cook, C.: Effect of Cortisone on Healing of Corneal Wounds Brit. J. Ophth. 35:708, 1951. 632. (m) Ashton, N.; Cook, C., and Langhan, M.: Effect of Cortisone on Vascularization and Opacification of Cornea Induced by Alloxan , Brit. J. Ophth. 35:718, 1951. 633. (n) Lister, A., and Greaves, D. P.: Effect of Cortisone on the Vascularization Which Follows Corneal Burns , Brit. J. Ophth. 35:725, 1951.Crossref 634. (o) Cook, C., and MacDonald, R. K.: Effect of Cortisone on the Permeability of the Blood-Aqueous Barrier to Fluorescein , Brit. J. Ophth. 35:730, 1951.Crossref 635. (p) Steen, A. S.: Effect of Cortisone on Tissue Cultures , Brit. J. Ophth. 35:741, 1951.Crossref 636. (q) von Sallmann, N. L.; Jones, I. S.; Wiggins, R. L., and Lokulosa, E. D.: Influence of Cortisone on Wound Healing, Macrophagocytosis, and Capillary Permeability , Wien. klin. Wchnschr. 63:684, 1951. 637. (r) Leopold, I. H.; Purnell, J. E.; Cannon, E. J.; Steinmetz, C. G., and McDonald, P. R.: Local Cortisone in Ophthalmology , Am. J. Ophth. 34:361, 1951. 638. (s) Fritz, A.: Study of the Effects of Cortisone on the Capillary Stream of the Eye , Bull. Soc. opht. France 2:153, 1951. 639. (t) Cordier, D.; Cordier, G., and Bavoux, M.: Changes in the Potassium Content of Aqueous Humor Caused by Experimental Traumatic Shock , Experientia 6:345, 1951.Crossref 640. (u) Lepri, G., and Montanari, L.: Action of Corticotropic Hormone, ACTH, of Desoxycorticosterone Acetate, and of Adrenal Cortex Extract on Contents of Hyaluronidase in the Aqueous Humor , Arch. ottal. 55:329, 1951. 641. (v) Simonelli, M., and Calamandrei, G.: Behavior of the Blood-Aqueous Barrier After the Administration of ACTH , Gior. ital. oftal. 4:340, 1951. 642. (w) Tarantino, C.: Presence of ACTH in the Placenta , Folia endocrinol. 4:197, 1951, 643. (y) Opsahl, J. C., and Long, C. N. H.: Identification of ACTH in Human Placental Tissue , Folia endocrinol. 24:199, 1952. 644. (z) Pelloja, M.: Role of Pituitary and Adrenal Glands in Inhibition of Hyaluronidase by Salicylates in Vivo , Lancet 1:733, 1952. 645. (a') Little, H. O.: Cortisone in a Perforating Eye Wound , Brit. J. Ophth. 35:790, 1951.Crossref 646. (a) Wood, R. M.: Effect of Cortisone and ACTH on Ocular Inflammation Secondary to the Injection of Irritant Substances , Bull. Johns Hopkins Hosp. 90:134, 1952. 647. (b) Clayton, B. E.; Hardesty, R. M., and Pinneger, J. L.: Studies on Antibody Formation to ACTH in Man , J. Endocrinol. 8:5, 1952. 648. Simpson and others.101e Woods.98a Pinkerton.98a' Horne.99b Kierland and others.99k Maddin and Danto.99l Beerman and others.99p Crawford.99u 649. Woods.98a Berens and Girand.98e McLean.98f Hill, Dennis, and Shannon.98g Paich-Szanto.98j Laws and Howard.98k Vesterdal.98l Duke-Elder and others.98w Perera and McLean.99a' Schwarz.99y Arruga.99z Meiffret.100j Agatston.100x 650. Millikan and Eaton.101b Torda and Wolff.101c 651. Bottino.101k Bourquin.101i Selye.32 von Sallmann and others.101q Leopold and others.101r Fritz.101s Wood.102a 652. Wood.102a Fritz.101h Ashten, Cook and Langhan.101m Lister and Greaves.101n von Sallmann and others.101q Leopold and others.101r Fritz.101s 653. Cook and MacDonald.101o von Sallmann and others.101q Leopold and others.101r Fritz.101s Simonelli and Calamandrei.101v Wood.102a 654. Wood.102a Ashtonand Cook.101l Steen.101p von Sallmann and others. 101q Leopold and others.101r 655. Leopold, I. H.: Autonomic Drugs: Their Influence on Choroidal Vessel Calber , Tr. Am. Ophth. Soc. 49:625, 1951. 656. Bergel, F.: Parasympathomimetics and Anticholinesterases , J. Pharm. & Pharmacol. 3:385, 1951. 657. Mazzella, H., and Minz, B.: Acetylcholine in the Aqueous Humor of the Rabbit Eye , Compt. rend. Soc. biol. 145:632, 1951. 658. McLennan, H., and Elliott, K. A. C.: Adenosine Diphosphate Concentration and the Synthesis of Acetylcholine by Brain Preparation , Arch. Biochem. 36:89, 1952. 659. Ing, H. R.; Kordick, P., and Tudor Williams, D. P. H.: Studies on the Structure Action Relationships of the Choline Group , Brit. J. Pharmacol. 7:103, 1952. 660. von Euler, U. S.: The Nature of Adrenergic Nerve Mediators , Pharmacol. Rev. 3:247, 1951 661. Arterenol-Adrenomedullary Hormone and Chemical Transmitter of Adrenergic Nerves , Ergebn. Physiol. 46:261, 1950.Crossref 662. Wakim, K. G., and Essex, H. E.: Comparison of the Circulatory Effects of Epinephrine and Norepinephrine , Circulatation 5:370, 1952.Crossref 663. West, G. B.: Nor-Adrenalin: A Depressor Action in the Normal Animal , J. Pharm. & Pharmacol. 3:340, 1951 664. Can Adrenaline Potentiate the Action of Noradrenaline? West J. Pharm. & Pharmacol. 3:571, 1951 665. Analysis of Pharmacopoeial Samples of Adrenaline, a Limit Test for Noradrenaline in Adrenaline , West J. Pharm. & Pharmacol. 4:95, 1952. 666. West, G. B.: Some Actions of Methylene Blue and of Mepyramine in the Body , J. Pharm. & Pharmacol. 3:656, 1951. 667. (b) Holmstedt, B.: Synthesis and Pharmacology of Dimethylamidoethoxy-Phosphoryl Cyanide (Tabun) , Acta physiol. scandinav. ( (Supp. 90) ) 25:11, 1951. 668. Schrader, G.: Development of New Insecticides on the Basis of Organic Fluorene and Phosphorus Compounds, Weinheim, Monographie zu Agnew Chemie, no. 62, 1951. 669. Hamblen, D. O., and Marchand, J. F.: Phosphate Ester Poisoning: A New Problem for the Internist , Ann. Int. Med. 36:50, 1952. 670. Douglas, W. W., and Matthews, P. B. C.: Acute Tetraethylpyrophosphate Poisoning in Cats and Its Modification by Atropine or Hyoscine , J. Physiol. 116:202, 1952. 671. Callaway, J.; Davies, D. R., and Rutland, J. P.: Blood Cholinesterase Levels and Range of Personal Variation in a Healthy Adult Population , Brit. M. J. 2:812, 1951. 672. Barnes, J. M., and Davies, D. R.: Blood Cholinesterase Levels in Workers Exposed to Organo-Phosphorus Insecticides , Brit. M. J. 2:816, 1951. 673. Dickens, P. F., Jr.; Rizzolo, J., and Bayliss, M. W.: Treatment of Nerve Gas Casualties , U. S. Armed Forces M. J. 2:1609, 1951. 674. Mouter, L. A.: Specificity of Cobra Venom Cholinesterase , Biochem. J. 50:122, 1951. 675. Reder, J. A.; Ellenwood, L. E., and Coon, J. M.: Tolerance to Octamethyl Pyrophosphoramide , Federation Proc. 11:386, 1952. 676. Koelle, G.: Types and Distributions of Cholinesterases in the Rabbit , Federation Proc. 11:363, 1952. 677. Whittaker, V. P.: Specificity Mode of Action and Distribution of CHE , Physiol. Rev. 31:312, 1951. 678. Kalow, W.: A Comparison of the Serum Cholinesterases of Man and Horse , Federation Proc. 11:360, 1952. 679. Brooks, V. B., and Myers, D. K.: Cholinesterase Content of Normal and Denervated Skeletal Muscle in the Guinea-Pig , J. Physiol. 116:158, 1952. 680. Kamijo, K., and Koelle, G. B.: Relationship Between Cholinesterase Inhibition and Ganglionic Transmission in the Cat , Federation Proc. 11:360, 1952. 681. Duke, H. N.; Pickford, M., and Watt, J. A.: The Immediate and Delayed Effect of DFP Injected into the Supraoptic Nuclei of Dogs , J. Physiol. 111:81, 1950. 682. Greig, M. E., and Mayberry, T. C.: Relationship Between Cholinesterase Activity and Brain Permeability , J. Pharmacol. & Exper. Therap. 102:1, 1951. 683. Hutchinson, A. O., and Widdowson, E. M.: Cholinesterase Activities in the Serum of Healthy British Children , Nature, London , 169:284, 1952. 684. Vorhaus, L. J.: Serum Cholinesterase in Health and Disease , Am. J. Med. 12:112, 1952. 685. DeRoetth, A., Jr.: Further Studies on Cholinesterase Activity in Ocular Tissues , Am. J. Ophth. 34:120, 1951. 686. Keele, C. A.: The Actions of Methonium Compounds with Special Reference to Paralysis of Autonomic Ganglia , Arch. Middlesex Hosp. 2:23, 1952. 687. Leopold, I. H.: Autonomic Drugs in Ophthalmology, read before the Chicago Ophthalmologic Society, Feb. 22, 1952. 688. Leopold, I. H.: Autonomic Drugs, read before the Pan-American Congress of Ophthalmology, Mexico, D. F., January, 1952. 689. Swan, K., and Gehrsitz, L.: Competitive Action of Myotics on the Iris Sphincter , A. M. A. Arch. Ophth. 46:477, 1951. 690. (a) Burns, B. D., and Paton, W. D. M.: Depolarization of the Motor End-Plate by Decamethonium and Acetylcholine , J. Physiol. 115:41, 1951. 691. (b) Taylor, D. B.: Some Basic Aspects of the Pharmacology of Synthetic Curariform Drugs , Pharmacol. Rev. 3:412, 1951. 692. (c) Paton, W. D. M., and Zaimis, E. J.: Actions and Clinical Assessment of Drugs Which Produce Neuromuscular Block , Lancet 1:568, 1950. 693. (d) Salama, A., and Wright, S.: Action in the Central Nervous System of Compounds RP3565 and RP3697 and of Tetramethyl Ammonium and Tetraethyl Ammonium , Brit. J. Pharmacol. 7:1: 1952 694. (e) Influence of Various Drugs on the Action of Curare on the Central System of the Cat , Salama Brit. J. Pharmacol. 7:14, 1952. 695. (f) Hey, P.: On Relationships Between Structure and Nicotine-Like Stimulant Activity in Choline Esters and Ethers , Brit. J. Pharmacol. 7:117, 1952. 696. (g) Kunkel, A. M.; Oikemus, A. H., and Wills, J. H.: Bis-Quarternary Aliphatic Compounds , Federation Proc. 11:365, 1952. 697. (h) Harvey, S. C.; Bankal, J. L.; Blaser, G.; Heaton, F. W., and Stewart, L. H.: Interrelation of Autonomic Ganglionic Effects of Hexamethylene-Bis-Hemethylammonium and Tetraethylammonium , Federation Proc. 11:355, 1952. 698. (i) Li, T. H.; Jacobs, B. R.; Aviado, D. M., Jr., and Schmidt, C. F.: Early Respiratory Depression by Curare and Curare-Potassium Antagonism , J. Pharmacol. & Exper. Therap. 104:149, 1952. 699. (j) Methonium Compounds in Hypertension, Letters to the Editor , Lancet 1:642, 1951. 700. (k) Hexamethonium Bitartrate, Letters to the Editor , Lancet 1:797, 1951. 701. (l) Douthwaite, A. H., and Thorne, M. G.: Effects of Hexamethonium Bromide on the Stomach , Brit. M. J. 1:111, 1951. 702. (m) Enderby, G. E. H., and Pelmore, J. F.: Controlled Hypotension and Postural Ischaemia to Reduce Bleeding in Surgery , Lancet 1:663, 1951. 703. (n) Bromism on Law-Salt Diets, Letters to the Editor , Enderby Lancet 1:347, 1951. 704. (o) Paton, W. D. M., and Perry, W. L. M.: Pharmacology of Toxiferines , Brit. J. Pharmacol. 6:299, 1951. 705. Greenafest, H.; Nachmansohn, D.; Kao, C. Y., and Chambers, R.: Mode of Blocking of Axonal Activity by Curare and Inhibitors of Acetyl Cholinesterase , Nature, London 169:190, 1952. 706. Margolin, S.; Doyle, M.; Giblin, J.; Makovsky, A.; Sprerlein, M. T.; Stephens, I.; Berchtold, H.; Belloff, G., and Tislow, R.: Pharmacological Properties of a New Parasympathetic Blocking Agent, N,N-Dimethyl 4-Piperidylidene 1,1 Diphenylmethane Methyl Sulfate (Prantal) , Proc. Soc. Exper. Biol. & Med. 78:576, 1951 707. Kiess, R. D., and Fralick, F. B.: A Preliminary Report on a New Cycloplegic and Mydriatic Drug , Am. J. Ophth. 34:1593, 1952. 708. Priestley, B. S., and Medine, M. M.: New Mydriatic and Cycloplegic Drug , Am. J. Ophth. 34:572, 1951. 709. Feldman, J. B.: Lachesine (E3) , Am. J. Ophth. 34:442, 1951. 710. Drucker, A. P., and Kazort, R. J.: Clinical Trial of a New Atropine-Like Drug , Am. J. Ophth. 34:847, 1951. 711. Gettes, B., and Leopold, I. H.: Cholinergic Blocking Agents in Ophthalmology, read before the Fourth Wills Hospital Clinical Conference, March 22, 1952. 712. Herzog, H.: Additional Comment Regarding Toxic Manifestations After the Application of Scopolamine Ointment to the Eye , Klin. monatsbl. Augenh. 118:636, 1951. 713. Brown, H. S.; Reekie, R. D., and Sinclair, W. J.: Acute Herpes Zoster Treated with Banthine , Northwest Med. 50:432, 1951. 714. Tuede, K. M., and Cahea, R. L.: Action of Atropine on Sympathetic Ganglia , Federation Proc. 11:398, 1952. 715. Reiter, C.: A New Synergistic Mydriatic Combination , Am. J. Ophth. 35:412, 1952. 716. Rycroft, B. W., and Romanes, G. J.: Preliminary Report on the Use of Methonium Compounds and General Anesthesia in Ophthalmic Surgery , Brit. J. Ophth. 36:29, 1952. 717. Berger, P. S.; Nathanson, M., and Bender, M. B.: Electrical Recordings of Normal and Abnormal Eye Movements Modified by Drugs , A. M. A. Arch. Neurol. & Psychiat. 67:357, 1952. 718. Bender, M. B.; Nathanson, M., and Green, M.: Effect of Intravenous Tolserol in Normal and Abnormal Ocular Movements , Am. J. Ophth. 34:579, 1951. 719. Burn, J. H., and Robinson, J.: Noradrenalin and Adrenaline in Vessels of the Rabbit Ear in Relation to Action of Amine Oxidase , Brit. J. Pharmacol. 6:101, 1951. 720. Robinson, J.: Amine Oxidase in the Iris and Nictitating Membrane of the Cat and the Rabbit , Brit. J. Pharmacol. 7:99, 1952. 721. Thompson, R. H. S., and Tickner, A.: Amine Oxidase in the Large and Small Arteries and Veins of the Rabbit , J. Physiol. 115:34, 1951. 722. Thompson, R. H. S., and Tickner, A.: The Occurrence and Distribution of Monoamine-Oxidase in Blood Vessels , J. Physiol. 115:34, 1951. 723. Spink, A., and Burn, J. H.: Thyroid Activity and Amine Oxidase in the Liver , Brit. J. Pharmacol. 7:93, 1952. 724. Fink, A. I.: The Inhibition of Thiamine Chloride on the Retinal Responses Caused by Nicotine , Am. J. Ophth. 34:139, 1951. 725. Iitsuka, T.: The Study of Micrometry of the Retinal Vessels , Acta Soc. Ophth. Jap. 55:170, 1951. 726. Henkes, H. E.: The Use of Electroretinography in Measuring the Effect of Vasodilatation , Angiology 2:125, 1951.Crossref 727. Bonamour, G.: The Choice and Method of Use of Vasodilators in Retinal Vascular Occlusions , Ann. ocul. 184:729, 1951. 728. Yamagishi, H.: The Effect of Physical Influences on the Retinal Arterial Blood Pressure , Acta Soc. ophth. jap. 55:197, 1951. 729. Iwanaga, T.: Effects of the Nitrite Group on the Caliber of the Retinal Vessels , Acta Soc. ophth. jap. 55:178, 1951. 730. Ferrata, L.: Action of Vasoconstrictors and Angioscotometry , Ann. ottal. e clin. ocul. 77:115, 1951. 731. Zahn, K.: Influence of Nicotinic Acid on Angioscotomata , Ceskoslav. ofth. 7:407, 1951. 732. (a) Stern, J. J.: Priscoline, a New Vasodilator , Am. J. Ophth. 35:187, 1952. 733. (b) Cholst, M. R.; Schilback, H. F.; Handelsman, M. B., and Levitt, L. M.: Retinal Response to Priscoline , Am. J. Ophth. 35:191, 1952 734. (c) Response of the Retinal Vessels to Priscoline in Diabetes Mellitus , Cholst Am. J. Ophth. 35:375, 1952. 735. (d) Frank, N.; Strazza, J. A., Jr., and Helsber, J. T.: Effects of Priscol in Treatment of Peripheral Vascular Diseases , Ann. Int. Med. 35:19, 1951.Crossref 736. (e) Selecka, I.: Priscol in Therapy of Degenerative Myopia , Českoslov. ofth. 7:209, 1951. 737. (f) Zarrabi, M.: Observations on Priscol in Ophthalmology , Ophthalmologica 122:76, 1951.Crossref 738. (g) Gallois, J.: Acute Glaucoma Following Priscol Administration , Bull. Soc. ophth. France 2:131, 1951. 739. Frede, R.: Use of Priscol in Chronic Eye Disease with Particular Reference to Intravitreous Injection , Med. Klin. 46:519, 1951. 740. Rosenman, R. H.; Freed, S. C., and Friedman, M.: The Peripheral Vascular Reactivity of Potassium Deficient Rats , Circulation 5:412, 1952.Crossref 741. Friedman, M.; Freed, S. C., and Rosenman, R. H.: Effect of Potassium Administration on (1) Peripheral Vascular Reactivity and (2) Blood Pressure of the Potassium Deficient Rat , Circulation 5:415, 1952.Crossref 742. Coston, T. O.: Ocular Symptoms of Stellate Ganglion Block , Am. J. Ophth. 34:1289, 1951. 743. (a) Scott, D. H.: Stellate Ganglion Block for Cerebrovascular Accident Involving Homonymous Hemianopsia , A. M. A. Arch. Ophth. 45:471, 1951.Crossref 744. (b) Leriche, R.: Treatment of Embolism and Thrombosis of the Cerebral Vessels , Brit. M. J. 1:231, 1952.Crossref 745. (c) Vascular Spasm, editorial , Leriche Brit. M. J. 1:93, 1952.Crossref 746. Page, I. H., and McCubbin, J. W.: Influence of Thyroidal Function on Vascular Reactivity in Dogs , Circulation 5:390, 1952.Crossref 747. Page, I. H.: Humoral and Vasomotor Controls of Blood Vessels , Bull. New York Acad. Med. 28:131, 1952. 748. Sayne, H. W.; Scheinberg, P.; Rich, M., and Belle, M. S.: Effect of Intravenous Papaverine Hydrochloride on the Cerebral Circulation , J. Clin. Invest. 31:111, 1952.Crossref 749. (a) Shenkin, H. A.: Effect of Various Drugs Upon Cerebral Circulation and Metabolism of Man , J. Appl. Physiol. 3:465, 1951. 750. (b) Morita, S.: Experimental Studies of the Relation Between the Pituitary Body and Intraocular Pressure , Acta Soc. Ophth. Jap. 55:134, 1951. 751. (c) Goodwin, R. C.: Changes in the Intraocular Pressure in Normal and Glaucomatous Eyes Following Furmethide , Am. J. Ophth. 34:1139, 1951. 752. Lourie, E. M.: Pharmacological Effects of Some Derivatives of Furan and Choline , Brit. J. Pharmacol. 7:130, 1952. 753. Grewal, R. S.: Methyl Furmethide , Brit. J. Pharmacol. 6:696, 1951. 754. Iselle, R.: Synthetic Miotic TS219 , Českoslov. ofth. 7:174, 1951. 755. Radnot, M.: Effect of Hormones in Cases of Glaucoma , Szemészet ophth. Hungary 88:114, 1951. 756. Treumer, K.: Treatment of Glaucoma with Lutein Hormone , Klin. Monatsbl. Augenh. 118:644, 1951. 757. Davson, H., and Matchett, P. A.: The Control of the Intraocular Pressure in the Rabbit , J. Physiol. 113:387, 1951. 758. Eidelman, V. M.: The Comparative Action of Carbachol, Pilocarpine, E. serin and Proserine on the Intraocular Tension , Vestnik. oftal. 30:34, 1951. 759. van Alphen, G. W. H. M., and Stokvis, B.: Psychosomatic Aspects of Intraocular Pressure , Nederl. tijdschr. geneesk. 95:2246, 1951. 760. Keasling, H. H.; Featherstone, R. M.; Schueler, F. W., and Gross, E. G.: Further Observations on Anesthetization of Rabbit's Cornea by Non-Surface Anesthetics , Proc Soc. Exper. Biol. & Med. 77:31, 1951. 761. Grieg, M. B.; Holland, W. C., and Lindvig, P. E.: Anesthetization of the Rabbit's Cornea by Nonsurface Anesthetics , Brit. J. Pharmacol. 5:461, 1950. 762. Apter, J. G.: Significance of the Unilateral Argyll Robinson Pupil, read before the Chicago Ophthalmological Society, Jan. 21, 1952. 763. Karp, M., and Sokol, J.: Intravenous Use of Alcohol in a Surgical Patient , J. A. M. A. 146:21, 1951. 764. (a) Seegers, W. H.: Influence of Certain Drugs on Blood Coagulation and Related Phenomena , Pharmacol. Rev. 3:278, 1951. 765. (b) Wright, I. S.: Pathogenesis and Treatment of Thrombosis , Circulation 5:161, 1952.Crossref 766. (c) Rehbein, A.; Jaretski, A., and Habif, D. V.: Response of Dicoumarol-Induced Hypoprothrombinemia to Vitamin K , Ann. Surg. 135:454, 1952.Crossref 767. (d) Gruber, C. M.; Lee, K. S., and Rieders, F.: Absorption, Distribution and Activity of Tromexan , Federation Proc. 11:352, 1952. 768. (e) Stirling, M., and Hunter, R. B.: Pharmacology of Bis 3-3'-(4 Oxycoumarinyl) Ethyl Acetate (Tromexan) , Lancet 2:611, 1951.Crossref 769. (f) Mangieri, C. N.; Engelberg, R., and Randall, L. O.: The Heparin-Like Activity of a New Anticoagulant, Treburon , J. Pharmacol. & Exper. Therap. 102:156, 1951. 770. (g) Lituras, J.; Vorzuner, J. J.; Sussman, L. N.; Applezweig, M., and Etiss, A. D.: Sublingual Administration of Heparin , Proc. Soc. Exper. Biol. & Med. 77:325, 1951. 771. (h) Manchester, B.; Sageman, C. B.; Rabkin, B., and Hill, E. B.: Experience with the New Anticoagulant Paritol C , Ann. West. Med. & Surg. 6:209, 1952. 772. (i) Hour, G. W.; Armbrust, C. A., Jr.; Levy, M. D., and Wagner, E. L.: Preliminary Report of the Antirheumatic Action of Heparin and Paritol C , Am. J. M. Sc. 223:258, 1952. 773. (j) Glick, D., and Sylvén, B.: Evidence for the Heparin Nature of the Nonspecific Hyaluronidase Inhibitor in Tissue Extracts and Blood Serum , Science 113:388, 1951. 774. (k) Crane, C.: Use of Heparin-Gelatin-Dextrose in Venous Thrombosis and Pulmonary Embolism , New England J. Med. 245:926, 1951. 775. (l) Cartasegna, F.: Treatment of Thrombosis of the Retinal Veins with Dicoumarol , Rass. ital. ottal. 20:153, 1951. 776. (m) Gasparri, F.: Anticoagulant Treatment in Venous Thrombosis of the Retina , Boll. ocul. 30:309, 1951. 777. (n) Wellman, E. W., and Allen, E. B.: Variable Effects of Identical Amounts of Dicoumarol on Prothrombin Values of Different Persons , Proc. Staff Meet., Mayo Clin. 26:257, 1951. 778. (o) Tullock, J. A., and Gilchrist, A. R.: Tromexan in the Treatment of Coronary Thrombosis , Am. Heart J. 42:864, 1951. 779. (p) Antibiotics and Blood Coagulation, editorial , New England J. Med. 246:240, 1952. 780. (q) Long, C. N.: Antibiotics and Blood Coagulation , J. A. M. A. 142:49, 1950. 781. (r) Macht, D. I.: Influence of Some Drugs and of Emotions on Blood Coagulation , J. A. M. A. 148:265, 1952. 782. (s) Duff, I. F.; Falls, H. F., and Linman, J. W.: Anticoagulant Therapy in Occlusive Vascular Disease of the Retina , A. M. A. Arch. Ophth. 46:601, 1951. 783. (t) Zwiauer, A., and Deutsch, E.: Influence of the Prothrombin Level on the Coagulation of Albumin in the Aqueous of the Anterior Chamber , von Graefes Arch. Ophth. 151:744, 1951. 784. (u) Elrod, P. D.; McCleery, R. S., and Ball, C. O. T.: An Experimental Study of the Effect of Heparin on Survival Time Following Lethal Burns , Surg. Gynec. & Obst. 92:35, 1951. 785. (v) Zwiauer, A.; Bornschein, H., and Deutsch, E.: Effect of Anticoagulants on the Clotting in the Plasmoid Fluid and Its Significance for the Intraocular Pressure , Am. J. Ophth. 34:1403, 1951. 786. (w) Hanson, H.; Mann, F., and Barker, N. W.: Clinical Experience with Anticoagulant No. 63 , Circulation 4:844, 1951.Crossref 787. (x) Coon, R. W.; Flynn, J. E., and Vassar, P. S.: In Vivo and in Vitro Effects of a Lipid Inhibitor of Blood Clotting , Federation Proc. 10:352, 1951. 788. (y) Barker, N. W.; Hanson, H. H., and Mann, F. D.: Bishydroxycoumarin, Ethyl Biscoumacetate and 4-Hydroxycoumarin Anticoagulant No. 63 , J. A. M. A. 148:274, 1952.Crossref 789. (z) Overman, R. S.; Sorenson, C. W., and Wright, I. S.: Effectiveness of Synthetic Water-Soluble Vitamin K Preparations in Bishydroxycoumarin-Induced Hypoprothrombinemia , J. A. M. A. 145:393, 1951.Crossref 790. (a') Watkin, D. M.; Van Italie, T. B.; Logan, W. B.; Geyer, R. P.; Davidson, C. J., and Stone, F. J.: Treatment of Dicoumarol-Induced Hypoprothrombinemia in Man with Emulsified Vitamin K, Administered Intravenously , J. Lab. & Clin. Med. 37:269, 1951. 791. Wright.174b Rehbein, Jaretski, and Habif.174c Gruber, Lee, and Rieders.174d Stirling and Hunter.174e Mangieri, Engelberg, and Randall.174f Lituras and others.174g Manchester and others.174h Crane.174k Cartasegna.174l Gasparri.174m Tullock and Gilchrist.174o Duff, Falls, and Linman.174s 792. Wright.174b Coon, Flynn, and Vassar.174x 793. Watkin and others.174a' Rehbein and others 174c Overman, Sorenson and Wright.174z 794. Zwiauer and Deutsch.174t Zwiauer, Bornschein, and Deutsch.174v 795. (a) Spoerl, E.: The Lethal Effects of Radiation , Scient. Am. 185:22 ( (Dec.) ) 1951. 796. (b) Wolf, B. S.: Mechanism of Biological Effects of Radiation , J. Mt. Sinai Hosp. 18:330, 1952. 797. (c) Hempelman, L. H.; Lisco, H., and Hoffman, J. G.: The Acute Radiation Syndrome , Ann. Int. Med. 36:279, 1952. 798. (d) Christenberry, K. W., and Furth, J.: Induction of Cataracts in Mice by Slow Neutrons and X-Rays , Proc. Soc. Exper. Biol. & Med. 77:559, 1951. 799. (e) Cogan, D. G., and Donaldson, D. D.: Experimental Radiation Cataracts , A. M. A. Arch. Ophth. 45:508, 1951. 800. (f) Cogan, D. G.; Donaldson, D. D., and Reese, A. B.: Clinical and Pathological Characteristics of Radiation Cataract , A. M. A. Arch. Ophth. 47:53, 1952. 801. (g) Kimura, S. J., and Ikui, H.: Atomic Bomb Radiation Cataract , Am. J. Ophth. 34:811, 1951. 802. (h) Rabinowitz, A.: Medical Aspects of the Atomic Bomb , South African M. J. 25:488, 1951. 803. (i) von Sallmann, L.; Munoz, C. M., and Barr, E.: Experimental Studies on Early Lens Changes After Roentgen Irradiation , A. M. A. Arch. Ophth. 47:305, 1952. 804. (j) von Sallmann, L.; Dische, Z.; Ehrlich, G., and Munoz, C. M.: Study on Penetration of Cysteine and Cystine into the Aqueous Humor of Rabbits and Its Relation to Early X-Irradiation Effects on the Eye , Am. J. Ophth. 34:95, 1951. 805. (k) von Sallmann, L., and Munoz, C. M.: Further Efforts to Influence X-Ray Cataract by Chemical Agents , A. M. A. Arch. Ophth. 47:21, 1952. 806. (l) Slepyan, A. H., and Cornbleet, T.: Cysteine as a Local Protective to Human Skin Against X-Rays , A. M. A. Arch. Dermat. & Syph. 64:425, 1951. 807. (m) Trovati, E.: Visual Disturbances and Temporary Ophthalmoscopic Changes in Children After Cranial Roentgen Therapy for Ringworm , Ann. ottal. e clin. ocul. 77:127, 1951. 808. (n) Brattgard, S. O.: The Study of the Effects of X-Ray on the Ganglionic Cells of the Retina , Nord. med. 46:1422, 1951. 809. (o) Barber, A. N.; Brauer, R. W., and Muelling, R. J., Jr.: Studies on the Effects of Beta Irradiation Applied Circumferentially to the Ciliary Body of Rabbits , Am. J. Ophth. 34:175, (May (Pt. 2) ) 1951. 810. (p) Paufique, L.; Papillon, J., and Guinet, P.: Roentgen Therapy of Edematous Exophthalmos Without Hyperthyroidism , J. radiol. et. electrol. 32:21, 1951. 811. (q) Salerno, P. R.; Mattis, P. A., and Friedell, H. L.: Administration of Pharmacological Agents as a Protective Measure Against Lethal Effects of X-Irradiation in Mice , Federation Proc. 11:387, 1952. 812. (r) Burnett, W. T., Jr.; Stapleton, G. E.; Morse, M. L., and Hollaender, A.: Reduction of X-Ray Sensitivity of Escherichia Coli B/r by Sulfhydryl Compounds, Alcohols, Glycols, and Sodium Hydrosulfite , Proc. Soc. Exper. Biol. & Med. 77:636, 1951. 813. (s) Kahn, J. B., Jr.: Modification of Sensitivity to X-Irradiation by Morphine Sulfate , Proc. Soc. Exper. Biol. & Med. 78:486, 1951. 814. (t) Jacobson, L. O., and Robson, M. J.: Factors Affecting X-Ray Inhibition of Antibody Formation , J. Lab. & Clin. Med. 39:169, 1952. 815. (u) Burn, J. H.; Kordik, P., and Mole, R. H.: The Effect of X-Irradiation on the Response of the Intestine to Acetyl Choline and on Its Content of Pseudo-Cholinesterase , Brit. J. Pharmacol. 7:58, 1952. 816. (v) Anderson, C. T.; Blaschko, H.; Burn, J. H., and Mole, R. H.: Influence of X-Irradiation on Response of the Intestine , Brit. J. Pharmacol. 6:342, 1951. 817. (w) Roberts, J. E.: Some Clinical Applications of Radioactive Isotopes , Arch. Middlesex Hosp. 1:219, 1951. 818. (x) Mitchell, J. S.: Practical Aspects of Radioactive Isotopes in Relation to Medical Treatment , Brit. M. J. 2:747, 1951. 819. (y) Wormall, A.: Theoretical Aspects of Isotopes in Relation to Medicine , Brit. M. J. 2:757, 1951. 820. (z) Duffy, B. F., Jr., and Howland, J. W.: Radiophosphorus (P-32) in Diagnosis and Treatment , New York J. Med. 52:551, 1952. 821. (a') Thomas, C. I.; Krohmer, J. S., and Storaasli, J. P.: Detection of Intraocular Tumors with Radioactive Phosphorus , A. M. A. Arch. Ophth. 47:276, 1952. 822. (b') Eisenberg, J.; Sklaroff, D.; Leopold, I. H., and Hallett, J.: Radioactive Isotopes in the Differential Diagnosis of Intraocular Tumors, read before the Monthly Wills Hospital Conference, February, 1952. 823. (c') Chou, S. N.; Aust, J. B.; Moore, G. E., and Payton, W. P.: Radioactive Iodinated Human Serum Albumin as Tracer Agent for Diagnosing and Localizing Intracranial Lesions , Proc. Soc. Exper. Biol. & Med. 77:193, 1951. 824. (d') Moore, G. E.; Caudill, C. M.; Marvin, J. F., and others: Clinical and Experimental Studies of Intracranial Tumors with Fluorescein Dyes: With an Additional Note Concerning the Possible Use of K42 and Iodine 133 Tagged Human Albumin , Am. J. Roentgenol. 66:1, 1951. 825. (a) Fitzgerald, P. J.: Radioautography in Cancer , Cancer 5:166, 1952. 826. (b) Mayneord, W. V.: Radiography of the Human Body with Radioactive Isotopes , Lancet 1:276, 1952. 827. Footnote deleted. 828. Kass, I.: Studies on the in Vitro Effects of Radioactive 1-131 Labeled 3,5 Diiodoparaminosalicylic Acid on the Tubercle Bacillus , Am. Rev. Tuberc. 65:316, 1952. 829. Schurr, P. H.: Angiography of the Normal Ophthalmic Artery and Choroidal Plexus of the Eye , Brit. J. Ophth. 35:473, 1951. 830. Falls, H. F.; Bassett, R. C., and Lamberts, A. E.: Ocular Complications Encountered in Intracranial Arteriography , A. M. A. Arch. Ophth. 45:623, 1951. 831. di Luca, G.: Observations of Sympathetic Ophthalmitis from the Clinical and Therapeutic Point of View with Special Reference to X-Ray Therapy , Boll. ocul. 33:54, 1951. 832. (a) Belz and Bouchel: Ultrasound Therapy in Hemorrhage of the Vitreous , Lyon Med. 184:187, 1951. 833. (b) Belz: Ultrasonics in Ophthalmology , Ann. ocul. 184:673, 1951. 834. (a) Hallermann, W.; Basch, A., and Ladeburg, H.: The Effect of Ultrasonic Waves on the Animal Eye , Klin. Monatsbl. Augenh. 119:401, 1951. 835. (b) Krusen, H.: Present Status of the Use of Ultrasonic Energy in Physical Medicine , South. M. J. 45:55, 1952.Crossref 836. Lavine, C.; Langenstrass, K. H.; Bowyer, C. M.; Fox, S. E.; Griffin, G. B., and Thaler, W.: Effect of Ultrasonic Waves on the Refractive Media of the Eye , A. M. A. Arch. Ophth. 47:204, 1952.Crossref 837. (a) Barraquer-Moner, J. I.: The Present State of Tissue Therapy in Ophthalmology , Arch. soc. oftal. hispano-am. 11:837, 1951. 838. (b) Lijó Pavia, J., and Arouh, J.: Biogeno-Therapy in Ophthalmology , Rev. oto-neuro-oftal. 26:73, 1951. 839. (c) Arouh, J., and Lijó Pavia, J.: Biogenic Treatment in Ophthalmology , Arch. oftal. Buenos Aires 26:131, 1951. 840. (d) Karaz, Z.: Tissue Therapy in Ophthalmology , Oto-neuro-oftal. 6:42, 1951. 841. (e) Kriz, R.: Our Experience with Placental Extract , Českoslov. Ofth. 7:105, 1951. 842. (f) Wei, C. H.; Pai, H. L., and Yamazaki: Final Report on Cases Treated with Tissue Therapy , Chinese J. Ophth. 1:184, 1951. 843. (g) LeGrand, J.: Limitations of Tissue Therapy , Bull. Soc. opht. France 1:92, 1951. 844. (h) LeGroux, R.: Acute Hypertony After Placental Implantations in a Case of Retinitis Pigmentosa , Bull. Soc. opht. France 1:46, 1951 845. (i) Placental Implants: Therapeutic Results , LeGroux Bull. Soc. opht. France 1:47, 1951. 846. (j) Oudot, N.: Tissue Therapy in Some Cases of Severe Keratitis , Bull. Soc. opht. France 1:88, 1951. 847. (k) Macki, E. G.: Placental Implantations for Retinitis Pigmentosa , Proc. Soc. Med. 44:977, 1951. 848. (l) Bourdier, F.: The Use of Reticuloendothelial Sero-Therapy in Ophthalmology , Ann. ocul. 184:769, 1951. 849. (m) Azzolini, U., and Faldi, S.: Oidiumycine-101 in Ocular Therapy , Arch. ottal. 55:285, 1951. 850. (n) Granirer, L. W.: Clinical Response of Rheumatoid Arthritis to Postpartum Plasma: A Two-Year Study , J. A. M. A. 146:995, 1951.Crossref 851. (o) Dillon, R. N., and Majnarich, J. J.: Placental Extract in Treatment of Rheumatoid Arthritis , Northwest Med. 56:77, 1951. 852. (p) Stewart, H. L., Jr.: Hormone Secretion by Human Placenta Grown in the Eyes of Rabbits , Am. J. Obst. & Gynec. 61:990, 1951. 853. (q) Gaba, V.; Skacel, J., and Sabata, J.: Treatment of Eye Diseases with Refrigerated Autogenous Blood , Českoslov. ofth. 7:271, 1951. 854. Opsahl, Long, and Fry.65c Tarantino.101w Opsahl and Long.101y Pelloja.101z Granirer.189n Dillon and Majnarich.189o Stewart.189p 855. Johnson, E. A.: Intravenous Morphine in Ocular Surgery , Canad. M. A. J. 64:429, 1951. 856. (a) Farquharson, H.: Curare with Local Anesthesia in Cataract Surgery , Am. J. Ophth. 34:554, 1951. 857. (b) Cordes, F. C., and Mullen, R. S.: The Use of Curare in Cataract Surgery , Am. J. Ophth. 34:557, 1951. 858. (c) Escuin Vera, J. M.: Curare: One Thousand Cases of Administration in Ocular Surgery , Día méd. 23:64, 1951. 859. (d) Barraquer Moner, J.: Curare in Ocular Surgery , Presse méd. 59:1078, 1951. 860. (e) Curare in Ophthalmic Surgery , Arch. Soc. oftal. hispano-am. 11:683, 1951. 861. (f) Patterson, R. L.: The Use of Muscle Relaxing Drugs in Anesthesia , Anesth. & Analg. 31:65, 1952. 862. Offenbach, B.: Trichlorethylene as an Analgesic in Ophthalmic Practice , Am. J. Ophth. 35:250, 1952. 863. Scharf, J., and Grethe, H.: The Use of Trichlorethylene for Inhalation Analgesia in Ophthalmology , Klin. Monatsbl. Augenh. 119:49, 1951. 864. Leffingwell, F. E.: Office Practice of Anesthesia , J. A. M. A. 148:1181, 1952. 865. Deming, M. N.: Agents and Techniques for Induction of Anesthesia in Infants and Young Children , Anesth. & Analg. 31:113, 1952. 866. Good, M. G.: Theory of Local Anesthesia , Anesth. & Analg. 31:120, 1952. 867. (a) Moore, D. C.: Pontocaine Solutions for Regional Analgesia Other Than Spinal and Epidural Block , J. A. M. A. 146:803, 1951. 868. (b) Bonica, J. J.: Use of Pontocaine for Regional Anesthesia , Anesth. & Analg. 30:76, 1951. 869. Sadove, M. S.; Wyant, G. M.; Gittelson, L. A., and Kretchmer, H. E.: Classification and Management of Reactions to Local Anesthesic Agents , J. A. M. A. 148:17, 1952. 870. Ludenna, F. P., and Hoppe, J. O.: Local Anesthetic Activity, Toxicity and Irritancy of 2-Alkoxy Analogs of Procaine and Tetracaine , J. Pharmacol. & Exper. Therap. 104:40, 1952. 871. Thiel, R.: Corneal Injury Through Misuse of Analgesics , Deutsche med. Wchnschr. 76:278, 1951. 872. Lane, C. G., and Luikart, R.: Dermatitis from Local Anesthetics , J. A. M. A. 146:717, 1951.Crossref 873. Weisel, W., and Tela, R. A.: Reaction to Tetracaine (Pontocaine) Used as a Topical Anesthetic in Bronchoscopy , J. A. M. A. 147:218, 1951.Crossref 874. Ireland, P. E.; Fergusson, J. K. W., and Stark, E. G.: Clinical and Experimental Comparison of Cocaine and Pontocaine as Topical Anesthetics in Otolaryngological Practice , Laryngoscope 61:767, 1951.Crossref 875. Young, P. A.: Duration of Cocaine Anesthesia in the Rabbit Cornea , Brit. J. Pharmacol. 60:73, 1951. 876. Tullar, P. E.: Local Anesthetic Studies with Procaine and Xylocaine , Federation Proc. 11:398, 1952. 877. Sadove, M. S.; Wynant, G. M.; Kretchmer, H. E., and Gittelson, L. A.: Procaine Amide: A Clinical Study , Anesth. & Analg. 31:45, 1952. 878. Fellows, E., and Mackoe, J. P.: Topical Anesthetic Activity of an Isoquinoline Compound , J. Pharmacol. & Exper. Therap. 103:306, 1951. 879. Cullen, S. C., and Gross, E. G.: The Anesthetic Properties of Xenon in Animals and Human Beings with Additional Observations on Krypton , Science 113:580, 1951. 880. Winter, C. A., and Flataker, L.: The Effect of Cortisone, Desoxycorticosterone and ACTH on the Response of Animals to Analgesic Drugs , J. Pharmacol. & Exper. Therap. 103:93, 1951. 881. Kalow, W.: Hydrolysis of Local Anesthetics by Human Serum Cholinesterase , J. Pharmacol. & Exper. Therap. 104:122, 1952. 882. Kennedy, R. J., and McGannon, W. J.: Stellate Ganglion Block in Retinitis Pigmentosa , A. M. A. Arch. Ophth. 47:287, 1952. 883. Coston.158 Scott. 159a Leriche.159b Editorial.159c 884. Pollin, I. M., and Deutsch, E. V.: Death Following Stellate Ganglion Block , Ann. Surg. 133:232, 1951. 885. Cohen, E. N., and Beecher, H. K.: Narcotics in Preanesthetic Medication , J. A. M. A. 147:1664, 1951. 886. (a) Freis, E. D.: Veratrum Viride and Hexamethonium in the Treatment of Severe Diastolic Hypertension , M. Ann. District of Columbia 20:297, 1951. 887. (b) Schroeder, A. A.: Effects of (1) Hydrazinophthalozine in Neurogenic Hypertension, read before the 24th Scientific Sessions of the American Heart Association, Atlantic City, June 8, 1951. 888. (c) Page, I. H.: Treatment of Essential Malignant Hypertension , J. A. M. A. 147:1311, 1951. 889. (d) Corcoran, A. C.; Taylor, R. D., and Page, I. H.: Controlled Observations on Effect of Low-Sodium Dieto-Therapy in Essential Hypertension , Circulation 3:1, 1951. 890. (e) Smirk, F. H.: Methonium Halides in High Blood Pressure , Science 114:4, 1951. 891. (f) Taylor, R. D.; Page, I. H., and Corcoran, A. C.: A Hormonal Neurogenic Vasopressor Mechanism , A. M. A. Arch. Int. Med. 88:1, 1951. 892. (g) Hormonal Cerebral Vasopressor Substance, editorial , J. A. M. A. 146:1326, 1951. 893. (h) Campbell, A. J. M.; Graham, J. G., and Maxwell, R. D. H.: Treatment of Hypertension by Oral Methonium Compounds , Brit. M. J. 1:251, 1952. 894. (i) Murphy, E. A.: Treatment of Hypertension with Hexamethonium Bromide , Lancet 2:899, 1951.Crossref 895. (j) Smirk, F. H., and Alstad, K. S.: Treatment of Arterial Hypertension by Penta- and Hexamethonium Salts , Brit. M. J. 1:1217, 1951.Crossref 896. (k) Peersson, I.: Treatment of Arterial Hypertension with Hexamethonium Bromide , Nord. med. 46:1564, 1951. 897. (l) Mackey, W. A., and Shaws, G. B.: Oral Hexamethonium Bromide in Essential Hypertension , Brit. M. J. 2:259, 1951.Crossref 898. (m) Shapiro, A. P., and Ferris, E. B.: The Effects of Intravenously Administered Veratrum Viride in Hypertension and Normotensive Subjects , Ann. Int. Med. 36:792, 1952.Crossref 899. (n) Anderson, W. B.: Fundus Changes Before and After the Rice Diet , Tr. Am. Acad. Ophth. 55:627, 1951. 900. (o) Rice, T. B.: Low-Sodium Diet: A Manual for the Patient , Philadelphia, Lea & Febiger, 1951. 901. (p) Loofbourow, D. G.; Callahan, D., and Palmer, R. S.: A Rice Diet in Ambulatory Patients with Essential Hypertension: A Two-Year Study of 105 Patients , New England J. Med. 244:577, 1951.Crossref 902. (q) Wolferth, C. C.; Jeffers, W. A.; Lukens, F. D. W., and others: Observations on Results of Subtotal Adrenalectomy in Treatment of Severe, Otherwise Intractable Hypertension and Their Bearing on Mechanism by Which Hypertension is Maintained , Ann. Int. Med. 35:8, 1951.Crossref 903. (r) Borsook, H., and Borsook, M. E.: Biochemical Basis of Betaine-Glycocyamine Therapy , Ann. West. Med. & Surg. 5:825, 1951. 904. (s) Graybiel, A., and Patterson, C. A.: Use of Betaine-Glycocyamine in Treatment of Patients with Heart Disease , Ann. West. Med. & Surg. 5:863, 1951. 905. (t) Feinberg, A. W., and Rosenberg, B.: Use of Carboxylic Cation Exchange Resins in Therapy of Congestive Heart Failure , Am. Heart J. 42:698, 1951. 906. (u) Wood, J. E., Jr.; Ferguson, D. H., and Lawrence, T.: Cation Exchange Resins as an Adjunct in Treatment of Heart Failure , J. A. M. A. 148:820, 1952. 907. (v) McChesney, E. W.; Dock, W., and Tainter, M. L.: Ion Exchange Resins in Edema , Medicine 30:183, 1951. 908. (w) Nickel, J. F.; Lowrance, P., and Leifer, E.: Effect of Sodium Depletion and Repletion on Renal Function and Body Fluids During Uremia , J. Clin. Invest. 30:664, 1951. 909. (x) Martz, B. L.; Kohlstaedt, K. G., and Heiner, O. M.: Use of a Combination of Anion and Cation Exchange Resins in the Treatment of Edema and Ascites , Circulation 5:524, 1952. 910. (y) Danowski, T. S.; Greenman, L.; Reters, J. H., and Mateer, F. M.: An Introduction to Experimental and Clinical Studies of Carboxylic Cation Exchange Resins , J. Clin. Invest. 30:979, 1951. 911. (z) Duncan, C. F.: Theory and Practice of Ion Exchange , Nature, London 169:22, 1952. 912. Lippman, R. W.: Cation Exchange Resin in Treatment of Nephrotic Syndrome , A. M. A. Arch. Int. Med. 88:9, 1951. 913. Chapman, D. W.; Pannill, F. C., Jr., and Skaggs, R. H.: New Cation Exchange Resins in Therapy of Edematous States , Am. Pract. & Digest. Treat. 2:945, 1951. 914. Emerson, K., Jr.; Conn, S. S.; Vester, J. W., and Nelson, K. P.: Oral Use of Cation Exchange Resins in Treatment of Edema , A. M. A. Arch. Int. Med. 88:605, 1951. 915. McChesney, E. W.; Dock, W., and Tainter, M. L.: Ion Exchange Resins in Edema , Medecine 30:183, 1951.Crossref 916. Flanagan, T. L.; Sax, M. F., and Heming, A. E.: Toxicity Studies on Amberlite XE-96, A Carboxylic Type Cation Exchange Resin , J. Pharmacol. & Exper. Therap. 103:215, 1951. 917. McChesney, E. W.: Studies on Cation Exchange Resins , J. Lab. & Clin. Med. 38:199, 1951. 918. Lee, R. E., and Holze, E. A.: Peripheral Vascular Hemodynamics in Bulbar Conjunctiva of Subjects with Hypertensive Vascular Disease , J. Clin. Invest. 30:539, 1951. 919. Schlezinger, N. S.: Present Status of Therapy in Myasthenia Gravis , J. A. M. A. 148:508, 1952. 920. Holmes Sellors, T.: Surgery of the Thymus Gland and Myasthenia Gravis , Arch. Middlesex Hosp. 2:1, 1952. 921. Kemp Harper, R. H.: The Investigation of Thymic Tumors in Myasthenia Gravis , J. Fac. Radiologists 3:164, 1952. 922. McKeever, G. E.: Myasthenia Gravis in a Mother and a Newborn Son , J. A. M. A. 147:320, 1951. 923. Botelho, S.; Deaterly, C. F., and Comroe, J. H., Jr.: Electromyogram from Orbicularis Oculi in Normal Persons and in Patient with Myasthenia Gravis , A. M. A. Arch. Neurol. & Psychiat. 67:348, 1952. 924. (a) Chaikoff, I. L., and Chernick, S. S.: Significance of Endogenous Cholesterol in Arteriosclerosis , Science 113:47, 1951. 925. (b) Blood Lipids in Atherosclerosis, editorial , J. A. M. A. 148:207, 1952. 926. (c) Keyes, A.: (Cholesterol Giant Molecules) in Atherosclerosis , J. A. M. A. 147:1514, 1951. 927. (d) McMahon, A.; Allen, H. N.; Weber, C. J., and Missey, W. C., Jr.: Hypercholesterolemia , South. M. J. 44:993, 1950. 928. (e) Stampler, J., and Katz, L. M.: Effect of Pancreatectomy on Lipemia, Tissue Lipidosis and Atherogenesis in Chicks , Circulation 4:255, 1951. 929. (f) Pollak, O. J., and Wadler, P.: Studies in Experimental Atherosclerosis , J. Gerontol. 6:217, 1951. 930. (g) Fredman, M.; Byers, S. O., and Rosenman, R. H.: Accumulation of Serum Cholate and Its Relationship to Hypercholesterinemia , Science 115:313, 1952. 931. (h) Wilmot, V. A., and Swank, R. L.: The Influence of Low-Fat Diet on Blood Lipid Levels in Health and in Multiple Sclerosis , Am. J. M. Sc. 223:25, 1952. 932. (i) Kellner, A.: Lipid Metabolism and Atherosclerosis , Bull. New York Acad. Med. 28:11, 1952. 933. (j) Priddle, W. W.: Hypercholesteremia , Ann. Int. Med. 35:836, 1951. 934. (k) Tuttle, E.: Dietary Cholesterol and Atherosclerosis , Geriatrics 7:37, 1952. 935. (1) Pollak, O. J.: Report on Current Trends in Arteriosclerosis Research , Geriatrics 7:59, 1952. 936. (m) Popkin, R. J.: Evaluation of Inositol in Treatment of Arteriosclerosis Obliterans , Angiology 2:398, 1951.Crossref 937. (n) Morrison, L. M.: Arteriosclerosis , J. A. M. A. 145:1232, 1951.Crossref 938. (o) Davidson, J. D.; Meyer, W., and Kendall, F. E.: Effect of Choline upon Experimental Canine Arteriosclerosis , Circulation 3:332, 1951.Crossref 939. (p) Gofman, J. W.; Lindgren, F. T.; Jones, H. B.; Lyon, T. P., and Strisower, B.: Lipoproteins and Atherosclerosis , J. Gerontol. 6:105, 1951.Crossref 940. (q) Gold, H.: Low Cholesterol Diet in the Treatment of Atherosclerosis , Am. J. Med. 12:357, 1952.Crossref 941. (r) Lindgren, F. T.; Elliott, H. H., and Gofman, J. W.: The Ultracentrifugal Characterization and Isolation of Human Blood Lipids and Lipoproteins with Applications to the Study of Atherosclerosis , J. Phys. & Colloid Chem. 55:80, 1951. 942. (s) Gofman, J. W., and Jones, H. B.: Obesity, Fat Metabolism and Cardiovascular Disease , Circulation 5:514, 1952. 943. (t) Pierce, F. I., Jr.: The Relationship of Serum Lipoproteins to Atherosclerosis in Cholesterol Fed Alloxanized Rabbit , Circulation 5:401, 1952. 944. (u) Steiner, A.; Kendall, F. E., and Mathers, J. A. L.: The Abnormal Serum Lipid Pattern in Patients with Coronary Arteriosclerosis , Circulation 5:605, 1952. 945. (v) Epstein, N. N.; Rosenman, R. H., and Gofman, J. W.: Serum Lipoproteins and Cholesterol Metabolism in Xanthelasma , A. M. A. Arch. Dermat. & Syph. 65:70, 1952. 946. (w) Van Itallie, B. T.; Waddell, W. R.; Geyer, R. P., and Stone, F. J.: Clinical Use of Fat Injected Intravenously , A. M. A. Arch. Int. Med. 89:353, 1952. 947. (x) Eggers, H.: Lipotropic Substances for the Absorption of Vitreous Opacities , New York. J. M. 51:2255, 1951. 948. Editorial.216b Kellner.216i Tuttle.216k Pollak.216l Gofman and others.216p Gold.216q Lindgren, Elliott, and Gofman.216r Gofman and Jones.216s Pierce.216t Steiner, Kendall, and Mathers.216u 949. Code, C. F.: Histamine in Blood , Physiol. Rev. 32:47, 1952. 950. Gaddum, J. H.: Metabolism of Histamine , Brit. M. J. 2:987, 1951. 951. Cuco, G.: Histamine and Permeability of the Blood-Eye Barrier , Ann. ottal. e clin. ocul. 77:118, 1951. 952. d'Ermo, F.: Ocular Changes in the Course of Anaphylactic Shock in the Guinea Pig and Rabbit , Acta allergol. 4:270, 1951. 953. Bowman, K. L.; Siegel, B. B., and Walzer, M.: Influence of a Single Dose of ACTH on the Atopic and Histamine Skin Reactions , J. Allergy 23:130, 1952. 954. Shure, N., and Harris, M. C.: Evaluation of Drugs Used in the Management of Allergy , M. Clin. North America 35:1543, 1951. 955. Azzolini, U., and Faldi, S.: Experimental Cataract Due to Synthetic Antihistaminic Drugs , Boll. ocul. 31:29, 1951. 956. (a) Leong Way, E., and Herbert, W. C.: Effect of Sodium Pentobarbital on the Toxicity of Certain Antihistaminics , J. Pharmacol. & Exper. Therap. 104:115, 1952. 957. (b) Wyngaarden, J. B., and Seevers, M. H.: Toxic Feature of Antihistaminics , J. A. M. A. 145:277, 1951. 958. (c) Lecks, H. I.: Acute Antihistamine Toxicity in Children , Quart. Rev. Pediat. 6:294, 1951. 959. Guerrant, J. L., and Hollifield, W. C.: Palpebral Dermatitis , Am. J. Ophth. 34:1318, 1951. 960. Komi, T.: Effect of Antihistaminic Drugs on the Rabbit Eye , Acta Soc. ophth. jap. 55:379, 1951. 961. d'Ermo, F., and Salvi, G. L.: Antihistaminic Drugs in the Eye , Boll. ocul. 30:3, 1951. 962. d'Ermo, F., and Santirocco, N.: Antihistaminic Drugs in the Eye , Boll. ocul. 30:99, 1951. 963. d'Ermo, F.: Antihistaminic Drugs in the Eye , Boll. ocul. 30:135, 1951. 964. Kulscher, A. H., and Chilton, H. W.: Effect of Antihistaminics on the Pain Threshold , Am. J. M. Sc. 223:239, 1952. 965. Moynahan, S. J.: Observations on the Effect of Antihistamine Drugs in the Reactions of the Skin Vessels to Carbaminoyl Choline , Brit. J. Dermat. 64:1, 1952. 966. Perry, D. T.; Hosmer, J. A., and Sternberg, T. H.: Urticarogenic Action of a Choline Ester Can be Modified or Obliterated by Antihistaminic Drugs , J. Invest. Dermat. 16:31, 1951. 967. (a) Chalmers, J. N. M.: Drug-Induced Blood Disease , Practitioner 168:235, 1952. 968. (b) Menzel, W., and Wilhoeft, I.: Hyperplastic Late Reaction of Blood-Forming Organs to Intoxication with Dichlor-Diethyl Sulfide (Mustard Gas) , Folia hæmat. 70:278, 1951. 969. (c) Modell, W., and Patterson, R.: Intestinal Bleeding Associated with Acetylsalicylic Acid , J. A. M. A. 147:124, 1951. 970. (d) Gelfand, M. L.: Visual Symptoms After Digitoxin Therapy , J. A. M. A. 147:1231, 1951. 971. (e) Cohen, B.: Digitalis Poisoning and Its Treatment , New England J. Med. 246:254 972. 225, 1952. 973. (f) Brooke, C., and Boggs, T.: Boric Acid Poisoning , A. M. A. Am. J. Dis. Child. 82:465, 1951. 974. (g) Slinger, W. N., and Hubbard, D. M.: Treatment of Seborrheic Dermatitis with a Shampoo Containing Selenium Sulfide , A. M. A. Arch. Dermat. & Syph. 64:41, 1951. 975. (h) Filatova, B. C.: Toxicity of Selenium Anhydride , Gigiena Sanit. 5:18, 1951. 976. (i) Ahlborg, G.: Hydrogen Sulfide Poisoning in Shale Oil Industry , A. M. A. Arch. Indust. Hyg. 3:247, 1951. 977. (j) Davidson, H. H.; Hingson, R. A., and Hellman, L. M.: Use of Various Plastic Catheters in the Subarachnoid and Peridural Spaces , A. M. A. Arch. Surg. 62:540, 1951.Crossref 978. (k) Ridley, H.: Intra-Ocular Acrylic Lenses: Recent Development in Surgery of the Cataract , Brit. J. Ophth. 36:113, 1952Crossref 979. (l) Tr. Ophth. Soc. U. Kingdom 71:617, 1951 980. (m) Intra-Ocular Acrylic Lenses After Cataract Extraction , Lancet 1:118, 1951. 981. (n) Vail, D.: Lint in the Anterior Chamber Following Intraocular Surgery , Am. J. Ophth. 34:1533, 1951. 982. (o) Enns, J. H.: Human Galactosemia Cataract , Am. J. Ophth. 34:1268, 1951. 983. (p) Reiter, C., and Lasky, M. A.: Galactose Cataractogenesis , Am. J. Ophth. 35:69, 1952. 984. (q) Falls, H. F.; Lowrey, G. H.; Anderson, W., and Glayton, C., Jr.: Galactosemia Cataract , Am. J. Ophth. 34:1271, 1951. 985. (r) Bellows, J.: Lens and Vitreous , A. M. A. Arch. Ophth. 47:516, 1952.Crossref 986. (s) Daily, L., Jr.; Zeller, E. A.; Wakin, J. G.; Herrick, J. F., and Benedict, W. L.: Microwaves and the Lens , Am. J. Ophth. 34:1301, 1951. 987. (t) Morillas, D.: Spastic Paraparesis and Bilateral Cataract Following an Electric Shock , Actas luso-españ. neurol. y psiquiat. 10:69, 1951. 988. (u) Habenberger: Change in the Fundus After a Lesion Due to a High-Frequency Current , Wien. klin. Wchnschr. 63:209, 1951. 989. (v) Lijo Pavia, J.: Radiations and the Ocular Alterations They Produce , Rev. oto-neuro-oftal. 26:25, 1951. 990. (w) Sykowski, P.: Ethylene Glycol Toxicity , Am. J. Ophth. 34:1599, 1951. 991. (x) di Ferdinando, R.: Lead Poisoning with Optic Neuritis Due to the Morocco Leather of the Patient's Hat , Gior. ital. oftal. 4:344, 1951. 992. (y) Roda, E.: Iritis of Unknown Cause Treated with Nitrogen Mustard , Arch. Soc. oftal. hispano-Am. 11:645. 1951. 993. (z) Jimenez Diaz, C.: Treatment of Dysreaction Diseases with Nitrogen Mustards , Ann. Rheumat. Dis. 10:144, 1951.Crossref 994. (a') Mitchell, R. G.: Laburnum Poisoning in Children , Lancet 2:57, 1951.Crossref 995. (b') Fink, A. I.: Carbon Monoxide Asphyxia with Visual Sequelae , Am. J. Ophth. 34:1024, 1951. 996. (c') Krejek, F.; Marlo, Z., and Soucek, B.: Experimental Carbon Disulfide Poisoning , Praktyka Lekanska, 1951, p. 124. 997. (d') Esente, I.: Ocular Manifestations in Acute Barbiturate Poisoning , Gior. ital. oftal. 4:162, 1951. 998. (e') Pagliarani, N.: Neuroocular Complications Due to Antirabic Vaccination , Riv. oto-neuro-oftal. 26:200, 1951. 999. (f') Sarkies, J. W. R.: Ophthalmoplegia Following a Scorpion Bite , Brit. J. Ophth. 35:502, 1951.Crossref 1000. (g') Roberts, A. E.: Platinosis: Five-Year Study of Effects of Soluble Platinum Salts on Employees in Platinum Laboratory and Refinery , A. M. A. Arch. Indust. Hyg. 4:549, 1951. 1001. Duffy, T. L., and Drehl, A. M.: Ferrous Sulfate Poisoning , J. Pediat. 40:1, 1952.Crossref 1002. Deichmann, W. B.; Pugliese, W., and Cassidy, J.: Effects of Dimethyl and Diethyl Paranitrophenyl Thiophosphate on Experimental Animals , A. M. A. Arch. Indust. Hyg. 5:44, 1952. 1003. Hamblin, D. O., and Marchand, J. F.: Parathion Poisoning , Am. Pract. & Digest Treat. 2:1, 1951. 1004. Bidstrup, P. L., and Payne, D. J. H.: Poisoning by Dinitro-Ortho-Cresol , Brit. M. J. 2:16, 1951. 1005. Aldridge, W. N., and Barnes, J. M.: Some Problems in Assessing Toxicity of the Organo-Phosphorus Insecticides Toward Mammals , Nature, London 169:345, 1952. 1006. Bergman, B. B.: Tetryl Toxicity , A. M. A. Arch. Indust. Hyg. 5:10, 1952. 1007. Morris, G. E.: Condensation Plastics , A. M. A. Arch. Indust. Hyg. 5:37, 1952. 1008. Schiff, B. L.: Contact Dermatitis Caused by Bamboo , A. M. A. Arch. Dermat. & Syph. 64:66, 1951. 1009. Van Ordstrand, H. S.: Beryllium Poisoning , Ann. Int. Med. 35:1203, 1951. 1010. White, M. R.; Finkel, A. J., and Schubert, J.: Protection Against Experimental Beryllium Poisoning of Aurin Tricarboxylic Acid , J. Pharmacol. & Exper. Therap. 102:88, 1951. 1011. Sterner, J. H., and Eisenbud, M.: Epidemiology of Beryllium Intoxication , A. M. A. Arch. Indust. Hyg. 4:123, 1951. 1012. Curtis, G. H.: Cutaneous Hypersensitivity Due to Beryllium , A. M. A. Arch. Dermat. & Syph. 64:470, 1951. 1013. Ginsberg, J. E., and Becker, L. A.: Silicon Granuloma of Skin Due to Traumatic Sand Inoculation , J. A. M. A. 147:751, 1951. 1014. Capri, A., and Alagna, G.: Action of Leucotaxin on the Cornea , Arch. ottal. 55:7, 1951. 1015. Leepton, C. H.: Treatment of Burns , J. Internat. Coll. Surgeons 17:354, 1952. 1016. Curtis, R. M.; Brewer, J. H., and Rose, I. W., Jr.: New Technique for Local Treatment of Burns , J. A. M. A. 147:741, 1951. 1017. Cruithirds, A. E.: Sulfhydryl Therapy in Ophthalmology: Progress Report , Ann. West. Med. & Surg. 5:554, 1951. 1018. McLaughlin, R. S.: Chemical Burns of the Eye , South. M. J. 44:446, 1951Crossref 1019. Hydrosulphosol as a Treatment of Chemical Burns of the Eye , Am. J. Ophth. 35:21, 1952. 1020. Harley, R. D.: An Experimental Study on the Evaluation of Hydrosulphosol in the Treatment of Ocular Injuries Due to Chemical Burns , Tr. Am. Ophth. Soc. 49:557, 1951. 1021. Strauss, J. S., and Rosenberg, E. J.: BAL Therapy of Gold Intoxication , Proc. Inst. Med. Chicago 18:330, 1951. 1022. Denny-Brown, D., and Porter, H.: Effect of BAL on Hepatolenticular Degeneration , Tr. Am. Neurol. A. , 1951. 1023. Cummings, J. N.: Effects of BAL in Hepatolenticular Degeneration , Brain 74:10, 1951.Crossref 1024. (a) Flaxman, N.: Drug Fatalities , J. A. M. A. 147:337, 1951. 1025. (b) The Use of New Drugs, editorial , Flaxman J. A. M. A. 147:62, 1951. 1026. Dunham, C. L.; Cronkite, E. P.; Leroy, G. V., and Warren, S.: Atomic Bomb Injury: Radiation, Council on National Emergency Medical Service , J. A. M. A. 147:50, 1951.Crossref 1027. Cady, L. D., and Miller, J. E.: A Symposium on Effects of Atomic Explosions , Mil. Surgeon 110:165, 1952. 1028. (a) Szewzzky, S. T.: Retrolental Fibroplasia: Etiology and Prophylaxis , Am. J. Ophth. 34:1649, 1951 1029. (b) Retrolental fibroplasia , Szewzzky Am. J. Ophth. 35:301, 1952. 1030. (c) Ingalls, T. H.; Tedeschi, C. G., and Helpern, M. M.: Malformations Induced by Maternal Anoxia , Am. J. Ophth. 35:311, 1952. 1031. (d) Ryan, H.: Retrolental Fibroplasia , Am. J. Ophth. 35:329, 1952. 1032. (e) Campbell, K.: Intensive Oxygen Therapy as a Possible Cause of Retrolental Fibroplasia , M. J. Australia 2:48, 1951. 1033. (f) Lelong, N.; Renard, G.; Rossier, A.; Lemasson, C., and Michelin, J.: The Retinopathy of Premature Infants , Presse. méd. 59:705, 1951. 1034. Lodato, G.: Experimental Retinitis Pigmentosa Due to Sodium Iodate in Albino Rabbits , Gior. ital. oftal. 4:226, 1951 1035. Experimental Pigmentary Degeneration of the Retina in Rabbits Undergoing Filatov's Treatment , Lodato Gior. ital. oftal. 4:125, 1951. 1036. Harrell, G. T., Jr., and Aikawa, J. K.: Alterations in Permeability of Membranes During Infections , J. A. M. A. 147:232, 1951.Crossref 1037. Trevor-Roper, T. D.: Present Status of Physiotherapy in Ocular Disease , Brit. J. Ophth. 35:583, 1951.Crossref 1038. Hoffmann, W.: A Lamp for the Ultraviolet Irradiation of the Anterior Segment of the Eye , Klin. Monatsbl. Augenh. 119:41, 1951. 1039. Paufique, L., and Rougier, J.: Treatment with Beta Rays in Ocular Disease , Ann. ocul. 184:577, 1951. 1040. Cutler, S. S.; Burbank, B., and Marzullo, E. R.: Hypocoagulability of Certain Irradiated Plasmas , J. A. M. A. 143:1057, 1950.Crossref 1041. Kaplan, S. R., and Freedman, I. A.: Effects of Ultraviolet Ray Irradiation on Clotting Mechanism of Plasma , J. A. M. A. 147:229, 1951.Crossref 1042. Rhoades, A. L.: Uveitis , Jackson Clin. Bull. 13: (Nov.) , 1951. 1043. Farmer, D. F.; Sullivan, C. P., and Sullivan, W. B.: The Use of Hemoirradiation (Knott Technique) in Eye Infections, at a meeting of the American Blood Irradiation Society, Atlantic City, N. J., June 9, 1951. 1044. (a) Wild, J. J., and Neal, D.: Use of High Frequency Ultrasonic Waves for Detecting Changes of Texture in Living Tissues , Lancet 1:655, 1951Crossref 1045. (b) Experimental Application of Ultrasonics to the Localization of Brain Tumors , J. Neurosurg. 8:198, 1951.Crossref 1046. (c) Ultrasonics in Diagnosis, editorial , J. A. M. A. 146:1033, 1951.Crossref 1047. Belz and Bouchel.186a Belz.186b Hallermann and others.187a Krusen.187b Lavine.188 1048. (a) Stuart, E. G.: Accelerating Effect of Pyromen in Contrast to Inhibitory Effect of Cortisone on Arthus Phenomenon in Rabbits , Federation Proc. 10:133, 1951 1049. (b) Accelerating Effect of Pyromen in Contrast to Inhibitory Effect of Cortisone on Arthritis Phenomenon in Rabbits , Am. J. M. Sc. 221:470, 1951.Crossref 1050. (c) Clemente, C. D.; Chambers, W. W.; Greene, L. C.; Mitchell, S. Q., and Windle, W. F.: Regeneration of the Transected Spinal Cord of Adult Cats , Anat. Rec. 109:280, 1951. 1051. (d) Zindler, G. A.: Pyromen therapy in the Treatment of Food Allergy , Ann. Allergy 9:494, 1951. 1052. (e) Wittich, F. W.: Pyromen in the Treatment of Perennial Respiratory Allergies , Ann. Allergy 9:502, 1951. 1053. (f) Clemente, C. D.: Production of Periods of Leukocytosis and Tolerance of Consecutive Oral Administration of Different Bacterial Pyrogens , Federation Proc. 10:27, 1951. 1054. (g) Soylemezogou, B., and Wells, J. A.: Comparison of Leukocyte Response to ACTH and Bacterial Pyrogen , Proc. Soc. Exper. Biol. & Med. 77:43, 1951. 1055. Alvis, V. Y.: The Role of Hyperpyrexia in the Management of Ocular Inflammatory Disease , Am. J. Ophth. 34:1741, 1951. 1056. Newell, F.: Foreign Protein Therapy in Ophthalmology , Am. J. Ophth. 34:1189, 1951. 1057. Wolffersdorff, H. V.: "Pyrifer" Therapy in Different Optic Nerve Affections in the Period 1939-1950 , Klin. Monatsbl. Augenh. 119:271, 1951. 1058. (a) Huck, H.: Usefulness of Fluorescein in Testing the Permeability of the Lachrymal Passage , Ophthalmologica 121:110, 1951. 1059. (b) Hager, H.: A Simple Apparatus for Fluorescein Measurements in the Anterior Chamber , Klin. Monatsbl. Augenh. 119:81, 1951. 1060. (c) Miller, S. J. H., and Swanljung, H.: Appearance of Fluorescein in the Aqueous of Glaucomatous Eyes , Brit. J. Ophth. 35:356, 1951. 1061. (a) Woods, A. C.: The Ocular Changes of Hyperthyroidism , West. J. Surg. 59:288, 1951. 1062. (b) Medine, M. M.: Malignant Exophthalmos , Am. J. Ophth. 34:1587, 1951. 1063. (c) Beierwaltes, W. H.: Irradiation of the Pituitary in Treatment of Malignant Exophthalmos , J. Clin. Endocrinol. 11:512, 1951.Crossref 1064. (d) Van Manen, J. G.: Exophthalmic Ophthalmoplegia , Ophthamologica 122:207, 1951.Crossref 1065. (e) Hermann, K.: Pituitary Exophthalmos: An Assessment of Methods of Treatment , Brit. J. Ophth. 36:1, 1952.Crossref 1066. (f) Cope, O.: Diseases of the Thyroid , New England J. Med. 246:408; 368; 451, 1952.Crossref 1067. (g) Wing, E. S., and Asper, S. P., Jr.: Propyl Thiouracil in Hyperthyroidism , Bull. Johns Hopkins Hosp. 92:1, 1952. 1068. (h) Mann, I.: A Further Report on Exophthalmic Ophthalmoplegia and Its Relation to Thyrotoxicosis , Am. J. Ophth. 34:960, 1951. 1069. (i) Weekers, R., and Dedoyard, J.: Endocrine Exophthalmos , Boll. Soc. belge opht. 97:122, 1951. 1070. Asboe-Hansen, G., and Iversen, K.: Influence of Thyrotropic Hormone on Connective Tissue: Pathogenetic Significance of Mucopolysaccharides in Experimental Exophthalmos , Acta endocrinol. 8:90, 1951. 1071. Duffy, B. J., Jr., and Howland, J. W.: Radio-Iodine Principles of Diagnosis and Treatment of Thyroid Disease , New York J. Med. 51:1399, 1951. 1072. Portmann, U. V.; Hayes, R. A.; McCullagh, E. P., and Richards, C. E.: Experiences in Treatment of Diseases of Thyroid with Radioactive Iodine , Am. J. Roentgenol. 66:179, 1951. 1073. Scott, W. G.; Seaman, W. B.; MacBryde, C., and others: Observations and Results in Treatment of Hyperthyroidism with Radioactive Iodine (I-131) , Am. J. Roentgenol. 66:171, 1951. 1074. Crile, G., Jr., and McCullagh, E. B.: Treatment of Hyperthyroidism , Ann. Surg. 134:18, 1951.Crossref 1075. Barnum, D. I.; De Takets, G., and Dolkart, R. E.: Periarteritis Following Thiouracil Therapy of Hyperthyroidism , Angiology 2:256, 1951.Crossref 1076. Astwood, E. B.: Use of Antithyroid Drugs During Pregnancy , J. Clin. Endocrinol. 11:1045, 1951.Crossref 1077. Catz, B. D.; Petit, D. W., and Starr, P.: Sodium 5-Iodo-2-Thiouracil in Treatment of Hyperthyroidism , J. Clin. Endocrinol. 11:978, 1951.Crossref 1078. D'Angelo, S. A.; Paschkis, K. E.; Gordon, A. S., and Cantarow, A.: Thyroid-Thyrotropic Hormone Balance in the Blood of Normal and Endocrinopathic Individuals , J. Clin. Endocrinol. 11:1237, 1951.Crossref 1079. Okie, M. B.; Denee, H. B., and Daley, W.: Estradiol Implants and Postoperative Pituitary Exophthalmos , J. Internat. Coll. Surgeons 16:98, 1951. 1080. Francois, J.: Estrogen Therapy in Graves' Disease , Bull. Soc. belge opht. 97:194, 1951. 1081. Deziewiatowski, D. D.: Chondroitin Sulfate , J. Biol. Chem. 189: (a) 187 1082. (b) 717, 1951. 1083. Campbell, D. A.; Hay, K. M., and Tonks, E. M.: An Investigation of the Salt and Water Balance in Migraine , Brit. M. J. 2:1424, 1951.Crossref 1084. Simidu, S.: (a) On Treatment of True Migraine , Acta Soc. Ophth. Jap. 55:121, 1951 1085. (b) Migraine Therapy, Department of Pharmacy, Philadelphia College of Pharmacy and Science , Philadelphia Med. 47:905, 1952. 1086. Campbell, Hay, and Tonks.272 Simidu.273a Editorial.273b 1087. (a) Nettleship, A.: Chemotherapeutics of Cancer , Current M. Dig. 19:46, 1952. 1088. (b) Code, J.: Chemotherapy in the Treatment of Malignant Disease , Brit. M. J. 2:1193, 1949.Crossref 1089. (c) Haddow, A.: The Chemotherapy of Cancer , Practitioner 167:36, 1951. 1090. (d) Udupa, K. N.: Present Status of Chemotherapy in Certain Malignant Diseases , Antiseptic 49:126, 1952. 1091. (e) Inactive Compounds in Tumor Chemotherapy, Announcement , Cancer Res. 12:241, 1952. 1092. (f) Golden, A.; Greenspan, E. M., and Schoenbach, E. B.: Studies on the Mechanism of Action of Chemotherapeutic Agents in Cancer , Cancer 5:153, 1952.Crossref 1093. (g) Iversen, K., and Meulengracht, E.: Oral Treatment of Polycythema Vera with Beta-Naphthyl-Di-2-Chloroethylamine (R48) , Brit. M. J. 2:510, 1951.Crossref 1094. (h) Buckley, S. M.; Stock, C. C.; Crossley, M. L.; Rhoads, C. P.; Patti, J., and Sata, E. S.: Inhibition of Crocker Mouse Sarcoma , Cancer 5:142, 1952.Crossref 1095. (i) Bayrd, E. D.; Stickney, J. M.; Hall, B. E., and Watkins, C. H.: Clinical Observations on the Use of Triethylenemelamine , Cancer 5:336, 1952.Crossref 1096. (j) Karnofsky, D. H.; Burchenal, J. H.; Armistead, G. C., Jr.; Southam, C. M.; Bernstein, J. L.; Craver, L. F., and Rhoad, C. P.: Triethylene Melamine in the Treatment of Neoplastic Disease , A. M. A. Arch. Int. Med. 87:477, 1951.Crossref 1097. (k) Meyer, L. M.; Beyers, M. R.; Sawitsky, A.; Brahn, C., and Ritz, N. D.: Treatment of Lymphomata with Triethylene Melamine , Cancer Res. 11:268, 1951. 1098. (l) Nathanson, I. T., and Kelley, R. M.: Hormonal Treatment of Cancer , New England J. Med. 246:180, 1952Crossref 1099. 135, 1952. 1100. (m) Luttgens, W. F., and Bayard, E. D.: Treatment of Multiple Myeloma with Urethane , J. A. M. A. 147:824, 1951.Crossref 1101. (n) Silverberg, J. H., and Dameshek, W.: Use of Triethylene Melamine in Treatment of Leukemia and Leukosarcoma , J. A. M. A. 148:1015, 1952.Crossref 1102. (o) Oncolytic Action of Epinephrine, editorial , Silverberg J. A. M. A. 147:578, 1951. 1103. (p) Lewis, M. R., and Aptekman, P. M.: Inhibitory Action of Adrenal on Growth of Rat Sarcoma , Science 113:557, 1951.Crossref 1104. (a) Morrell, C., and Weinberg, J. A.: Streptokinase and Streptodornase in Suppurative Lesions , West. J. Surg. 59:524, 1951. 1105. (b) Mienster, J. T.; Fiance, I. J., and Sweeney, B.: Treatment of Unresolved Pneumonia with Streptokinase and Streptodornase , Am. J. Med. 12:376, 1952.Crossref 1106. (c) Sherry, S., and Tillett, W. S.: The Local Use of Streptokinase and Streptodornase in Chronic Refractory Areas of Suppuration with Draining Sinuses , Ann. Surg. 135:479, 1952.Crossref 1107. (d) Wright, L. T.; Smith, D. H.; Rothman, M.; Metzger, W. I., and Quash, E. T.: Use of Streptokinase-Dornase in Certain Surgical Conditions , J. Internat. Coll. Surgeons 15:286, 1951. 1108. (e) McVay, L. V., Jr., and Sprunt, D. H.: Streptokinase and Streptodornase in the Treatment of Diabetic Gangrene , A. M. A. Arch. Int. Med. 87:551, 1951.Crossref 1109. (f) Hubbard, W. M., Jr.: Systemic Toxic Responses of Patients to Treatment with Streptokinase, Streptodornase , J. Clin. Invest. 30:1171, 1951.Crossref 1110. (g) Adie, G. C., and Childress, W. G.: Experiences with Streptokinase and Streptodornase , Ann. Surg. 134:659, 1951.Crossref 1111. (h) Jukofsky, S. L.: A New Technique in the Treatment of Hyphemia , Am. J. Ophth. 34:1692, 1951. 1112. (i) Prevention of Operative Adhesions, editorial , J. A. M. A. 145:1138, 1951. 1113. Fastier, L. B.: Failure of Hyaluronidase to Influence Growth of Pr 8 Virus in Chick Embryos , J. Immunol. 66:1, 1951. 1114. Di Caprio, J. M.; Rantz, L. A., and Randall, E.: Studies on Streptococcal Hyaluronidase and Antihyluronidase , A. M. A. Arch. Int. Med. 89:374, 1952.Crossref 1115. Glassman, J. M.; Blumenthal, A.; Beckfield, W. J., and Seifter, J.: Effect of Hyaluronidase in Inflammatory Response to Primary Irritants , Federation Proc. 11:348, 1952. 1116. Ende, M.: Use of Hyaluronidase in Chronic Ulcers , South. M. J. 44:661, 1951.Crossref 1117. Dunnington, J. H., and Regan, E. F.: Ocular Wound Healing , Am. J. Ophth. 35:167, 1952. 1118. Tassman, I.; DeLong, and Hallett: Fibrin and Thrombin in Ocular Wound Healing: Histological Study, read before the Fourth Wills Clinical Conference, March 20, 1952. 1119. De Berardinis, E., and Bonavolontá, G.: Healing Activity of Some Amino Acids on Experimental Corneal Lesions and Their Influence on Corneal Metabolism , Gior. ital. oftal. 4:86, 1951. 1120. Swan, K. C.: Symposium: Corneal Diseases: Treatment , Tr. Am. Acad. Ophth. 55:387, 1951. 1121. Hind, H. W., and Goyan, F. M.: New Concept of the Role of Hydrogen Ion Concentration and Buffer Systems in Preparations of Ophthalmic Solutions , J. Am. Pharm. A. (Scient. Ed.) 36:33, 1947.Crossref 1122. Mims, J. L.: Methyl Cellulose Solution for Ophthalmic Use , A. M. A. Arch. Ophth. 46:644, 1951.Crossref 1123. Bell, R. P., Jr.: A New Ophthalmic Irrigating Solution , Am. J. Ophth. 34:1321, 1951. 1124. Schiller, A. A.: Rutin-Potientation of Epinephrine , Am. J. Physiol. 165:293, 1951. 1125. Ambrose, A.; Robbins, D. J., and DeEds, F.: Comparative Toxicities of Quercetin and Quercitrin , J. Am. Pharm. A. (Scient. Ed.) 41:119, 1952.Crossref 1126. Griffith, J. Q., Jr., and Couch, J. F.: Inhibition by Rutin of Capillary Injury by Alpha-Radiation in Rats , Blood 6:552, 1951. 1127. Arriga Cantullera, J.: Rutin and Bishydroxycoumarin in Ophthalmology , Arch. Soc. oftal. hispano-am. 11:373, 1951. 1128. Gördüren, S., and Tangun, A.: Rutin in Ophthalmology , Gáz. Klin. 9:55, 1951. 1129. Palmer, L. J.; Flaherty, N. F.; Crampton, J. H., and Johnson, R. H.: Influence of Rutin upon Diabetic Retinitis , Northwest Med. 56:69, 1951. 1130. Joslin, E. P.: Status of Living Diabetics with Onset Under 40 Years of Age , J. A. M. A. 147:209, 1951.Crossref 1131. Wilson, J. L.; Root, H. F., and Marble, A.: Prevention of Degenerative Vascular Lesions in Young Patients by Control of Diabetes , Am. J. M. Sc. 221:479, 1951.Crossref 1132. Lawrence, R. D.; Scott, G. I.; Ashton, N.; Whittington, T. H.; Martin, M. M., and Oakley, W. G.: Discussion on Diabetic Retinopathy , Proc. Roy. Soc. Med. 44:742, 1951. 1133. Sherrill, J. W.: Diabetic Retinitis , Bull. Scripps Metabolism Clinic 2: 1951. 1134. Spoont, S.; Dyer, W. W.; Day, R., and Balzer, H.: Incidence of Diabetic Retinopathy Relative to the Degree of Diabetic Control , Am. J. M. Sc. 221:490, 1951.Crossref 1135. Bell, E. T.: A Postmortem Study of 1,214 Diabetic Subjects with Special Reference to Vascular Lesions , Proc. Am. Diabetes A. 10:62, 1950. 1136. Sheppard, L. B.: Diabetic Retinopathy , Quart. Rev. Ophth. 7:3, 1951. 1137. Kennedy, R. J., and Kirschbaum, F. M.: Ocular Fundus Findings in 133 Cases of Diabetes Mellitus , Cleveland Clin. Quart. 18:134, 1951.Crossref 1138. Post, L. T., and Stickle, A. W., Jr.: Fundus Changes in Juvenile Diabetics , Am. J. Ophth. 34:1119, 1951. 1139. Panepinto, V.: Clinical and Anatomical Considerations in the Problem of Diabetic Retinopathy , Ann. ottal. e clin. ocul. 77:233, 1951. 1140. (a) Gronberg, A., and Svanteson, G.: Diabetic Retinopathy Improved by Gonadotrophic Hormones , Svenska läk-tidning. 48:2005, 1951. 1141. (b) Desvignes, P., and Sadoughi, G.: Trial of Treatment of Diabetic Retinitis with Lipocaic Hormone , Bull. Soc. opht. France 2:126, 1951. 1142. Saskin, E.; Waldman, S., and Pelner, L.: Diabetic Retinopathy , Am. J. Ophth. 34:613, 1951. 1143. Cholst, M. R.; Schilback, H. F.; Handelsman, M. B., and Levitt, L. M.: Response of Retinal Vessels to Priscoline in Various Vascular Conditions , Am. J. Ophth. 35:191, 1952. 1144. Cholst, M. R.; Schilback, H. F.; Handelsman, M. B., and Levitt, L. M.: Response of the Retinal Vessels to Priscoline in Diabetes Mellitus , Am. J. Ophth. 35:375, 1952 1145. Zubrod, C. G.; Eversole, S. L., and Dana, G. W.: Amelioration of Diabetes and Striking Rarity of Acidosis in Patients with Kimmelsteil-Wilson Lesions , New England J. Med. 245:518, 1951.Crossref 1146. Swallow, K. A., and Chute, A. L.: NPH Insulin , Canad M. A. J. 65:23, 1951. 1147. Jameson, M.; Lacey, A. H., and Fisher, A. M.: NPH Insulin , Canad M. A. J. 65:20, 1951. 1148. Rodriquez, R. R.: Influence of Diet and Insulin on the Incidence of Cataracts in Diabetic Rats , Yale J. Biol. & Med. 24:103, 1952. 1149. Hanbold, H.; Lackner, F., and Schmidt-Lecker: New Therapeutic Experiences with Emulsified Vitamin A , Med. Klin. 46:30, 1951. 1150. Niedermeier, S.: Medicinal Effect on Night Vision , Deutsche med. Wchnsch. 76:210, 1951. 1151. Dekking, H. M.: Chemical Influence of Retinal Functions , Acta physiol. et pharmacol. neerl. 2:141, 1951. 1152. Bair, G.: Chronic Vitamin A Poisoning , J. A. M. A. 146:1573, 1951. 1153. Sulzberger, M. B., and Lazar, M. P.: Hypervitaminosis, A , J. A. M. A. 146:788, 1951. 1154. Naz, J. F., and Edwards, W. M.: Hypervitaminosis A , New England J. Med. 246:87, 1952. 1155. Gribetz, D.; Silverman, S. H., and Sobel, A. E.: Vitamin A Poisoning , Pediatrics 7:372, 1951. 1156. Ojers, G. W., and Alfano, J.: Band Keratopathy in Disturbances of Calcium Metabolism , A. M. A. Arch. Ophth. 46:531, 1951. 1157. Chetwood, W. R., and Moore, C. D.: Anaphylactic Shock Following Intravenous Administration of Vitamin B Complex , J. A. M. A. 148:461, 1952. 1158. Pohlman, M. E., and Ritter, E. F., Jr.: Observations on Vitamin Deficiency , Am. J. Ophth. 35:228, 1952. 1159. Guha, G. S.: Role of Vitamins A, B and C in Affections of the Eye , Indian M. J. 45:949, 1951. 1160. Moren, A., and Pola, G.: Vitamin Therapy in Ophthalmology , Medicamenta 9:395, 1951. 1161. Bagnall, H. H., and Slock, F. G.: A Critical Account of the Spectrophotometric Estimation of Vitamin A , J. Pharm. & Pharmacol. 4:81, 1952. 1162. Simkova, M.: Influence of Local Treatment of Diseases of the Cornea with Vitamin B1 and B2 , Českoslov. ofth. 7:37, 1951. 1163. Edgerton, M. T.; Hanahan, E. M., and Davis, W. B., Use of Vitamin E in Treatment of Keloids , Plast. & Reconstruct. Surg. 8:224, 1951. 1164. Laupus, W., and Bousquet, F.: Retrolental Fibroplasia , A. M. A. Am. J. Dis. Child. 81:617, 1951. 1165. Dancis, J.; Lewis, J. M., and Guy, L. P.: Retrolental Fibroplasia: Statistical Study with Particular Reference to the Effect of Vitamin A , New England J. Med. 245:402, 1951. 1166. Kramer, B.; Gordon, S. M.; Berger, H. M., and Sobel, A. E.: Aqueous Dispersions of Vitamins A and D in Premature Infants , A. M. A. Am. J. Dis. Child. 82:17, 1951. 1167. Kinsey, V. E., and Crisholm, J. F.: Retrolental Fibroplasia: Evaluation of Several Changes of Dietary Supplements of Premature Infants with Respect to the Incidence of the Disease , Am. J. Ophth. 34:1259, 1951. 1168. Malatesta, C.: Histopathological Changes in the Eye in Experimental Avitaminosis E in Rats , Boll. ocul. 35:31, 1951. 1169. Stormont, R. T.: Pyridoxine Hydrochloride Vitamin B6 , J. A. M. A. 147:322, 1951.

Journal

A.M.A. Archives of OphthalmologyAmerican Medical Association

Published: Aug 1, 1952

References